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Schizophrenia is a complex and severe psychiatric disorder with positive symptoms, 
negative symptoms and cognitive deficits. Preclinical neurobiological studies showed 
that alterations of dopaminergic and glutamatergic neurotransmitter circuits 
involving the prefrontal cortex resulted in cognitive impairment such as working 
memory. Functional activation and functional connectivity findings of functional 
Magnetic Resonance Imaging (fMRI) data provided support for prefrontal 
dysfunction during fMRI working memory tasks in individuals with schizophrenia. 
However, these findings do not offer a neurobiological interpretation of the fMRI 
data. 
 
Biophysical modelling of functional large-scale networks has been designed for the 
analysis of fMRI data, which can be interpreted in a mechanistic way. This approach 
may enable the interpretation of fMRI data in terms of altered synaptic plasticity 
processes found in schizophrenia. One such process is gating mechanism, which has 
been shown to be altered for the thalamo-cortical and meso-cortical connection in 
schizophrenia. The primary aim of the thesis was to investigate altered synaptic 
plasticity and gating mechanisms with Dynamic Causal Modelling (DCM) within 
functional large-scale networks during two fMRI tasks in individuals with 
schizophrenia. 
 
Applying nonlinear DCM to the verbal fluency fMRI task of the Edinburgh High 
Risk Study, we showed that the connection strengths with nonlinear modulation for 
the thalamo-cortical connection was reduced in subjects at high familial risk of 
ii 
 
schizophrenia when compared to healthy controls. These results suggest that 
nonlinear DCM enables the investigation of altered synaptic plasticity and gating 
mechanism from fMRI data.  
 
For the Scottish Family Mental Health Study, we reported two different optimal 
linear models for individuals with established schizophrenia (EST) and healthy 
controls during working memory function. We suggested that this result may indicate 
that EST and healthy controls used different functional large-scale networks. The 
results of nonlinear DCM analyses may suggest that gating mechanism was intact in 
EST and healthy controls.  
 
In conclusion, the results presented in this thesis give evidence for the role of 
synaptic plasticity processes as assessed in functional large-scale networks during 
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Summary of organisation of thesis 
This thesis considers the analysis of functional large-scale networks with effective 
connectivity to fMRI data in individuals with schizophrenia. Nonlinear DCM for 
fMRI has been applied to examine hypothesised differences in effective connectivity 
between (i) individuals at high genetic risk of schizophrenia and healthy controls (as 
part of the Edinburgh High Risk Study) and between (ii) individuals with established 
schizophrenia and healthy controls (as part of the Scottish Family Mental Health 
Study). 
 
In chapter 1, functional activation and functional connectivity findings of working 
memory fMRI and Positron Emission Tomography studies in individuals with 
schizophrenia and healthy controls are summarised. These findings are discussed in 
context of the dopamine hypothesis of schizophrenia and the glutamate hypothesis of 
schizophrenia. 
 
Effective connectivity findings of working memory fMRI studies in individuals with 
schizophrenia and healthy controls as assessed with DCM are discussed in chapter 2. 
It is considered to what extent effective connectivity findings may increase the 
interpretability of functional large-scale networks in comparison to functional 
connectivity findings.    
 
In chapter 3, a protocol for the application of nonlinear DCM has been applied to the 
verbal fluency task in individuals at high genetic risk of schizophrenia and healthy 
controls as part of the Edinburgh High Risk Study. The main result was that effective 
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connectivity measures were significantly different of effective connectivity measures 
between high risk subjects and healthy controls, which may extend the previous 
functional connectivity findings. 
 
For the Scottish Family Mental Health Study, the developed protocol for the 
application of nonlinear DCM was adapted for the working memory task in 
individuals with established schizophrenia and healthy controls (chapter 4). The main 
result was that individuals with established schizophrenia used a different functional 
network for the working memory function than healthy controls. 
 
Finally, chapter 5 summarises and discusses the key findings to what extend these 
findings from the Edinburgh High Risk Study and the Scottish Family Mental Health 
Study may lead to a better insight into functional large-scale networks underlying 
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1.1 General introduction to the thesis 
Schizophrenia is a debilitating mental disorder, which is characterised by with 
positive symptoms, negative symptoms and cognitive deficits. Evidence from 
preclinical neurobiological studies showed that alterations of dopaminergic and 
glutamatergic neurotransmitter circuits involving the prefrontal cortex (PFC) resulted 
in cognitive deficits such as working memory. Functional activation (FA) and 
functional connectivity (FC) findings presented evidence for cortical impairment 
during fMRI working memory tasks in individuals with schizophrenia. However, 
these findings cannot be interpreted in neurobiological context. 
 
Dynamic Causal Modelling (DCM) for fMRI has been developed for the biophysical 
modelling of functional large-scale networks of fMRI data. This method may enable 
the indirect assessment and interpretation of fMRI data in terms of altered synaptic 
plasticity processes (via learning during a specific experimental task). One 
neurobiological process, which has been proposed to underlie learning processes, is 
gating control or gating mechanism. In preclinical and computational studies is has 
been shown that gating mechanism is altered for the thalamo-cortical and/or meso-
cortical connection in schizophrenia. The first overall aim of the thesis was to model 
connection strengths with nonlinear modulation, which may be interpreted as an 
indirect measure for gating mechanism during two fMRI tasks in individuals with 
schizophrenia. The second overall aim was to investigate, whether hypothesised 
altered cortical function or a compensation to impaired function may be found in 
individuals with schizophrenia when compared to healthy controls. 
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We applied nonlinear DCM to the Hayling sentence completion task (HSCT) fMRI 
task as part of the Edinburgh High Risk Study (EHRS). The HSCT is an established 
clinical tool for the assessment of PFC impairment (Burgess and Shallice et al., 
1996). The application of DCM for the assessment of (nonlinear) effective 
connectivity (EC) measures to the HSCT task builds on previously published FA 
findings (Whalley et al., 2004) and FC (Whalley et al., 2005); thus, the DCM 
analyses can be seen as an extension to these findings. We focused on the 
investigation of connection strengths with nonlinear modulation of the thalamo-
cortical connection. 
 
We used nonlinear DCM to test hypothesised altered (nonlinear) EC measures during 
the “N-Back” working memory task in individuals with established schizophrenia 
(EST) and healthy controls as part of the (Scottish Family Mental Health Study, 
SFMHS). In this, we examined the connection strengths with nonlinear modulation 
of the meso-cortical connection. 
 
We interpreted the findings of nonlinear EC measures of both studies in the context 
of (i) a possible indirect measure for gating mechanism; and (ii) an indication for 
altered cortical function or a compensatory process to impaired prefrontal function in 
individuals with schizophrenia when compared to healthy controls. In summary, the 
results presented in this PhD thesis suggest that synaptic plasticity processes (via 
learning processes) as indirectly assessed in functional large-scale networks during 
two cognitive tasks may be an underlying mechanism of prefrontal impairment or 
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compensatory mechanism in individuals with schizophrenia when compared to 
healthy controls. 
 
1.1.1 Overall aims 
There were two overall aims of the thesis, which applied to the modelling of 
functional large-scale networks with DCM for the EHRS and the SFMHS. The first 
aim was to assess nonlinear EC measures, which may be interpreted as an indirect 
measure for gating mechanism during two fMRI tasks in a given model in 
individuals with schizophrenia. The second overall aim was to examine possibly 
altered cortical function or compensation to impaired function during the two fMRI 
tasks in individuals with schizophrenia in contrast to healthy controls. 
 
We present the main hypotheses separately for the EHRS and the SFMHS due to the 
different cognitive tasks modelled and different study populations of individuals with 
schizophrenia. 
For the EHRS, we hypothesised that subjects at high familial risk of schizophrenia 
would show altered (nonlinear) EC measures between the mediodorsal (MD) 
thalamus and the inferior frontal gyrus (IFG) when compared to healthy controls, 
which may be an indirect indication of disrupted synaptic plasticity and gating 
mechanisms of the thalamo-cortical connection. This disruption of learning during 
the HSCT could be understood as a possible and indirect measure of a 
neurobiological process of altered prefrontal dysfunction during the HSCT, which 




For the SFMHS, we assumed that EST would display altered connection strengths 
with nonlinear modulation between the dorsolateral (DL)PFC and the ventral 
tegmental area (VTA) during the working memory “N-Back” task in contrast to 
healthy controls. Such an alteration during the “N-Back” task may indirectly 
resemble altered gating mechanism underlying prefrontal dysfunction or 
compensation to dysfunctional prefrontal function for the given experimental task 
and brain function in the modelled networks. 
 
1.1.2 Dynamic Causal Modelling 
DCM is a modelling framework for neuroimaging data (such as fMRI and 
electrophysiological data), which assesses neurobiophysiologically interpretable 
dynamic system models (Friston et al., 2003). In DCM for fMRI, these dynamic 
system models are fitted to fMRI data to provide estimates of connection strengths 
within a given model.  
Nonlinear DCM as an extension has been devised to indirectly measure gating 
mechanisms at the neuronal level that provides a more precise estimation of how the 
rate of change of activity in one region influences the rate of change in other regions 
(Stephan et al., 2008). It has been proposed that gating mechanisms (i.e. nonlinear 
modulation of neuronal connections) originate from activity-dependent synaptic 
plasticity processes (Abbot et al., 1997; Salinas and Sejnowski, 2001) and may 
underlie cortical dysconnectivity in schizophrenia (thalamo-cortical connection, 
Negyessy and Goldman-Rakic, 2005; meso-cortical connection, Wang et al., 2010). 
We selected DCM to measure EC in functional large-scale networks as part of the 
EHRS and the SMFHS in order to indirectly assess synaptic plasticity in a 
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hypothesis-driven way. In this, we devised a heuristic search protocol (chapter 
3.4.5.2) to systematically assess EC measures and build the model space based on 
published research findings. Lastly, we selected DCM8 version (instead of newer 
DCM10 or DCM12 versions) to avoid the risk of unstable results. 
It is noted that the assessment of synaptic plasticity processes via learning can only 
be considered indirect due to several factors and under certain conditions. For 
example, the limited temporal resolution of fMRI (Friston et al., 2003; Roiser et al., 
2013) to measure biophysical mechanisms from EPI time series (Daunizeau et al., 
2011a; Friston et al., 2012); and the lack of direct concentrations of dopamine (DA) or 
glutamate (Glu) do not allow the direct measurement of synaptic plasticity. 
Furthermore, the systematic testing of EC measures of task-dependent modulation can 
only be considered for the specific experimental task modelled and in a given model. 
We point out that EC findings cannot be interpreted as changes of neurotransmitter 
systems underlying the experimental task due to the lack of direct measurements of DA 
and Glu in the specific neuronal population. Thus, neuropsychological and 
neurocognitive interpretations must be considered in context of modelling of functional 
large-scale network findings. 
 
1.1.3 Outline of the thesis 
The PhD thesis considers the application of DCM for fMRI data in individuals with 
schizophrenia. Bilinear and nonlinear DCM has been used to investigate 
hypothesised alterations in EC measures between (i) individuals at high familial risk 
of schizophrenia and healthy controls (as part of the EHRS); and (ii) EST and 
healthy controls (as part of the SFMHS). 
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In chapter 1, FA and FC findings of working memory fMRI and Positron Emission 
Tomography (PET) studies in individuals with schizophrenia and healthy controls 
are summarised. These findings are discussed in context of the dopamine hypothesis 
of schizophrenia and the glutamate hypothesis of schizophrenia. 
 
In chapter 2, different methods for the assessment of EC and 
advantages/disadvantages of DCM in specific are discussed. EC findings of working 
memory fMRI studies in individuals with schizophrenia and healthy controls as 
assessed with DCM are reviewed. We consider to what extent EC findings may 
increase the interpretability of functional large-scale networks in comparison to FC 
findings.    
 
In chapter 3, a heuristic search protocol for the application of nonlinear DCM has 
been applied to the verbal fluency task in individuals at high genetic risk of 
schizophrenia and healthy controls (as part of the EHRS). The main result was that 
EC measures were significantly different between high risk subjects and healthy 
controls, which may extend the previous FC findings (Whalley et al., 2004). 
 
In chapter 4, the devised heuristic search protocol for the application of nonlinear 
DCM was adapted for the working memory task in EST and healthy controls. The 
main result was that EST used a different functional network for the working 




In chapter 5, a summary and discussion of the key findings from the EHRS and the 
SFMHS is presented in context of improved insight into functional large-scale 
networks underlying cognitive function in individuals with schizophrenia. 
 
1.2 Introduction to chapter 1 
It is widely established that schizophrenia is a brain disorder. This understanding has 
been formed by decades of research and it has been furthered through 
neurobiological and neuropsychopharmacological research. This research has 
revealed evidence of altered neurobiological mechanisms including brain molecular, 
cellular and chemical findings in schizophrenia. Furthermore, the notion of impaired 
working memory function in schizophrenia was originally based on research in 
animals and continues to provide novel knowledge of underlying neurobiological 
mechanisms (Goldman-Rakic and Selemon, 1997; Lewis and Moghaddam, 2006; 
Burgos-Gonzalez et al., 2010). One of the main findings for working memory 
impairment in schizophrenia was dysfunction of the PFC and alterations of 
neurotransmitter systems involving the PFC (Goldman-Rakic and Selemon, 1997; 
Goldman-Rakic et al., 1999). These findings have led to major neurobiological 
theories of schizophrenia such as the ‘dopamine hypothesis of schizophrenia’ and the 
‘glutamate hypothesis of schizophrenia’. The strength of the hypotheses of 
schizophrenia lies in the opportunity of investigating neurobiological alterations in 
individuals with schizophrenia with the aim of gaining a better insight into the 




It is well known that individuals with schizophrenia have cognitive deficits in 
addition to clinical symptoms. The most common of such cognitive deficits is 
working memory impairment, which is apparent at every stage of the illness (Fusar-
Poli et al., 2012; Seidman et al., 2010; Kim et al., 2011; Genevsky et al., 2010) and 
has been linked to the severity of clinical symptoms in schizophrenia (MacDonald 
and Schulz, 2009, Fusar-Poli et al., 2012). With the advent of clinical and cognitive 
neurosciences a plethora of functional Magnetic Resonance Imaging (fMRI) and 
positron emission tomography (PET) studies found that individuals with 
schizophrenia show altered DLPFC brain function in working memory in 
comparison to healthy controls (Goldberg and Weinberger, 1988; Goldman-Rakic 
1994; Callicott et al., 2000; Callicott et al., 2003). In the later years, altered FC 
findings involving the (DL)PFC in individuals with schizophrenia were reported 
(Tan et al., 2006) with the aim of providing a better translational interpretation 
of human neuroimaging findings to preclinical findings. 
 
In this chapter, we briefly describe the pathological and aetiological background of 
schizophrenia (chapter 1.2). We summarise neurobiological findings crucial for the 
understanding of schizophrenia as a brain disorder (chapter 1.3) by focusing on the 
description of the two main neurotransmitters and neurotransmitter systems 
implicated in schizophrenia: DA and Glu (chapter 1.3.1). Then we outline the main 
versions of the ‘dopamine hypothesis of schizophrenia’ and the ‘glutamate 
hypothesis of schizophrenia’, which were developed and revised based on the 
neurobiological findings (chapter 1.3.2). In the next step, we review clinical and 
cognitive neuroscientific findings of FA and FC findings from fMRI and PET studies 
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in working memory in individuals with schizophrenia and healthy subjects (chapter 
1.4.2). In particular, we discuss if and to what extent the reviewed FA and FC 
findings can be interpreted in light of the dopamine and/or glutamate hypotheses of 
schizophrenia. 
 
1.3 Schizophrenia – General overview 
We briefly describe the criteria for the clinical diagnosis of schizophrenia based on 
the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision (DSM-IV-TR; American Psychiatric Association, 2000). The individuals 
with established schizophrenia (EST), who took part in this study, were diagnosed on 
the criteria of DSM-IV-TR. 
 
1.3.1 Pathology 
Schizophrenia is a severe psychiatric disorder, which is initially manifested through 
positive symptoms including delusions, hallucinations and disorganised thoughts. As 
the illness progresses, negative symptoms such as avolition, alogia and apathy may 
occur. Prior to diagnosis of the illness, cognitive deficits can occur and illness 
progression can also be associated with cognitive deficits (MacDonald and Schulz, 
2009, Fusar-Poli et al., 2012). 
 
Lifetime prevalence of schizophrenia is approximately 1%. The gender ratio 
between men and women is nearly 1:1, although men seem to have an earlier age 
onset than women (van Os and Kapur, 2009). The onset of the illness occurs 
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typically in late adolescence or early adulthood, however the range of onset can 
vary between childhood and late adulthood (Kumra et al., 2001). 
 
The clinical symptoms are briefly described. Positive symptoms are characterized by 
delusions, hallucinations and formal thought disorders. Delusions are defined as 
unrealistic and dysfunctional beliefs. Hallucinations are pathological sensory 
sensations, mainly in the auditory modality without an objective basis for a stimulus. 
Formal thought disorders implicate a disruption of thought processes (Andreasen, 
1995). Negative symptoms are characterized by a pathological deficit in activity and 
responsiveness. This deficit can be seen in impoverishment of verbal and nonverbal 
communication, social withdrawal, anhedonia and general reduction in emotion, 
psychomotor deceleration and a general apathic appearance (Andreasen, 1995). 
It is widely established that cognitive deficits are considered a core symptom of 
schizophrenia (Elvevag and Goldberg, 2000, Kremen et al., 2000; Gold, 2004). 
These symptoms can encompass a range of executive functions such as impaired 
performance in attention, memory, planning, reasoning, language functions and 
social cognition. Working memory deficits are one of the main neurocognitive 
impairments found in subjects with first episode schizophrenia (FES) (Seidman et 
al., 2010; Kim et al., 2011) and EST (Genevsky et al., 2010). Similar deficits also 
occur in individuals at high risk of schizophrenia (HR; Fusar-Poli et al., 2012). 
Furthermore, recent evidence has been presented, which indicates a relationship 
between severity of working memory deficits and the severity of negative 
symptoms (Bora and Murray, 2013). The severity of working memory deficits that is 
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evident at the first episode of schizophrenia can predict the quality of life at the 
established stage of the illness (Seshadri et al., 2013; Kukla et al., 2013). 
 
The pattern of clinical positive and negative symptoms leads to different 
subtypes as classified by DSM-IV-TR. The four different subtypes are: (i) 
paranoid, (ii) catatonic, (iii) hebephrenic (or disorganized) and (iv) simple 
deteriorative disorder. Here, we focus on the paranoid subtype since the patients, 
who participated in the SFMHS, received this diagnosis. Paranoid schizophrenia 
is characterized by delusions or auditory hallucinations, whereas thought 
disorder, disorganized behaviour or affective flattening are not present.  
 
The course of schizophrenia is variable and can fluctuate. In some cases, 
individuals recover after the first psychotic episode, whereas in other cases, 
individuals fall chronically ill with the disorder. 
 
Phases of the illness are commonly subdivided into three subgroups: 
 High risk phase of the illness (also sometimes called prodrome);  
 First episode schizophrenia, which is described by a maximum illness 
duration of approximately 18 months;       
 Established phase of the illness, which is described by a minimum illness 
duration of approximately 18 months ranging to decades.  
The high risk phase is further subgrouped into clinical high risk phase or familial 
high risk phase of adolescents and young adults, who are at enhanced risk of 
developing schizophrenia in the following years. Relevance of research on the 
13 
 
high risk phase and transition to the first-episode schizophrenia can be seen in 
the growing number of studies in this field and the new diagnosis category in 
DSM-V (Fusar-Poli et al., 2014). 
For clinical risk of schizophrenia, it is thought that these people are at high risk 
because of the appearance of transient and partial psychotic symptoms (Fusar-
Poli et al., 2012). Research on individuals at increased clinical risk can be 
summarised by the study populations of (i) subjects with an At-Risk Mental 
State (ARMS) and (ii) subjects at ultra-high risk (UHR). Individuals are 
considered to be at increased familial risk of developing schizophrenia when 
they have one first-degree relative with the illness (Johnstone et al., 2000). 
Evidence has been presented that subjects at increased clinical risk and subjects 
at increased familial risk of schizophrenia show alterations in cognitive 
performance (clinical risk/familial risk, Bora et al., 2014), brain structure 
(clinical risk, Carletti et al. 2012; familial risk, Thermenos et al., 2013), brain 
function/connectivity (clinical risk, Pettersson-Yeo et al., 2011; familial risk, 
Thermenos et al., 2013), brain DA function (clinical risk, Egerton et al., 2013) 
and brain metabolite concentrations such as Glu (clinical risk, Egerton et al., 
2014; familial risk, Tibbo et al., 2004). 
 
1.3.2 Aetiology 
The aetiology of the illness is still unknown. Several possible factors have been 
proposed, however, there is controversy about each factor and its possible inter-
relationships with other factors. The primary factors and their interactions among 
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other risk factors are briefly summarised, which are believed to contribute to or 
mediate pathological mechanism(s) of schizophrenia: 
(i) Heritability and risk genes 
(ii) Environmental factors 
(iii) Brain alterations 
 
(i) First evidence of heritability of schizophrenia was published by twin 
studies (Gottesman and Shields, 1966; Shields and Gottesman, 1972). 
Similarly, susceptibility genes have been proposed to be involved in the 
pathophysiology of the illness (Harrison and Weinberger, 2005) but it has 
not been possible to prove this hypothesis. Twin and adoption studies 
suggested that rather an interaction between genetic and environmental 
factors may lead to schizophrenia than single genetic factors (Susser, 
1985). Evidence has been presented which shows that multiple 
susceptibility and candidate genes may result in schizophrenia rather than 
a single gene (Mirnics et al., 2000; Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, 2014). 
(ii) Environmental factors have been suggested to play a role in the 
pathophysiology of the illness such as pregnancy and birth complications, 
neurological insults and life stressors (Heinz et al., 2013). Despite 
decades of research, it has not been able to prove this hypothesis as an 
aetiological cause of the illness. Thus, it is thought that genetic and 
environmental factors may interact and lead to a greater likelihood of the 
occurrence of the illness than genetic or environmental factors 
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individually (McDonald and Murray, 2000). An example of linking both 
state and trait markers in schizophrenia is research on endophenotypes 
(Braff et al., 2007; Glahn et al., 2014). 
(iii) MRI studies reported evidence for brain alterations in brain structure, for 
example, enlarged third ventricles and grey matter loss in temporal 
regions (Raz and Raz, 1990; Tang et al., 2012) and brain function during 
cognitive tasks (for example, working during fMRI (Callicott et al., 2000; 
Callicott et al., 2003)). Neuroimaging studies showed not only alterations 
of brain structure and function but also possible interrelationships 
between brain alterations and genetic factors as well as environmental 
factors (Lenroot and Giedd, 2008). 
 
1.3.3 Treatment 
The most common treatment of individuals with schizophrenia is the prescription of 
antipsychotic medication. In some cases, patients may also undergo additional 
psychotherapy. 
The antipsychotic drugs are subdivided into (i) ‘first-generation antipsychotics’ 
(FGA) or ‘typical’ antipsychotics and; (ii) ‘second-generation antipsychotics’ (SGA) 
or ‘atypical’ antipsychotics. Briefly, commonly prescribed FGA comprise 
haloperidol, fluphenazine and chlorpromazine. Examples of SGA are clozapine, 
olanzapine, risperidone, quetiapine, ziprasidone and aripriprazole. Despite the fact 
that antipsychotic treatment remains the main treatment of patients with 
schizophrenia, the exact details of the mode of actions of these drugs is not well 




1.4 Neurobiology of schizophrenia 
1.4.1 Implicated neurotransmitters and neurotransmitter 
systems in schizophrenia 
Preclinical research has provided a wealth of findings on alterations of 
neurotransmitter systems in schizophrenia with the focus on two main 
neurotransmitter systems of DA and Glu and their interactions. Furthermore, 
evidence suggest that alterations of DA and Glu involving the (DL)PFC and 
prefrontal circuits could underlie the pathophysiology of disrupted working memory 
function in schizophrenia (Moghaddam et al., 1997; Lewis and Moghaddam, 2006; 
Arnsten et al., 2012). 
Besides DA and Glu, other neurotransmitters such as γ-amino-butter-acid (GABA), 
serotonin (5-hydroxytryptamine, 5-HT), acetylcholine (ACh) and noradrenaline (NA) 
are involved in the modulation of cognitive functions. In addition, alterations of 
GABA and 5-HT transmission are implicated in dopaminergic and/or glutamatergic 
circuits in schizophrenia (Carlsson et al., 1997; Lewis and Burgos-González, 2008; 
Lisman et al., 2008; Qi et al., 2010). 
Risk genes and candidate genes are known to play a role in alterations of 
dopaminergic and glutamatergic modulation of the (DL)PFC, which could result in 
disruption of synaptic plasticity and therefore cognitive impairment in schizophrenia. 
Examples of suggested risk genes comprise the susceptibility gene Disrupted-in-
schizophrenia-1 (DISC1) (Hayashi-Takagi et al., 2010; Ramsey et al., 2011), 





There are three main dopaminergic pathways, which are relevant for the innervation 
of motor and cognitive functions: (i) the nigro-striatal system; (ii) the meso-limbic 
system; and (iii) the meso-cortical system, of which the meso-limbic and meso-
cortical circuits are pivotal for cognitive functions. Here, we focus on the meso-
cortical DA system because of its relevant role in PFC neurotransmission and 
cognitive function such as working memory. The meso-cortical system modulates 
executive functions such as working memory from the VTA and to some extent from 
the substantia nigra (SN) to the PFC, in particular the DLPFC. 
Findings from animal studies provided evidence for dopaminergic modulation of the 
(DL)PFC and working memory via meso-cortical D1 receptor projection (D1 receptor 
subtype of the DA receptor) to prefrontal pyramidal cells and GABAergic 
interneurons (Goldman-Rakic, 1996; Durstewitz et al., 1999; Durstewitz and 
Seamans, 2002). Alterations of meso-cortical D1 receptor transmission of the 
(DL)PFC resulted in working memory impairment in schizophrenia (Durstewitz and 
Seamans, 2008; Goldman-Rakic, 1999). It is noted that findings have been reported 
that not only D1 receptors but also D2 receptors (D2 subtype of the DA receptor) are 
involved in changes of N-methyl-D-aspartate (NMDA) receptor-dependent synaptic 
plasticity in the DLPFC, for example through imbalance of D1/D2 receptor 
expression (Tzschentke, 2001; Laruelle et al., 2005; Durstewitz and Seamans, 2008). 
Furthermore, D4 and D5 receptors (D4 and D5 subtypes of the DA receptors) have 
been proposed to be involved in interactions with glutamatergic and GABAergic 





Glu is the primary excitatory neurotransmitter in the PFC, which has cortico-mesal 
glutamatergic efferent projections to the VTA (Tzschentke, 2001) and excitatory 
glutamatergic afferents from cortical and subcortical regions, for example the MD 
thalamus (Leonard, 1969; Gioanni et al., 1999). Iontropic Glu receptors are divided 
into three groups: (i) NMDA receptors; (ii) Alpha-Amino-3-hydody-5-methyl-
isoxazol-4-propioacid (AMPA) receptors; and (iii) kainate receptors. 
Glu is implicated in cognitive functions such as working memory in interaction with 
DA (Arnsten et al., 2012). Ionotropic receptors modulate several basic physiological 
processes such as neuronal growth and synaptic plasticity, which are context-
dependent or experience-dependent for the modulation of cognitive functions (Javitt, 
2007; Newpher and Ehlers, 2008; Pinault, 2011). 
 
1.4.1.3 Interactions between dopamine and glutamate 
Both DA and Glu modulate cognitive function involving the DL(PFC) and aberrant 
dopaminergic and/or glutamatergic modulation can lead to cognitive impairment 
such as working memory via aberrant NMDA receptor function (Gonzalez-Burgos et 
al., 2010; Arnsten et al., 2012). Here we focus on the meso-cortical circuit 
(Gonzalez-Burgos et al., 2005; Wang, 2010), which plays a crucial role in the 
modulation of working memory in schizophrenia. 
Dopaminergic and/or glutamatergic interactions have been first proposed after the 
observation of close proximity of both dopaminergic and glutamatergic terminals on 
same pyramidal cell in the PFC (Goldman-Rakic et al., 1989). Glutamatergic 
transmission from the PFC modulate dopaminergic neurons in the VTA (Jackson et 
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al., 2001; Sesack et al., 2002). These glutamatergic projections are mediated by 
NMDA receptor-dependent synaptic plasticity (Bonci et al., 1999; Overton et al., 
1999). The efferent glutamatergic projections impact on dopaminergic neurons in the 
VTA, which project to the D1 receptors in the DLPFC (Sesack et al., 2002, Carr et 
al., 2000; Gao and Wolf, 2007; Romanides et al., 1999). Based on these findings, it 
has been proposed that decreased glutamatergic projection from the PFC to the VTA 
results in reduced dopaminergic transmission via D1 receptors from the VTA to the 
DLPFC (Lewis and Gonzalez-Burgos, 2006; Lewis and Gonzalez-Burgos, 2008). 
These findings show that dopaminergic and glutamatergic projections activate cells 
and neurons reciprocally. They can be summarised by (i) DA – Glu interactions in 
the PFC and (ii) DA – Glu interactions in the VTA. Two examples for interactions in 
the PFC are (a) dopaminergic stimulation of the VTA leads to inhibition of prefrontal 
pyramidal cells and (b) glutamatergic regulation of prefrontal dopaminergic cells by 
ionotropic and/or metabotropic Glu receptors (mGluR) (Tzschentke, 2001). For DA 
– Glu interactions in the VTA, findings were reported of (a) Glu agonist/antagonist 
activity in dopaminergic neurons in the VTA, (b) midbrain glutamatergic regulation 
of different populations of DA neurons in the PFC and (c) prefrontal glutamatergic 
projections to the VTA generate dopaminergic burst activity in the VTA   
(Tzschentke, 2001). 
It is noteworthy that other neurotransmitter and neuromodulators such as GABA,    
5-HT, ACh, NA and nicotinic receptors (Tzschentke, 2001; Stephan et al., 2006; 
Stephan et al., 2009a) are involved in the meso-cortical-mesal circuit underlying 
working memory performance (Timofeeva and Levin, 2011), which are beyond the 
scope of this thesis. 
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1.4.1.4 Other implicated neurotransmitters and neurotransmitter 
systems 
It has been reported that neurotransmitters such as GABA, 5-HT, ACh and NA are 
involved in modulation of cognitive function and these neurotransmissions are 
altered in schizophrenia. Furthermore, it has been shown that interactions between 
those and the dopaminergic and glutamatergic circuits exist. Here, we briefly 
summarise the effects of GABA on DLPFC circuitry and working memory in 
schizophrenia as the main researched area. 
 
GABA is the primary inhibitory neurotransmitter and plays a major role in the 
DLPFC and prefrontal circuitries underlying working memory (Lewis and Gonzalez-
Burgos, 2008; Timofeeva and Levin, 2011). Disruptions of GABAergic modulations 
such as reduced GABA synthesis and reuptake in DLPFC neurons in patients with 
schizophrenia have been reported (Lewis and Gonzalez-Burgos, 2008). Furthermore, 
it has shown that reductions of GABAergic receptors, specifically glutamic acid 
decarboxylase 67 and parvalbumin receptors, and genetic alteration involved in 
GABAergic transmission can lead to disruption of synaptic plasticity processes 
(Lewis and Gonzalez-Burgos, 2008) and therefore working memory impairments in 
schizophrenia (Gonzalez-Burgos et al., 2010; Timofeeva and Levin, 2011). 
Evidence for interactions between glutamatergic and GABAergic projections, which 
could underlie cognitive functions such as working memory function in the (DL)PFC 
have been reported (Lewis and Gonzalez-Burgos, 2008). Prefrontal glutamatergic 
neurons project to the VTA and activate GABAergic neurons projecting to the 
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nucleus accumbens and may decrease meso-striatal projections (Sesack et al., 2002; 
Gao and Wolf, 2007). 
 
1.4.2 Neurobiological theories of schizophrenia 
DA and Glu circuits have been implicated in clinical and cognitive symptoms in 
subjects with schizophrenia. Evidence has been presented for alterations of DA, Glu 
and an alteration of the interaction between both neurotransmitters. The two main 
neurobiological hypotheses in schizophrenia are based on the theories of altered 
dopaminergic transmission (‘dopamine hypothesis of schizophrenia’) and altered 
glutamatergic transmission (‘glutamate hypothesis of schizophrenia’). It is thought 
that both DA and Glu modulate the DLPFC and in schizophrenia alter the 
performance in cognitive processes such as in working memory (Tanaka, 2006; Tan 
et al., 2007; Anticevic et al., 2012). 
 
Neurobiological research into alterations of dopaminergic and/or glutamatergic 
neurotransmission has paved the way for the understanding of schizophrenia as a 
disorder of the brain. The dopamine hypothesis posits that DA function is altered in 
schizophrenia and that this dysfunction may be the pathophysiological pathway 
leading to clinical and cognitive symptoms (Howes and Kapur, 2009; Qi et al., 
2010). The glutamate hypothesis proposes that the altered dopaminergic dysfunction 
may be secondary to aberrant glutamatergic dysregulation, which may contribute to 





1.4.2.1 Dopamine hypothesis of schizophrenia 
The origin of the dopamine hypothesis of schizophrenia is based on the 
discovery of antipsychotic drugs by Delay et al., in 1952. Carlsson and Lindqvit 
reported the first findings of an effect of antipsychotic drugs on the metabolism of 
DA (Carlsson, 1978). The original dopamine hypothesis posits that alterations of 
dopaminergic receptors may underlie the clinical symptoms of schizophrenia 
(Emilien et al., 1999). Over last three decades, the dopamine hypothesis of 
schizophrenia has undergone reformulations in light of newly available preclinical 
and clinical findings. Here, we consider the three main hypotheses: (i) the ‘dopamine 
receptor hypothesis’, (ii) the ‘modified dopamine hypothesis of schizophrenia’, and 
(iii) the ‘dopamine hypothesis: version III’. 
 
1.4.2.1.1 ‘Dopamine receptor hypothesis’ 
The dopamine receptor hypothesis goes back to studies reporting clinical efficacy 
correlates with D2 receptor affinity (Seeman and Lee, 1975; Creese et al., 1976; 
Seeman et al., 1976). Further evidence for the hypothesis was presented with 
increased synaptic monoamine levels during the induction of psychotic symptoms 
(Lieberman et al., 1987). The focus of this hypothesis rests on the excess of DA 
receptors. Thus, the clinical treatment is aimed at blocking the DA D2 subtype of the 
DA receptors (Snyder, 1976). 
 
1.4.2.1.2 ‘Modified dopamine hypothesis’ 
The modified dopamine hypothesis of schizophrenia has been formulated to integrate 
new findings (Davis et al., 1991). Preclinical and clinical studies (i.e. post-mortem, 
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metabolite and DA receptor neuroimaging studies) have advanced the 
understanding of relationships between affinity and occupancy of D2 and D1 subtypes 
of the DA receptors and regional specificity (Kapur and Seeman, 2001). 
Furthermore, it was assumed that findings of altered regional dopaminergic receptor 
function from preclinical and indirect clinical studies could be linked to clinical 
symptomatology in schizophrenia (Davis et al., 1991). The hypothesis suggests that 
‘hypofrontality’, as measured with reduced regional cerebral blood flow (rCBF) in 
the PFC may indicate low DA levels in the PFC (Davis et al., 1991). Findings from 
preclinical lesion studies proposed that prefrontal ‘hypodopaminergia’ leads to 
striatal ‘hyperdopaminergia’ (Pycock et al., 1980; Scatton et al., 1982). In addition, it 
is hypothesised that prefrontal ‘hypodopaminergia’ could cause negative symptoms, 
whereas striatal ‘hyperdopaminergia’ could lead to positive symptoms (Davis et al., 
1991). 
 
1.4.2.1.3 ‘Dopamine hypothesis: version III’ 
The dopamine hypothesis: version III synthesises published findings on DA and its 
potential role in schizophrenia from the main fields into one unifying hypothesis. 
The hypothesis aims to provide a framework for findings from developments in 
clinical research into genetic (risk) factors, environmental risk factors, 
neurochemical and neuroimaging studies, and preclinical studies, which may be 
related to increased presynaptic striatal dopaminergic function in schizophrenia 
(Howes and Kapur, 2009). The authors outline four components for the hypothesis in 
their review article: (i) The interaction of “hits” such as fronto-temporal dysfunction, 
genes, stress and drugs may lead to striatal DA dysregulation (i.e. increased 
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presynaptic DA synthesis capacity) and therefore to psychosis. (ii) It is hypothesised 
that the primary dopaminergic dysfunction is located at the presynaptic dopaminergic 
level instead of the D2 receptor level. (iii) The hypothesis assumes that the DA 
dysregulation combined with cultural and societal factors could lead to future clinical 
diagnosis of ‘‘psychosis’’ rather than schizophrenia. (iv) It has been proposed that 
the DA dysfunction could change the perception and judgment of stimuli (possibly 
through aberrant salience), which could result in cognitive deficits (Heinz, 2002; 
Kapur et al., 2003). 
 
Recent meta-analyses, which examined markers of striatal DA alterations in 
schizophrenia, reported evidence of different types of elevated DA dysfunction. 
Supporting evidence for the dopamine hypothesis has been shown by increased 
striatal presynaptic dopaminergic function in medication-free or medication-naïve 
patients with schizophrenia contrasted to healthy controls (Howes et al., 2012) and 
increased striatal DA synthesis capacity (Fusar-Poli and Meyer-Lindenberg, 2013a). 
Furthermore, Fusar-Poli and Meyer-Lindenberg (2013b) found no difference in 
striatal DA active transporter density between patients with schizophrenia and 
healthy controls, which presents evidence for DA elevation in presynaptic terminals 
(Howes et al., 2012; Fusar-Poli and Meyer-Lindenberg, 2013a). 
 
1.4.2.1.4 Summary 
In summary, while both the dopamine receptor hypothesis and the modified 
dopamine hypothesis of schizophrenia have their origins in the neurobiological 
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investigation of the mode of action of antipsychotics, the dopamine hypothesis: 
version III aims at integrating advances in research of schizophrenia into one 
unifying dopamine hypothesis. The scope of understanding of dopaminergic 
dysregulation has become more defined, ranging from the whole brain 
perspective, via the perspective of regional specificity between (DL)PFC and 
striatum, to the current perspective of elevated presynaptic striatal dopaminergic 
function. The development of the dopamine hypothesis over the three versions has 
helped shape the understanding of schizophrenia as a brain disorder. 
 
1.4.2.2 Glutamate hypothesis of schizophrenia 
The origin of the glutamate hypothesis of schizophrenia was based on the 
discovery of psychotomimetic effects of ketamine and phencyclidine, which 
elicited psychotic symptoms in healthy people. Symptoms such as delusions 
and hallucinations experienced by healthy individuals were compared to 
positive symptoms seen in FES (Krystal et al., 1994; Abi-Saab et al., 1998). 
The glutamate hypothesis postulates a mechanistic process of altered interacting 
glutamatergic and/or dopaminergic neurotransmitter circuitries implicated in the 
pathophysiology of clinical and cognitive symptoms in schizophrenia (Luby et al., 
1959; Carlsson et al., 2000; Farber et al., 2002; Javitt, 2007). In this review, we 
consider three models of the glutamate hypothesis with relevance to the investigation 
of altered working memory function in people with schizophrenia: (i) the NMDA 
receptor hypofunction model’ of schizophrenia, (ii) the ‘acute ketamine model’, and 




1.4.2.2.1 ‘N-Methyl-D-aspartate acid (NMDA) receptor hypofunction 
model’ 
The NMDA receptor hypofunction model of schizophrenia posits that the subtype of 
the Glu receptor is implicated in multiple pathological brain mechanisms of 
schizophrenia ranging across cellular, chemical and neuronal levels (Coyle, 2006; 
Coyle et al., 2010; Moghaddam and Krystal, 2012; Javitt et al., 2012). It has been 
proposed that NMDA receptor hypofunction could underlie the pathophysiology of 
negative and cognitive symptoms in schizophrenia (Carlsson et al., 1999; Coyle, 
2006; Javitt, 2010; Goff and Coyle, 2001). Clinical trials with agents modulating the 
NMDA receptor in addition to treatment with FGA (such as chlorpromazine, 
haloperidol and perphenazine) and SGA (such as clozapine and olanzapine) 
presented supporting evidence for amelioration of negative and cognitive 
symptoms (Coyle, 2006; Heresco-Levy et al., 2002; Lane et al., 2005). Evidence for 
the involvement of NMDA receptor hypofunction through interactions among 
different neurotransmitters such as GABAergic interneurons (Coyle, 2006) and DA 
(Tzschentke, 2001; Sesack and Carr, 2002) has also been reported. 
 
1.4.2.2.2 ‘Acute ketamine model’ 
Evidence for the glutamate hypothesis in humans is based on clinical studies 
with ketamine in healthy subjects. Results suggest that glutamatergic 
alterations could explain the pathophysiological mechanisms resulting in 
positive symptoms predominantly experienced by FES and those with first 
episode psychosis (FEP) (Krystal et al., 1994; Krystal et al., 1999). While 
findings from ketamine injection studies have aided the understanding of 
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glutamatergic signalling in the development of delusions and hallucinations, 
evidence for altered glutamatergic transmission in negative and cognitive 
symptoms is scarce. FMRI findings from ketamine studies in healthy subjects 
propose that altered glutamatergic signalling could be implicated in working 
memory (Krystal et al., 1994; Anticevic et al., 2012; Driesen et al., 2013). 
These findings are in keeping with evidence from glutamatergic animal models, 
which report aberrant working memory function after the inhibition of 
glutamatergic receptors (Moghaddam et al., 1997; Timofeeva and Levin, 2011; 
Fitzgerald, 2012; Arnsten et al., 2012). 
 
1.4.2.2.3 ‘Dysconnection hypothesis’ 
The dysconnection hypothesis of schizophrenia posits that altered NMDA receptor-
mediated synaptic plasticity may be the underlying pathophysiological mechanism in 
individuals with schizophrenia (Stephan et al., 2006; Stephan et al., 2009a). The 
authors propose that altered synaptic plasticity may explain both clinical symptoms 
and cognitive deficits in people with schizophrenia neurobiologically by altered 
NMDA receptor neuromodulation. It is thought that NMDA receptor transmission is 
modulated by multiple intracellular mechanisms and activation of specific D1 and D2 
receptors, Glu receptor subtypes and GABA receptors on PFC pyramidal cells 
(Tseng and O’Donnell, 2004). The dysconnection hypothesis synthesises 
neurobiological findings (i.e. DA as one of the main neuromodulators leading to 
aberrant NMDA receptor function) with clinical and cognitive neuroscientific 
findings (i.e. cognitive impairment) in individuals with schizophrenia. The 
dysconnection hypothesis is based on the notion that schizophrenia can be considered 
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as a ‘disconnection syndrome’ (Friston and Frith, 1995) and extends the conceptual 
hypothesis of disrupted large-scale functional networks during cognitive tasks to 
aberrant synaptic plasticity. In the original review, Friston and Frith propose that 
schizophrenia can be considered as an illness, which relates aberrant FC during 
cognitive and sensorimotor function with positive symptomatology in individuals 
with schizophrenia. In addition to this conceptual notion, the dysconnection 
hypothesis offers a new approach of analysing altered synaptic plasticity, which 
allows a new interpretation of neurophysiological and neuroimaging data. This may 
be used to assist in the understanding of altered cognitive function in people with 
schizophrenia. For functional neuroimaging data, the biophysical modelling 
approach of DCM (Friston et al., 2003) has been proposed to infer biophysical 
processes (namely, NMDA receptor-dependent synaptic plasticity) underlying the 
Blood-Oxygen-Level Dependent (BOLD) responses. In addition, the authors provide 
arguments that the development of positive symptoms such as delusions can be 
explained by a ‘failure of self-monitoring mechanism’ or ‘corollary discharge’ 
(Stephan et al., 2009a). Abnormal EC findings from electroencephalogram (EEG) 
and fMRI studies across a range of cognitive tasks in subjects with schizophrenia in 
contrast to healthy controls have been reported (Dima et al., 2009; Dima et al., 2010; 
Wagner et al., 2013). These lead to a new insight into altered connectivity above 
those provided by FC studies, which are formulated under different theoretical 
frameworks. Specifically, DCM findings enable the inference of biophysical 
processes underlying neural responses (Friston et al., 2003; Friston and Dolan, 2010; 





In summary, the three hypotheses, the NMDA receptor hypofunction model, the 
acute ketamine model and the dysconnection hypothesis, have motivated researchers 
to investigate biophysical circuit processes implicated in glutamatergic and 
dopaminergic interactions in negative symptoms and cognitive function in 
schizophrenia. These circuit mechanisms are thought to underlie altered working 
memory function in schizophrenia. Research on the NMDA receptor hypofunction 
model has its roots in the pharmacological examination of antipsychotics, the 
development of new agents and its effects on clinical and cognitive symptoms in 
preclinical and clinical research in schizophrenia. The focus of researchers 
examining the acute ketamine model and the dysconnection hypothesis lies on 
elucidating proposed neurobiological processes of blockade of NMDA receptor 
underlying altered cognitive brain function in schizophrenia. The study designs of 
both versions differ in the investigation of (i) the pharmacological effect of ketamine 
on altered cognitive brain function and clinical symptomatology in healthy controls 
(the acute ketamine model) and (ii) altered synaptic plasticity during altered 
cognitive brain function in subjects with schizophrenia. Despite the different 
approaches, researchers of both versions of the glutamate hypothesis share the 
common aim of increasing our insight into schizophrenia by the translation of 
neurobiological knowledge from basic research to clinical research in schizophrenia. 
Furthermore, researchers share the common methodological approach of large-scale 
network analysis of fMRI data. Taken together, development over the three versions 
of the glutamate hypothesis of schizophrenia supports the notion of schizophrenia as 
a brain disorder. 
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1.5 Clinical and cognitive neuroscience of working 
memory in schizophrenia 
Clinical and cognitive neuroscience studies have applied in vivo neuroimaging 
techniques of fMRI, PET and single-photon emission computed tomography 
(SPECT) to assess neurobiological processes that underlie working memory function 
in people with schizophrenia. Techniques such as PET and SPECT use injections of 
positron-emitting radionuclide as tracer (for PET) or gamma-emitting radionuclide 
as tracer (for SPECT) in the living brain. Although these nuclear medical imaging 
techniques are non-invasive they require the administration of tracers. FMRI 
provides non-invasive in vivo imaging, which measures brain function by means of 
the BOLD response (Ogawa et al., 1990). 
 
1.5.1 Working memory 
Working memory is thought to comprise executive functions such as attention, 
inhibition and planning (Baddeley, 1981, Hitch, 1984; Smith and Jonides, 1998; 
Smith and Jonides, 1999). Working memory is defined as the ability to briefly hold 
information in mind for manipulation or for long-term storage (Baddeley, 1996; 
Goldman-Rakic, 1996), which is necessary for the performance of cognitive tasks. 
The computational approach of cognitive control by Braver and Cohen is similar to 
the construct of working memory (Braver et al., 1999; Cohen et al., 1992; Braver et 
al., 1997). However, two of the main novelties of the construct of cognitive control 
lie in: (i) the extension of the existing working memory definition; and (ii) the 




Braver et al., 1999 advanced the existing definition of working memory by the 
description of ‘context’ information as an element of working memory. The term 
‘context’ indicates that relevant information is needed for the performance of the task 
(Braver et al., 1999; Cohen et al., 2002). Three specific processes within the 
construct of cognitive control have been described (Cohen et al., 2002) in order to 
define ‘context’. Furthermore, these hypothesised psychological processes have been 
related to known neurobiological findings. 
The first process is active maintenance of representations, which is described as the 
ability to actively process relevant representations of the task's requirements, rules 
and aims. The second process of adaptive updating is the mechanism that ensures the 
continuous updating of previously maintained representations. This updating process 
encompasses two specific processes: (i) The detection of task-relevant stimuli and 
(ii) the detection of task-irrelevant stimuli, which are both essential for the successful 
performance of the cognitive task. Neurobiological findings support the hypothesis 
that updating is mediated by dopaminergic gating mechanisms via the VTA (Braver 
and Cohen, 1999; Cohen et al., 2002). The third process, conflict monitoring, is an 
attention process, which ensures the minimization of conflicts (i.e. errors such as 
false alarms or misses). It is thought that monitoring for potential conflicts can be 
measured as brain function in the anterior cingulate cortex (ACC; Cohen et al., 
2002). 
Different types of information can be manipulated, maintained, updated and stored 
during working memory performance: 
 Verbal information, i.e. letters 
 Numeric information, i.e. digits 
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 Visual images 
 Auditory information, i.e. tones 
Here, we focus on verbal and numeric working memory processes to ensure 
interpretability of BOLD responses between individuals with schizophrenia and 
healthy controls, which are not confounded by differences in domains of working 
memory stimuli. To further increase the interpretability among studies, FA and FC 
studies are reviewed that applied the verbal or numeric “N-back” task. The “N-back” 
task is considered to be as one of the most reliable experimental paradigms for the 
assessment of verbal/numeric working memory function in humans. 
 
1.5.2 Findings of functional activation studies of 
verbal/numeric working memory in healthy subjects and 
subjects with schizophrenia 
FMRI and PET findings of altered FA and FC during working memory have been 
reported in people with schizophrenia when they are compared to healthy controls 
(Kim et al., 2003; Honey and Fletcher, 2006). Furthermore, PET studies have 
presented evidence for indirect markers of altered DA transmission, which was 
correlated with working memory performance (Abi-Dargham et al., 2002; Fusar-
Poli et al., 2010). 
 
1.5.2.1 Functional magnetic resonance imaging studies 
Working memory tasks were initially investigated with fMRI in healthy subjects 
(Cohen and Servan- Schreiber, 1992; Cohen et al., 1996; Smith and Jonides, 1999; 
Collette and Van der Linden, 2002). These initial studies used fMRI as a tool for 
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examining neurobiological markers that could be related to working memory 
performance. The examination of working memory function was extended to 
individuals with schizophrenia. 
Reported findings of brain function during working memory (among several domains 
and components of working memory tasks) in healthy controls have led to the 
understanding that DA modulates working memory (Braver et al., 1999; Cohen et al., 
2002; Cools et al., 2008). This evidence of dopaminergic involvement in working 
memory was extended by the findings of altered dopaminergic modulation in 
schizophrenia (Braver et al., 1999; Hazy et al., 2006). Subsequently, converging 
findings were reported that regions such as DLPFC, ACC and parietal cortex (PC) 
are activated in working memory in both healthy controls and in subjects with 
schizophrenia (Cole and Schneider, 2007; Lenartowicz and McIntosh, 2005; 
Woodward et al., 2006; Gazzaley and Nobre, 2012). However, in those with 
schizophrenia, these regions exhibit increased or reduced FAs and FC between 
prefrontal and parietal regions as well as between prefrontal and temporal regions in 
contrast to healthy controls. Alterations in FC occur at all stages of the illness 
(Broome et al., 2009; Liemburg et al., 2012): (i) in HR subjects (Rasetti et al., 2011); 
(ii) in FES and FEP (Barch et al., 2001) and (iii) in subjects with EST (Potkin et al., 
2009). 
Systematic reviews and meta-analyses of working memory fMRI studies in people 
with schizophrenia do not report consistent findings (Brown and Thompson, 2010; 
Manoach, 2003; Wager and Smith, 2003; Glahn et al., 2005). Some studies report 
increased activation of the DLPFC, commonly referred to as ‘hyperfrontality’, 
however other report decreased activation or ‘hypofrontality’. This picture of 
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differing FA in terms of the direction, extent and/or pattern of BOLD responses was 
attributed to the variation of domains and components of working memory tasks 
(Brown and Thompson, 2010; Manoach, 2003; Wager and Smith, 2003; Glahn et 
al., 2005). Also it was considered that methodological factors in the applied analyses 
(such as differences in behavioural performance at different working memory loads 
and their relationship with FA patterns) would contribute to these variations in FA 
(Manoach, 2003; van Snellenberg et al., 2006, Glahn et al., 2005). In addition, 
differences in medication could contribute to variation in the reported FA between 
studies. 
Here, we review fMRI studies using the numeric or verbal “N-back” task to enable 
comparability among the studies (as outlined in chapter 1.4.1) in subjects with 
established schizophrenia (EST) and healthy controls, which reported FA findings 
(Table 1.1). The reviewed studies present group differences between subjects with 
schizophrenia and healthy controls. 
In FA studies, evidence was reported for increased activation in DLPFC, PFC, 
ventral PFC (vPFC), medial frontal gyrus (MFG) and anterior cingulate (AC) during 
high working memory load in subjects with EST (Callicott et al., 2000; Callicott et 
al., 2003; Thermenos et al., 2005; Tan et al., 2006; Rasetti et al., 2011; Quidé et al., 
2013). However, reduced activation in prefrontal regions, such as vPFC, DLPFC, AC 
and parietal regions was found during high working memory load in subjects with 
EST (Callicott et al., 2000; Perlstein et al., 2001; Callicott et al., 2003). One study in 
FES found a reduction activation in IFG, superior frontal gyrus (SFG) and AC during 
high working memory load (Guerrero-Pedraza et al., 2012). We note three factors, 
which contributed to difficulties in comparing the findings across the reviewed 
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studies: (i) missing information of phase of schizophrenia (Tan et al., 2006), (ii)  
heterogeneous groups of subjects with EST (Callicott et al., 2000; Guerrero-Pedraza 
et al., 2012; Quidé et al., 2013), and (iii) limited information on antipsychotic 
treatment (Callicott et al., 2000; Callicott et al., 2003; Thermenos et al., 2005; Tan et 
al., 2006; Rasetti et al., 2011; Guerrero-Pedraza et al., 2012; Quidé et al., 2013). 
Fundamentally, none of the FA findings was interpreted in context of the dopamine 
or glutamate hypothesis. The lack of a clear understanding in terms of neural 
activation and pathophysiological mechanism (with and without performance 
differences) suggests there is a need for studies examining wider prefrontal circuitry 




Table 1.1 Schizophrenia as a cognitive brain disorder - Summary of main FA findings 







Subjects - Phase 
of 
Schizophrenia 
HC –  












Not reported Numeric “2-
back” 
   with increasing WM load 
in right DLPFC, left PFC, 
left AC; 
   with increasing WM load 







17 EST, stable 
injectable 




Main effect of group:    
subgenual AC gyrus;   
Group X WM load 
interaction for high WM 




14 patients2,  
subdivided into 
HP:    8 HC, 7 
patients; 










  and     for high WM load in 
different subdivisions of the 
right and left DLPFC in 14 
patients; 
Bilateral prefrontal areas of      
and    for high WM load in 
HP patients; 
Bilateral prefrontal areas of     
for high WM load in LP 
patients. 
Thermenos 
et al., 2005 
22 HC 
14 EST 
Not reported Verbal “2-
back” 
   for high WM load in right 
medial FG; 
   for hits during for high 
WM load in right medial 
FG. 
 
    Increased in subjects with schizophrenia in contrast to HC;  
    Decreased in subjects with schizophrenia in contrast to HC;  
AC, anterior cingulate; DLPFC, dorsolateral prefrontal cortex; dPFC, dorsal prefrontal cortex; 
EST, subjects with established schizophrenia; FES, subjects with first episode 
schizophrenia; FG, frontal gyrus; FGA, First-generation antipsychotics; HC, healthy controls; 
HF, hippocampal formation; HP, high-performers; HR, Subjects at high risk of schizophrenia; 
IFG, inferior frontal gyrus; IPL, inferior parietal lobe; LP, low-performers; OFG, orbitofrontal 
gyrus; PCi, posterior cingulate; PHG, parahippocampal gyrus; ROI, region of interest; SGA, 
Second-generation antipsychotics; SFG, superior frontal gyrus; SPL, superior parietal lobule; 
vPFC, ventral prefrontal cortex; vlPFC, ventrolateral PFC; WM, working memory. 
1 Patients with different schizophrenia subtypes, such as paranoid subtype, schizoaffective 
subtype, undifferentiated subtype; 
2 Phase of illness, illness onset and illness duration not reported. Phase of illness based on 
symptoms scores; 
3 Chlorpromazine equivalents in mg/day. 
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1.5.2.2 Positron emission tomography studies 
PET and SPECT imaging in schizophrenia research are used to investigate indirect 
markers of DA measures such as D2/3 receptors, presynaptic dopaminergic function, 
DA synthesis capacity, DA release and DA transporters. Three [H2
15O] PET studies 
consistently reported reduced rCBF in DLPFC and posterior cingulate (PCi) in 
verbal/numeric “2-back” in subjects with EST in contrast to healthy controls (Carter 










Subjects - Phase of 
Schizophrenia 
HC –  
HR, FES, EST 
Medication Experimental Paradigm PET Technique/Method Main Finding(s) 









No details of 
medication reported 
Verbal “2-back” rCBF measurement; 
Radioactive water [H215O] 
  for high WM load in   right 
DLPFC; 
  for high WM load in   right 
PPC; 
  for low WM load in right 
DLPFC, but not in right PPC. 
Meyer-Lindenberg 









13 patients not 
medicated for 
minimum 2 weeks; 
No details of 
medication reported 
Numeric “2-back” Multiple rCBF measurements; 
Administration of  bolus 
injection of 10  mCi of 
radioactive water [H215O] per 
scan; 
Condition X group interaction 
(high WM load):    in bilateral 
DLPFC and bilateal IPL; 
Condition X group interaction 
(high WM load):    in medial 
FG, left STG, right PHG, right 
ICG. 
Meyer-Lindenberg 






22 patients not 
medicated for 
minimum 2 weeks; 
No details of 
medication reported. 
Numeric “2-back” Multiple rCBF measurements; 
Administration of bolus 
injection of 10 mCi of 
radioactive water [H215O] per 
scan 
Group X task interaction (high 
WM load):    in right DLPFC 
and in left cerebellar region. 
    Increased in subjects with schizophrenia in contrast to HC;     Decreased in subjects with schizophrenia in contrast to HC;  
DLPFC, dorsolateral prefrontal cortex; EST, subjects with established schizophrenia; FES, subjects with first episode schizophrenia; medial FG, frontal 
gyrus; HC, healthy controls; HR, Subjects at high risk of schizophrenia; ICG, inferior occipital gyrus; IPL, inferior parietal lobe; mCi, millicurie; PHG, 
parahippocampal gyrus; PET, positron emission tomography; PPC, posterior parietal cortex; rCBF, regional cerebral blood flow; STG, superior temporal 
gyrus; WM, working memory. 
1 Phase of illness, illness onset and illness duration not specified; 
2 Patients with paranoid subtype; schizoaffective subtype; undifferentiated subtype. 
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1.5.3 Functional connectivity studies of verbal/numeric 
working memory 
FC studies mark the beginning of the notion of “disconnection” or “dysconnection” 
(Friston and Frith, 1995; Stephan et al., 2006; Stephan et al., 2009a) in investigating 
working memory deficits in people with schizophrenia. FC is defined as the statistical 
association or dependency among two or more anatomically distinct time-series 
(Friston and Frith, 1995). FC findings cannot be interpreted in terms of causal effects 
between connected regions and thus does not allow for a mechanistic inference of the 
BOLD responses. 
 
1.5.3.1 Functional magnetic resonance imaging studies 
FC studies applied voxel-based seed approaches to the BOLD response (Tan et al., 
2006; Rasetti et al., 2011; Guerrero-Pedraza et al., 2012), with the exception of one 
study, which applied an ROI-to-ROI approach (Quidé et al., 2013) (Table 1.3). 
Despite the use of equivalent methodological approach of voxel-based seed 
correlation, the FC findings are not entirely comparable due to the use of different 
seed locations. Findings of reduced connectivity involving subregions of the PFC 
were found in FES and EST. Reduced FC findings in subjects with schizophrenia 
and EST were reported in the majority of studies: (i) Reduced prefrontal-parietal1 FC 
in subjects with schizophrenia (Tan et al., 2006); (ii) Reduced prefrontal-
hippocampal, prefrontal-striatal and within-PFC FC in EST (Rasetti et al., 2011) and 
(iii) Reduced parieto-prefrontal FC and between putamen and ventrolateral PFC 
(vlPFC) in EST (Quidé et al., 2013). Further evidence for reduced FC between MFG 
                                                          
1 Reduced FC between the dorsal PFC and posterior PC.  
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and putamen was found in FES (Guerrero-Pedraza et al., 2012). In contrast to most 
studies that report reduced FC in the early and late phases of the illness, increased FC 
between the vPFC and posterior PC was shown in subjects with schizophrenia (Tan 
et al., 2006). The findings of both reduced and increased FC between subregions of 
the PFC and the posterior PC may be related to variations in behavioural response to 
task load for subjects with schizophrenia (Tan et al., 2006). Similar difficulties in 
comparing the FC findings among the studies are present as in the comparison of the 
FA studies due to unclear and missing information regarding the illness phase, 
diagnosis and medication treatment. Similarly, no reference is made to the dopamine 









Table 1.3 Schizophrenia as a cognitive brain disorder - Summary of main functional activation / functional connectivity findings in 





Subjects - Phase of 
Schizophrenia 
HC –  
HR, FES, EST 
Medication Experimental Paradigm Functional Connectivity 
Method 
Seed regions/ROIs/VOIs 




Tan et al., 2006 26 HC 
15 patients2,  
subdivided into 
HP:  14 HC, 8 
patients; 
LP: 12 HC, 7 
patients 
15 patients, 501 
(337.0)3; 
Numeric “2-back” Seed-based cross-correlation 
Seed regions: right dPFC and 
left vPFC; 
Functional ROIs 
10 mm sphere size 
 
 
   FA with increasing WM 
load in bilateral vPFC in 15 
patients; 
    FC between left vPFC and 
left SPL in 15 patients; 
    FC between right dPFC and 
bilateral IPL in 15 patients. 
Rasetti et al., 2011 153 HC 
78 EST2 
75 EST, FGA and 
SGA; 
3 EST, data missing; 
Numeric “2-back” Seed-based cross-correlation4 
Seed regions: right DLPFC  
Functional ROIs 
6 mm sphere size 
 
   FA for high WM load in 
right DLPFC; 
   FC between right DLPFC 
and bilateral HF; 
   FC between right DLPFC 
and right IPL. 
Guerrero-Pedraza 













Not reported Numeric “2-back” Seed-based cross-correlation 
Seed regions: left gyrus rectus, 
left IFG, left SFG, left AC, 
right PHG, right amygdala  
Functional ROIs 
Sphere size not reported 
 
   FA for high WM load    in 
left gyrus rectus, left IFG, left 
SFG, left AC, right PHG, right 
amygdala;  
    FC between medial FG and 
right precuneus; between 
medial FG and left OFG;                
between medial frontal gyrus 
and right precentral gyrus. 
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Quidé et al., 2013 28 HC 
28 EST1,2 
24 EST, 294.45 
(316.36)3; 
Numeric “2-back” ROI-to-ROI FC 
ROIs: bilateral DLPFC, vlPFC, 
putamen, caudate nuclei, IPL  
Functional ROIs 




    FA for high WM load in 
bilateral putamen, left DLPFC, 
OFC, cuneus and PC; 
   FC between left putamen 
and right vlPFC; 
   FC between left putamen 
and left vlPFC;   between right 
IPL and right vlPFC. 
    Increased in subjects with schizophrenia in contrast to HC;     Decreased in subjects with schizophrenia in contrast to HC;  
AC, anterior cingulate; DLPFC, dorsolateral prefrontal cortex; dPFC, dorsal prefrontal cortex; EST, subjects with established schizophrenia; FA, 
functional activation; FC, Functional connectivity; FES, subjects with first episode schizophrenia; FG, frontal gyrus; FGA, First-generation 
antipsychotics; HC, healthy controls; HF, hippocampal formation; HP, high-performers; HR, Subjects at high risk of schizophrenia; IFG, inferior frontal 
gyrus; IPL, inferior parietal lobe; LP, low-performers; OFG, orbitofrontal gyrus; PC, posterior cingulate; PHG, parahippocampal gyrus; ROI, region of 
interest; SGA, Second-generation antipsychotics; SFG, superior frontal gyrus; SPL, superior parietal lobule; vPFC, ventral prefrontal cortex; vlPFC, 
ventrolateral PFC; WM, working memory. 
1 Patients with different schizophrenia subtypes, such as paranoid subtype, schizoaffective subtype, undifferentiated subtype; 
2 Phase of illness, illness onset and illness duration not reported. Phase of illness based on symptoms scores. 
3 Chlorpromazine equivalents in mg/day 








1.5.3.2 Positron emission tomography studies 
In PET studies, reduced prefrontal-hippocampal FC findings in subjects with 
schizophrenia in contrast to healthy controls (Meyer-Lindenberg et al., 2001; Meyer-
Lindenberg et al., 2005) confirmed the hypothesis of reduced functional connections 
in working memory (Table 1.4). Correlational PET studies provided indirect support 
for dopaminergic alterations during working memory function by significant 
correlations between rCBF and behavioural performance of the “2-back” task in 
subjects with schizophrenia (Abi-Dargham et al., 2002; Fusar-Poli et al., 2010). 
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Subjects - Phase of 
Schizophrenia 
HC –  
HR, FES, EST 
Medication Experimental Paradigm Functional Connectivity 
Method 
Seed regions/ROIs/VOIs 





et al., 2001 
13 HC 
13 patients1,2 
13 patients not 
medicated for 
minimum 2 weeks; 
No details of 
medication reported 
Numeric “2-back” Canonical variates analysis; 




Negative FC between ITL, HC 
and CER in patients; 
Positive FC between DLPFC 
and CG in HC; 
Meyer-Lindenberg 
et al., 2005 
22 HC 
22 patients 
22 patients not 
medicated for 
minimum 2 weeks; 
No details of 
medication reported. 
Numeric “2-back” Linear covariation approach; 
VOIs: HF (incl. ipsilateral 
temporal lobe) and medial 
frontal cortex (incl. AC); 
Anatomical VOIs; 
Sphere size not reported. 
 
Positive correlation between 
left HF and right DLPFC for 
high WM load in patients. 
Negative correlation between 
left HF and right DLPFC for 
high working memory load in 
HC. 
AC anterior cingulate; CER, cerebellum; CG, cingulate gyrus; DLPFC, dorsolateral prefrontal cortex; EST, subjects with established schizophrenia; FC, 
functional connectivity; FES, subjects with first episode schizophrenia; HC, healthy controls; HF, hippocampal formation; HR, Subjects at high risk of 
schizophrenia; ITL, inferior temporal lobe; WM, working memory. 
1 Phase of illness, illness onset and illness duration not specified; 




In summary, findings presented by FC studies during the “N-back” task have paved 
the way for the understanding of large-scale functional networks in working 
memory. Furthermore, the insight of brain alterations in subjects with schizophrenia 
has advanced with FC from individually activated regions to connectivity between 
brain regions. The perspective of circuit-based neurobiology and cognitive brain 
function opens the doors for translational research from preclinical and clinical 
research in schizophrenia. However, FC is limited as the connection assessments are 
based upon regional correlations and this approach does not allow inferences of 
directions or causality between connected regions (Friston et al., 2003). 
In summary, fMRI and PET studies in the field of clinical and cognitive 
neurosciences have been used to investigate brain function during working memory 
in people with schizophrenia. Both fMRI and PET findings have advanced the 
understanding of altered working memory performance, brain function and FC in 
subjects with schizophrenia by linking their findings to preclinical evidence and two 
versions of the dopamine hypothesis (i.e. the ‘Modified dopamine hypothesis’ 
(chapter 1.3.2.1.2) and the ‘Dopamine hypothesis: version III’ (chapter 1.3.2.1.2) as 
summarised in Figure 1.1. This has led to better insight into the interaction between 
altered working memory function and experimental/clinical factors (such as 
cognitive domains of working memory function, performance level, phases of illness, 
clinical symptomatology and effects of antipsychotic medication) in individuals with 
schizophrenia. We suggest that studies such as these reviewed here have contributed 






Figure 1.1 Understanding of schizophrenia as a cognitive brain disorder – 
Verbal/numeric “N-back” task (Reproduced from Dauvermann et al., 2014). 
a fMRI;  
b PET Positron emission tomography 
 
1.6 Discussion 
The two main neurobiological hypotheses of schizophrenia, the dopamine hypothesis 
and the glutamate hypothesis, have deeply influenced the understanding of 
schizophrenia as a brain disorder. More recently, those two hypotheses have 
introduced the notion of schizophrenia as a cognitive brain disorder, which has its 
basis from findings of altered dopaminergic and/or glutamatergic neurotransmission 
modulating and mediating working memory dysfunction in schizophrenia. Both the 




neuroscientists to examine the underlying neurobiological mechanisms of working 
memory impairment in individuals with schizophrenia with the potential of gaining a 
better insight into the pathophysiological pathway of working memory deficits. 
Researchers in clinical and cognitive neurosciences have advanced the understanding 
of altered working memory function in subjects with schizophrenia. FMRI and PET 
studies in working memory among other neuroimaging and electrophysiological 
techniques, have reported on FA and FC findings in subjects with schizophrenia. The 
reviewed findings of FA and FC during the verbal/numeric “N-back” task revealed 
significantly reduced or increased BOLD responses or FC findings in subjects with 
schizophrenia in contrast to healthy subjects. These FC findings have introduced the 
notion of human large-scale networks underlying brain function during working 
memory and have formed the understanding of schizophrenia as a cognitive brain 
disorder. 
In regard to the interpretability of FA and FC findings in context of the dopamine 
hypothesis and glutamate hypothesis we conclude that neither the FA nor the FC 
findings can fulfil this criterion due to the technical and methodological nature of 
the BOLD contrast (for the FA results) and the correlational analysis (for the FC 
results). For the FC findings, the correlational analyses do not allow for the inference 
of directions or weights of in functional connections. Thus, from FC findings it is not 
possible to draw inferences on causal processing. 
Neurobiological hypotheses offer the potential for translational neuropsychiatry from 
preclinical to clinical data in schizophrenia. However, the challenge is to find 
equivalent techniques to interpret clinical neuroimaging data translationally to 




fMRI, which has been introduced by Friston (Friston et al., 2003). By the means of 
DCM, mechanistic responses can be inferred from the computational modelling 
of cognitive brain function where the localised brain function is monitored 
through the BOLD response (Stephan and Mathys, 2014). This modelling 
approach may further our understanding of the neurobiological processes, which 



























2 Modelling of functional large-scale 




















Clinical and cognitive neurosciences have advanced the understanding of altered 
working memory function in subjects with schizophrenia through the use of 
neuroimaging. The notion of schizophrenia as a ‘disconnection’ and ‘dysconnection 
disorder has been introduced, which has its beginnings in the idea of altered brain 
connectivity (Friston and Frith, 1995; Stephan et al., 2006; Stephan et al., 2009a) or 
altered functional large-scale networks. 
 
Recent studies examining biophysical mechanisms underlying altered functional 
large-scale networks aim to bridge the gap between the human functional network 
activated in cognitive function such as working memory and preclinical 
neurobiological processes modulating cognitive function. Examples of such 
computational neuropsychiatric studies include EC of fMRI studies during working 
memory in subjects with schizophrenia among other modalities such as EEG and 
magnetoencephalography (MEG). The modelling of functional large-scale networks 
during working memory function could provide mechanistic explanations for altered 
brain function in individuals with schizophrenia. The advantage of modelling functional 
large-scale networks in terms of EC over FC is that inferences can be drawn on 
mechanistic processes based on probabilistic inference. We compare EC methods (i.e. 
Structural Equation Modelling (SEM), psychophysiological interaction (PPI), 
Granger causal modelling (GCM) and DCM) to analyse fMRI data before we focus 





In our review of EC studies, we focus on DCM studies for fMRI investigating the 
numeric/verbal “N-back” task in subjects with schizophrenia and healthy controls 
and consider those studies in context of the dopamine and glutamate hypotheses of 
schizophrenia. DCM has been selected over other methods for assessing EC 
measures in working memory in subjects with schizophrenia such as SEM studies, 
Granger causality studies and PPI studies. DCM provides for the indirect 
measurement of altered synaptic plasticity processes via task-dependent changes in 
given models (Stephan et al., 2008; Stephan and Friston, 2010). Thus, it provides for 
the analysis of the numeric/verbal “N-back” task, which is sensitive to cognition 
impairments associated with schizophrenia. The potential of DCM research lies in 
the biophysical modelling of fMRI data in individuals with schizophrenia and this 
could result in development in the interpretability of clinical neuroimaging data in 
patients and may therefore lead to more effective treatments. 
 
In this chapter, we summarise findings from studies modelling working memory 
function. In particular, evidence for modelling synaptic plasticity and gating 
mechanisms underlying the working memory function is considered. Furthermore, 
findings of disruptions of synaptic plasticity and gating processes in schizophrenia 
are presented (chapter 2.2.2). Evidence for these disruptions are presented for the 
thalamo-cortical and meso-cortical connection, which are known to be implicated in 
cognitive dysfunction and pathophysiology of schizophrenia. In the next step, DCM 
studies examining EC during working memory in people with schizophrenia 




regard to the dopamine hypothesis and glutamate hypothesis of schizophrenia 
(chapter 2.2.4). 
 
2.2 Computational modelling of working memory in 
schizophrenia 
2.2.1 Computational neuroscience 
New insights into the high-level computations of the brain such as working memory 
and its alterations in schizophrenia have been reported from computational modelling 
studies. These insights were enabled by the multi-disciplinary approach of 
computational neuroscience and preclinical neurobiology. The computational 
neuroscience approach has been influenced by Marr’s theoretical framework for 
computational neuroscience research comprising three levels (Marr, 1976), which 
has paved the way for the computational implementation of preclinical 
neurobiological findings. 
Modelling of neurobiological processes of synaptic plasticity and gating mechanisms 
lie at the basis of computational modelling approaches of learning and cognitive 
processes. These findings may lead to a better understanding of altered cognitive 
function such as working memory via altered functional large-scale networks in 





2.2.2 Computational modelling of synaptic plasticity and 
gating mechanism 
Short-term synaptic modulation encompasses biophysical processes which are 
known to be highly relevant for cognitive tasks (Abbott and Regehr, 2004; Deng and 
Klyachko, 2011; Neher and Sakaba, 2008; Pan and Zucker, 2009). It has been 
reported that probabilistic computational modelling of short-term depression 
processes resembles gating mechanisms at the synaptic level (Pfister et al., 2010). 
It is assumed that nonlinear effects originate from activity-dependent synaptic 
plasticity processes (Abbott et al., 1997; Rothman et al., 2009; Salinas and 
Sejnowski, 2001; Shu et al., 2003), which gate cognitive functions (Salinas and 
Sejnowski, 2001; Stephan et al., 2008) in a multiplicative nonlinear way. Gating 
processes show comparable nonlinear mechanisms (Abbott et al., 1997; Ardid et al., 
2007; Berends et al., 2005; Chance et al., 2002; Freyer et al., 2011; Murphy and 
Miller, 2003; Rothman et al., 2009; Salinas and Sejnowski, 2001; Shu et al., 2003). 
This indicates that neurons from two or more sources integrate information for 
cognitive performance (Salinas and Sejnowski, 2001; Stephan et al., 2008). 
It has been shown that gating at the synaptic level is mediated by glutamatergic 
neurotransmission (Berends et al., 2005; Neher and Sakaba, 2008; Pan and Zucker, 
2009; Sun and Beierlein, 2011; Volman et al., 2010), which is modulated by 
excitatory (mainly glutamatergic) and inhibitory (inhibitory interneurons) inputs 
(Murphy and Miller, 2003; Salinas and Sejnowski, 2001; Salinas and Sejnowski, 





There is evidence that alterations of glutamatergic neurotransmission may contribute 
to disrupted synaptic plasticity in schizophrenia (Balu and Coyle, 2012; Coyle, 
2006). The glutamate hypothesis of schizophrenia proposes that altered 
glutamatergic modulation may underlie the pathophysiology of the disorder (Coyle, 
2006; Coyle et al., 2010; Javitt, 2010). This suggests that Glu neurotransmission, 
specifically NMDA receptor-mediated transmission, may be disrupted in 
schizophrenia (Goff and Coyle, 2001; Goff et al., 1995; Javitt et al., 1994; 
Moghaddam et al., 1997). Despite the evidence for glutamatergic neurotransmission, 
it is thought that altered interactions between glutamatergic and dopaminergic 
neurotransmission may lead to the cortical dysconnectivity in schizophrenia (Alelú-
Paz and Giménez-Amaya, 2008; Coyle, 2006; Javitt, 2010; Moghaddam et al., 1997). 
It is further known that other neurotransmitters such as GABA among others is 
implicated in neurotransmitter systems in prefrontal deficits (Thierry et al., 1988; 
Simpson et al., 1989; Akbarian et al., 1995; Lewis and Burgos-Gonzalez, 2008; 
Burgos-Gonzalez et al., 2010). 
The majority of recent computational studies focused on the investigation of gating 
mechanisms on circumscribed connections between two brain regions, i.e. the 
thalamo-cortical connection and the meso-cortical connection. It is noted that the 
focus on these two connections is a simplification of a more complex circuit system, 
which has not been fully understood yet. Hypotheses and theories have been 
proposed, which posit a complex system consisting of interaction between several 
neurotransmitter systems (i.e. DA, Glu, GABA, 5-HT) and several brain regions (i.e. 
(DL)PFC, MD thalamus, VTA/SN area, hippocampus and striatum) (Mantz et al., 




2.2.2.1 Thalamo-cortical connection 
Thalamo-cortical synapses underlie nonlinear dynamic modulation (Chance et al., 
2002; Deng and Klyachko, 2011; Destexhe, 2009; Negyessy and Goldman-Rakic, 
2005), which indicates gating of the thalamo-cortical connection (Alelú-Paz and 
Giménez-Amaya, 2008; Chance et al., 2002; Deng and Klyachko, 2011; Destexhe, 
2009; Kolluri et al., 2005; Negyessy and Goldman-Rakic, 2005). Gating mechanisms 
have also been shown to be implicated for the cortico-thalamic connection (Freyer et 
al., 2011; Shu et al., 2003). 
Neurobiological studies examining neurotransmission underlying the thalamo-
cortical connection in schizophrenia showed that this thalamo-cortical projection is 
primarily altered by excitatory glutamatergic neurotransmission (Balu and Coyle, 
2012; Gray and Roth, 2007; McCormick and Bal, 1997; Romanides et al., 1999; 
Watis et al., 2008), which could be attributed to NMDA receptor dysfunction (Kiss et 
al., 2011; Santana et al., 2009), but also to thalamic inhibitory interneurons 
(Augustinaite and Heggelund, 2007; Crandall and Cox, 2012; Errington et al., 2010; 
Lewis and González-Burgos, 2008; Neher and Sakaba, 2008; Pan and Zucker, 2009), 
interneurons in the DLPFC (Wang, 2010); mGluR (Jones, 1997; Newpher and 
Ehlers, 2008; Pinault, 2011; Sodhi et al., 2011) and ionotropic receptors (Meador-
Woodruff et al., 2003). 
 
Findings from neurobiological preclinical studies suggest that altered gain control 
(i.e. nonlinear modulation of neuronal connections) of the thalamo-cortical 
connection could be one of the underlying factors for altered cortical dysconnectivity 




In patients with schizophrenia, alterations of the thalamus, in particular the MD 
thalamus, have been associated with the pathology of schizophrenia (Clinton and 
Meador-Woodruff, 2004; Meador-Woodruff et al., 2003; Oh et al., 2009) because of 
its cortio-thalamo-cortico network (Briggs and Usray, 2008; Kantrowitz and Javitt, 
2012; Oh et al., 2009). Alterations of cortical dysfunction and cognitive deficits have 
been reported in HR and patients with schizophrenia in verbal fluency tasks (Curtis 
et al., 1998; Fu et al., 2002; Fusar-Poli et al., 2011; Clinton and Meador-Woodruff, 
2004; Jones, 1997; Meador-Woodruff et al., 2003). FC studies also demonstrated that 
the connection between the left MD thalamus and the DLPFC was disrupted, which 
emphasises the crucial role of the thalamo-cortical connection in schizophrenia 
(Hazlett et al., 2004; Krystal et al., 2003; Mitelman et al., 2005; Thermenos et al., 
2004). These alterations of the thalamo-cortical connection may contribute to cortical 
dysfunction observed in schizophrenia (Balu and Coyle, 2012; Byne et al., 2009; 
Lewis and Lieberman, 2000; Pakkenberg et al., 2009; Sodhi et al., 2011; Watis et al., 
2008). 
 
2.2.2.2 Meso-cortical connection 
Findings from preclinical and computational studies suggest that working memory 
could be gated at the level of microcircuits in the PFC (Salinas and Sejnowski, 2001; 
Deng and Klyachko, 2011; Barak et al., 2010; Mongillo et al., 2008; Pfister et al., 
2010; Wang et al., 2010). It is thought that working memory as an executive function 
is centred on the (DL)PFC based on its role as a highly recurrent area (Goldman-
Rakic, 1995; Deng and Klyachko, 2011; Brunel and Wang, 2001; Miller and Wang, 




prefrontal-midbrain regions (i.e. VTA (Levin et al., 1994; Romanides et al., 1999; 
Tzschentke, 2001; Wang et al., 2010). 
The neurobiological neurotransmission of the meso-cortical connection in working 
memory is based on the same synaptic plasticity and gating mechanism processes as 
summarised for the thalamo-cortical connection (chapter 2.2.2). Evidence of 
neuromodulation of the gating mechanism of the meso-cortical connection has been 
shown to be mediated by DA (Durstewitz et al., 2000; Gao et al., 2003) and Glu 
(Tzschentke, 2001; Wang et al., 2010; Arnsten et al., 2010; Arnsten et al., 2012) such 
as AMPA receptors (Gao and Wolf, 2007; Sun et al., 2005) and NMDA receptors 
(Berends et al., 2005; Durstewitz, et al., 2000; Gao and Wolf, 2008; Tseng and 
O’Donnell, 2004). 
 
In clinical fMRI studies, altered BOLD responses of the VTA/SN area in working 
memory in patients with schizophrenia in contrast to healthy controls have been 
reported (Braver et al., 1999; Braver and Cohen, 1999; Hazy et al., 2006). 
Furthermore, Braver and Cohen proposed the theory that altered midbrain activation 
could results from altered gating of the VTA (Braver et al., 1999; Braver and Cohen, 
1999). Evidence from two recent studies provide support for altered VTA/SN 
activity during working memory in healthy controls, which has been interpreted as an 
indication of dopaminergic modulation of meso-cortical gating (Murty et al., 2011; 
D’Ardenne et al., 2012). Murty et al., (2011) examined FC from the VTA/SN area 
via the caudate to the DLPFC. D’Ardenne et al., (2012) suggested gain modulation 
between the VTA/SN and the DLPFC using a combined fMRI and transcranial 




working memory performance, which ensured the computation of signal changes of 
the VTA/SN area and the DLPFC. In summary, it has been suggested that gain 
control processes could be altered in people with schizophrenia, which could result in 
(DL)PFC dysfunction and working memory impairment in patients with 
schizophrenia when compared to healthy controls (Wang et al., 2010; Pettersson-Yeo 
et al., 2011; D’Ardenne et al., 2012). 
 
2.2.3 Computational psychiatry and computational 
neuropsychiatry 
Computational psychiatry is an emerging field within computational neuroscience.  
Computational psychiatry aims to provide an explanatory bridge between altered 
cognitive function and neurobiological mechanisms associated with the development 
of mental illness (Huys et al., 2011; Montague et al., 2012). Computational 
psychiatry in humans has been defined by outlining a set of components, which 
include biophysical modelling and computational modelling (Montague et al., 2012). 
Different types of computational models at different neural levels are used dependent 
on the study hypothesis (Huys et al., 2011). 
 
Computational neuropsychiatry is a subfield of computational psychiatry, which is 
particularly concerned with the modelling of functional large-scale networks. 
Computational neuropsychiatry aims to provide an insight into neurobiological 
processes, which mediate altered cognitive function such as working memory 
function in individuals with schizophrenia. 




subjects with schizophrenia have added to our understanding of both the brain 
function and the neurobiological mechanism underlying working memory (Cohen et 
al., 1996; Braver et al., 1999). The strength of these models are based on the 
translational link between human brain function (i.e. FA) and preclinical 
neurobiological evidence (namely, dopaminergic modulation) during working 
memory. 
Following on from the work of Cohen and Braver, evidence for the understanding of 
schizophrenia as a cognitive network disorder has been presented by both preclinical 
studies (Tanaka et al., 2006; Lewis and Moghaddam, 2006; Lewis and Gonzalez-
Burgos, 2008; Gonzalez-Burgos, 2010; Volk et al., 2010, Seshadri et al., 2013) and 
human FC studies in working memory (Tan et al., 2006; Rasetti et al., 2011; 
Guerrero-Pedraza et al., 2012; Quidé et al., 2013). 
Recent studies examining biophysical mechanisms underlying altered functional 
large-scale networks aim to bridge the gap between the human functional network 
used in working memory and the preclinical neurobiological processes. Examples of 
such computational neuropsychiatric studies, including EC of working memory in 
subjects with schizophrenia, are reviewed. In this, we focus on DCM studies 
investigating the numeric/verbal “N-back” task in subjects with schizophrenia and 
healthy controls. These findings are considered in the context of the dopamine and 





2.2.4 Biophysical modelling of functional large-scale 
networks from fMRI data – Dynamic causal modelling 
for fMRI 
2.2.4.1 Effective connectivity 
EC has been introduced to provide insight into the notion of ‘functional 
integration’ during cognitive performance. ‘Functional integration’ has been 
advanced from the historic notion of ‘functional specialization’ (Friston, 2002) and is 
defined by context-dependent interactions among different brain regions (McIntosh, 
2000; Friston et al., 2003). 
Four methods for the EC assessment of fMRI data have been developed: (i) SEM; 
(ii) PPI; (iii) GCM; and (iv) DCM; the latter two are considered biophysical 
modelling methods. We provide an overview over those four methods before we 
outline the advantages and disadvantages in the application of DCM.   
 
2.2.4.2 Methods for the assessment of effective connectivity of fMRI 
data 
2.2.4.2.1 Psychophysiological interaction 
The first EC analysis was published in 1995; this analysis was extended in the 
following years and was named PPI (Friston et al., 1997). PPIs were defined as 
interaction effects between the responses of one region, another region and 
experimental (i.e. task-related) variables (Friston et al., 1997). This PPI method is 
seen as the first application of EC and forms the basic concept for DCM, which was 
developed in 2003 (Friston et al., 2003) since the interaction terms introduce context-





2.2.4.2.2 Structural equation modelling 
In clinical and cognitive neurosciences, SEM has been introduced to analyse EC for 
PET data (McIntosh et al., 1994) and fMRI data (Büchel and Friston, 1997). In the 
following years, SEM has been applied to a variety of higher cognitive functions 
such as verbal/numeric working memory fMRI data in healthy controls and/or 
individuals with schizophrenia (for example, Honey et al.; 2002; Schlösser et al., 
2003a; Schlösser et al. 2003b) for the hypothesis-driven investigation of underlying 
functional large-scale networks.  
The application for SEM for fMRI studies is based on the methodological 
framework of the ‘measurement model’ and the ‘structural model’ (Schlösser et al. 
2006), which both describe relationships between measures and unobserved 
variables in the data set. SEM is a multivariate tool to examine a priori hypotheses 
about connections (and their directions) among specified regions in a network for a 
given fMRI data set. In SEM, EC can be defined ‘within a path model as a system of 
linear equations’ (Schlösser et al. 2006). The path coefficients are computed by the 
minimization of the difference between observed and estimated variables. Thus, EC 
is measured as the change of activation in one region (‘target region’) in dependence 
to the change of activation of another region (‘source region’) and covaried over all 
participants (of a population group) or over time. 
A comparison between SEM and DCM for fMRI data has been published previously 
(Penny et al., 2004). There are two general commonalities, which SEM and DCM 
share: Firstly, the basic concept of both approaches is model comparison of fMRI 




and EC changes due to a specific experimental task. At the same time, SEM and 
DCM can be differentiated by the generative models used to assess EC measures. In 
SEM, the assessment of changes in EC are linked to changes of haemodynamic 
changes underlying the observed BOLD signal. In contrast, in DCM, task-dependent 
changes in EC are measured at the neuronal level, which are compared with the 
observed haemodynamic signal by Bayesian inference (Buxton et al.; 1998). We 
selected the application of DCM over SEM to increase the biological interpretability 
of EC changes measured at the neuronal level.  
 
2.2.4.2.3 Granger causal modelling 
Granger causality was developed in the 1960s and has been widely used in 
economics since then (Granger, 1969). GCM rests on the concept Granger causality 
and the implementation of vector autoregressive models for fMRI data (Harrison et 
al., 2003), which forms the conceptual basis for the modelling approach for fMRI 
data (Goebel et al., 2003; Roebroeck et al., 2005). The development from vector 
regressive models to GCM is based on progress of Bayesian inference methods 
(such as haemodynamic models, model inversion and Bayesian model selection), 
which have contributed to the development of DCM (Stephan and Roebroeck, 
2012).  
The aim of Granger causality to fMRI data is to provide a description of (i) the 
structural and/or (ii) functional network underlying the given fMRI data, where the 
second case is part of GCM. For the structural network, indirect interactions and 




understood as the combination between the network structure and the modulations 
of the functional task in relation to the network structure (Seth, 2005).  
GCM has been applied to measure nonlinear connectivity (Marinazzo et al., 2011). 
Different nonlinear approaches have been proposed, which have used autoregressive 
and Kernel methods (Marinazzo et al., 2011). In particular, Kernel methods have 
received attention for the modelling of nonlinearity (‘Kernel Granger Causality’).   
Reviews on the comparison of GCM and DCM for fMRI data (for example, Stephan 
and Roebroeck, 2012) and Kernel Granger Causality have been published 
(Marinazzo et al. 2011). GCM and DCM are both generic models that are based on 
the conceptual framework of the haemodynamic forward model to infer EC from 
fMRI data. Furthermore, both approaches share model inversion techniques for the 
model validation, which enables the assessment of changes in EC (Stephan and 
Roebroeck, 2012). The main differences between GCM and DCM lies in the applied 
approaches, which lead to potential problems of robustness of statistical analyses 
and biophysical interpretability of EC measures. GCM has been questioned for 
dealing with uncertainty of model parameters and neurobiophysical interpretability. 
DCM has been criticised for robustness of Bayesian inversion techniques (Stephan 
and Roebroeck, 2012). GCM and DCM are the only EC methods that have 
developed methods to assess nonlinear EC measures. In GCM, Kernel Granger 
Causality is based on Kernel methods to measure nonlinear effects in fMRI data 
(Marinazzo et al. 2011), whereas nonlinear DCM is based on the multiplicative 
computation of nonlinear modulation in DCM (Stephan et al., 2008). We selected 
DCM for the measurement of (nonlinear) EC over GCM because (i) DCM allows 




modulation is similar to equations used for gating mechanism (Salinas and 
Sejnowski, 2001), which is not provided by GCM (Marinazzo et al. 2011).       
     
2.2.4.2.4 Dynamic causal modelling for fMRI 
DCM has been described as a biophysical modelling approach of neuronal dynamic 
processes (Friston et al., 2003; Friston and Dolan, 2010)2, which can be used as a 
method for the computation of synaptic plasticity from fMRI task-based studies 
(Stephan et al., 2006, 2009a). Together biophysical modelling and Bayesian 
inference analysis form the framework for DCM (Daunizeau et al., 2011a; 
Daunizeau et al., 2011b; Stephan and Friston, 2010). Thus, DCM is a modelling 
approach, which combines defined network models (i.e. hypotheses) with Bayesian 
inversion methods (Friston and Dolan, 2010; Daunizeau et al., 2011a). Specifically, 
DCM assesses interregional EC through assessment of experimentally induced 
changes (Friston et al., 2003) and therefore allows for mechanistic inferences from 
neuronal function. Interregional EC is assessed by three modulations, which are 
defined in the model space: (i) Matrix A denotes endogenous connection strength 
between two regions in the absence of experimental manipulations (‘intrinsic 
connections’); (ii) Matrix B reflects the experimental task modulation; and (iii) 
Matrix C denotes the connection strength of driving inputs, which represent extrinsic 
parameters that change the neuronal state of brain regions within the model (i.e. 
visual presentation of stimuli of the experimental task). 
DCM for fMRI has been extended to nonlinear DCM to capture nonlinear 
interactions within the functional network (Stephan et al.; 2008). In nonlinear DCM, 
                                                          
2 We consider DCM as the generative model approach as introduced in the seminal article by Friston 




the assessment of EC has been advanced to model connection strengths, which are 
modulated by the neural activity in one or more network regions (Matrix D; 
Stephan et al., 2008). The computation for the nonlinear modulation uses similar 
equations as previously reported in computational neuroscientific studies (Salinas 
and Sejnowski, 2001; Volman et al., 2010).  
 
We summarise main advantages and disadvantages of DCM. The main advantages in 
the use of DCM over other EC methods are:  
(i) The ability to model the experimental task modulation enables the 
investigation of task parameters.  Thus, changes in connection strengths of 
the modulatory input (Matrix B) can be directly linked to the experimental 
condition of the task and therefore be interpreted in terms of learning. 
(ii) The forward model of DCM, which lies at the basis of the conceptual 
framework of DCM for fMRI, in combination with Bayesian inference the 
haemodynamic “Balloon” model (Buxton et al.; 1998) has led to the 
implementation of DCM as the first generative model of fMRI data (Stephan 
and Roebroeck, 2012). DCM allows to infer EC at a neuronal level in 
contrast to the BOLD level in the other EC methods, which minimizes the 
interregional variance in BOLD responses (Stephan and Roebroeck, 2012). 
(iii) Nonlinear DCM for fMRI enables the modelling of connection strength with 
nonlinear modulation, which has the potential to increase the biophysical 
plausibility of modelling fMRI data. 
(iv) Developments in Bayesian inference methods for the use of DCM have 




models in subjects, which may be relevant for clinical studies (Penny et al., 
2010).     
Not only advantages but also disadvantages in the application of DCM have been 
raised. The main disadvantages can be subdivided into (i) limitations of biophysical 
interpretability and (ii) robustness of statistical inference methods (Daunizeau et al., 
2011a): 
(i) DCM for fMRI has undergone developments to increase the biophysical 
plausibility despite the extension of nonlinear DCM for fMRI. One of the main 
criticism is based on the limited temporal resolution of fMRI (Friston et al., 
2003; Roiser et al., 2013) to measure biophysical mechanisms from EPI time 
series (Daunizeau et al., 2011a; Friston et al., 2012). Thus, DCM can only be 
used as an indirect measure of synaptic plasticity when specific conditions are 
considered: Firstly, a principled investigation of assessment of connection 
strengths of task-dependent change in a given model space, which can be 
interpreted as synaptic plasticity (i.e. learning). Secondly, findings derived from 
DCM analyses cannot be solely interpreted as changes of neurotransmitter 
systems underlying the experimental task. Neuropsychological and 
neurocognitive interpretations should be considered in context of modelling of 
functional large-scale network findings.  
(ii) The robustness of the statistical inference techniques used in DCM10 and 
DCM12 for all modalities in addition to fMRI has been discussed (Daunizeau et 
al., 2011a), which may result in the risk of unstable results over repeated runs of 




In summary, DCM is a useful tool for inferring EC underlying neural responses when 
DCM is applied in a principled and systematic way as a generic model when 
advantages and disadvantages are considered. Furthermore, the interpreted DCM 
findings in terms of neurobiological context (i.e. neurotransmitter systems) are 
complemented by neurocognitive interpretations. 
 
2.2.4.3 Effective connectivity studies of verbal/numeric working 
memory in healthy subjects and subjects with schizophrenia 
The first DCM studies in healthy controls described large-scale networks in working 
memory and a similar task (continuous performance test; Tana et al., 2010; Wang et 
al., 2009; Brázdil et al., 2007).  A  recent  study  in  healthy  controls  built  the  
linkage  between  EC results and underlying dopaminergic modulation of large-scale 
networks comprising of the DLPFC and PC during working memory performance 
(Tan et al., 2012). 
To date four DCM studies have examined the verbal/numeric “N-back” task in 
subjects with schizophrenia using bilinear DCM (Crossley et al., 2009; Deserno et 
al., 2012; Schmidt et al., 2013; Zhang et al., 2013) (Table 2.1). These provide novel 
insights into reduced task-dependent EC and increased task-independent EC 
measures through modelling large-scale networks in schizophrenia. 
 
In the first study, increased fronto-temporal intrinsic connectivity was found to be 
associated with increased FA of the superior temporal gyrus (STG) during the 
numeric “N-back” task in the subjects at the prodromal and at the acute psychotic 




suggested to be a potential marker for vulnerability to the disorder (Crossley et al., 
2009). Furthermore, progressively decreased intrinsic connectivity between the STG 
and the MFG in ARMS and FES subjects in contrast to the healthy controls  
was reported. This finding suggested that FA may resemble increased task-
independent EC between the PFC and the STG. However, the results of the study 
are not comparable to other DCM studies because (i) only one model was examined 
and (ii) the biological plausibility of the EC measures is not clearly accessible. No 
reference to the dopamine or glutamate hypotheses was made. 
The second study investigated the working memory-dependent modulatory effect for 
the prefrontal-parietal connectivity in subjects with EST and healthy subjects during 
the numeric “N-back” task (Deserno et al., 2012). The large-scale networks 
included the right DLPFC, the PC and the visual cortex (VC) with bidirectional 
connections between all regions. The main finding was decreased task-dependent 
EC from the DLPFC to the PC in the subjects with EST in contrast to healthy 
controls. Thus, this finding could resemble evidence for the glutamate hypothesis of 
schizophrenia, specifically the NMDA receptor hypofunction model and the 
dysconnection hypothesis. 
The third study examined possible vulnerability markers for psychosis from the 
verbal “N-back” task in ARMS subjects, FES subjects and healthy subjects 
(Schmidt et al., 2013). This study examined reduced task-dependent EC measures as 
well as relationships between connectivity parameters and antipsychotic medication 
received by subjects. In this study, EC in interhemispheric large-scale networks 
between the bilateral superior parietal lobes (SPL) and the bilateral MFG was 




memory and induced modulation of connectivity between the MFG and the SPL 
(from healthy subjects to ARMS). Additionally, further decreased EC of 
modulatory effects were observed in non-medicated subjects with FEP contrasted 
to healthy controls. Evidence for amelioration of reduced EC between the MFG 
and the SPL in subjects with FES, who received SGA medication, could reflect 
alterations of dopaminergic regulation of NMDA receptor–dependent synaptic 
plasticity of fronto-parietal connections. However, this interpretation is limited by 
the lack of a control group of FES who are treated with different types of 
antipsychotic medication. These findings across different subpopulations of 
schizophrenia together with the effect of antipsychotic medication may reflect 
support for the NMDA receptor hypofunction model and the dysconnection 
hypothesis. 
In the fourth study, Zhang et al (2013) explored EC measures in terms of possible 
neurobiological markers in groups of FES with high or low suicide risk and 
contrasted these with healthy controls during the verbal “N-back” task. The large-
scale networks were defined by unidirectional and bidirectional connections between 
the two regions of the medial PFC and PC as well as working memory effects on 
these regions. This pilot study presented novel findings in FES at suicidal risk in 
terms of increased intrinsic connectivity from the PC to the MFG in both groups 
with FES (in comparison to healthy controls). This finding was interpreted as a 
possible association to schizophrenia, in which increased intrinsic connectivity from 
the MFG to the PC in the subjects with high risk of suicide could reflect 
vulnerability of suicide. However, the results are not directly comparable to the 




suicide. The findings were also not interpreted in context of the dopamine or 
glutamate hypotheses. 




Table 2.1 Schizophrenia as a cognitive brain network disorder - Summary of main findings in verbal/numeric working memory – 






Subjects - Phase 
of Schizophrenia 
HC – 





Number of models      
Regions 
DCM Settings – 
DCM version   






















1 left hemispheric 
model; 
STG, SMA, MFG, 
INS, PPC  
DCM in SPM5; 
Sphere sizes not 
reported; 
BMS not performed 
Progressively     IC 
of the prefrontal-
temporal 
connection in HR 
and FES. 





35 EST, FGA; 
5 EST, SGA 
1EST, not 
medicated 
Numeric “2-back”  48 intrahemispheric 
models; 
3 model families; 
DLPFC, PC, VC 
DCM10 in SPM8; 




  EC (effect of task-
modulation) from 
























naïve at the 
time of 
scanning;  
8 FEP, SGA 
 




DCM10 in SPM8; 
12 mm spheres; 
Random-effects BMS5; 
BMA 
Progressively    EC 
(effect of task-
modulation) 
between MFG and 
SPL in HC, HR and 
FES. Ameliorated 



















Verbal “2-back” 5 left hemispheric 
models; 
Medial PFC, PCC 
DCM version not 
reported. 
SPM8; 
6 mm spheres; 
BMS5; 
BMA 
  IC from PCC to 
medial PFC in both 
FES5 and FES6. 
    Increased in subjects with schizophrenia in contrast to HC; 
    Decreased in subjects with schizophrenia in contrast to HC; 
BMA, Bayesian Model Averaging; BMS, Bayesian Model Selection; DLPFC, dorsolateral prefrontal cortex; EC, effective connectivity; EST, subjects with 
established schizophrenia; FES, subjects with first episode schizophrenia; FEP, subjects with first episode psychosis; FGA, first-generation 
antipsychotics; HC, healthy controls; HR, Subjects at high risk of schizophrenia; IC, Intrinsic connectivity; IFG, inferior frontal gyrus; INS, insula; MFG, 
middle frontal gyrus; PC, parietal cortex; PCC, posterior parietal cortex; PFC, prefrontal cortex; SGA, second-generation antipsychotics; SMA, 
supramarginal area; SPL, superior parietal lobe; SPM, Statistical Parametric Mapping; STG, superior temporal gyrus; VC, visual cortex. 
1 Subjects at high clinical risk of schizophrenia 
2 With high suicidal risk 
3 With low suicidal risk 
4 Chlorpromazine equivalents in mg/day 
5 BMS at the group-level 




We highlight main experimental and methodological limitations in the four DCM 
studies, which impede the comparability of findings (please see Table 2.1 for details). 
The main experimental limitation focuses on the discrepancies between the different 
patient subpopulations. Two studies analysed working memory fMRI data of 
subjects with ARMS and FES in comparison to healthy controls (Crossley et al., 
2009; Schmidt et al., 2013), whereas one study modelled scans from subjects 
with EST (Deserno et al., 2012). Zhang et al., 2013 reported findings of a unique 
patient population of FES with high and low suicidal risk. In terms of 
methodological issues, one limitation lies in different definitions of model spaces 
for the large-scale networks, despite equivalence in the experimental tasks. Another 
limitation is that the reviewed DCM studies employed deterministic DCM for the 
comparison of the models. Deterministic models can predict processes perfectly if 
all inputs are known (Dayan and Abbot, 2000). However, at this early stage of 
employing biophysical modelling approaches to human brain function we do not 
have a full understanding of the brain responses to working memory. Future 
studies may employ stochastic DCM as an extension (Daunizeau et al., 2011a, 
Daunizeau et al., 2011b; Li et al., 2011). A further limitation is that different DCM 
versions were applied across the four studies, which impede the comparability of the 
findings. The priors are differently defined in the used DCM versions, which give 
rise to a variation in model evidence between the studies (Daunizeau et al., 
2011a). Thus, it is possible that discrepancies in EC findings could be due to the 
prior definition and may not be solely due to differences in performance, brain 
function or clinical aspects of subjects with schizophrenia. Lastly, a general 
limitation of DCM for fMRI
 




network can be modelled. This simplification results in difficulties of biophysical 
modelling of tasks, which are likely to encompass more than ten regions. 
Furthermore, not only the definition of different regions and different numbers of 
regions but also different modulatory inputs result in further extensions to the model 
space. Such model spaces are difficult to validate and analyse. 
 
The four DCM studies presented evidence for increased task-dependent EC and 
increased task-independent EC findings during verbal/numeric working memory in 
subjects with schizophrenia. We discuss these EC findings in context of (i) the 
dopamine and glutamate hypothesis and (ii) FC findings during verbal/numeric 
working memory in subjects with schizophrenia. 
(i) The four studies modelled large-scale networks during the “N-back” task in 
subjects with schizophrenia. However, only two out of these four studies 
consider their DCM results in the light of biophysical processes (Deserno et 
al., 2012 and Schmidt et al., 2013). The findings of reduced EC (namely, the 
effect of task-modulation) of the prefrontal-parietal connection in subjects 
with schizophrenia in contrast to healthy controls were interpreted 
biophysically and linked to the NMDA receptor hypofunction model and the 
dysconnection hypothesis (Deserno et al., 2012; Schmidt et al., 2013). Both 
studies reported reduced EC findings of the prefrontal-parietal connection 
during working memory, however, these findings need to be considered 
carefully due to different experimental designs (i.e. patient subpopulations, 
antipsychotic medication treatment of FGA and SGA) and methodological 




(ii) Three of the DCM studies reported altered EC findings of the prefrontal–
parietal and parieto-prefrontal connections during the “N-back” task in 
subjects with schizophrenia in contrast to healthy controls. Deserno et al., 
(2012) and Schmidt et al., (2013) presented reduced EC (effect of task-
modulation) of the prefrontal-parietal connection in subjects with 
schizophrenia in contrast to healthy controls, whereas Zhang et al., (2013) 
found increased EC (intrinsic connectivity) of the parietal-prefrontal 
connection. The reduced task-dependent EC findings are in keeping with 
reduced FC findings of these connections, although increased FC between 
a different prefrontal subregion and the PC was reported (Tan et al., 2006). 
The study by Crossley et al., (2009) reported increased EC (intrinsic connectivity) of 
the prefrontal-temporal connection in subjects at HR and FES (in contrast to healthy 
controls). Reduced FC of the prefrontal-temporal connection during the “N-back” 
task in subjects with schizophrenia has been previously reported in PET studies 
(Meyer-Lindenberg et al., 2001; Meyer-Lindenberg et al., 2005). However, the 
regions within the PFC and temporal regions differ between the studies. 
 
2.2.4.4 Summary 
Evidence from brain function in working memory in subjects with schizophrenia at 
the level of functional large-scale networks (i.e. clinical and cognitive neurosciences) 
and neurobiological mechanisms in working memory in animal models of 
schizophrenia (i.e. preclinical neurobiological research) in combination with 





DCM studies using the verbal/numeric “N-Back” task in subjects with schizophrenia 
have reported both increased and reduced EC findings during cognition in subjects 
with schizophrenia in contrast to healthy controls. These studies applied DCM as a 
biophysical modelling approach to functional large-scale networks, which enabled 
the interpretation of EC findings on the basis of the glutamate hypothesis of 
schizophrenia, namely the NMDA receptor hypofunction model (chapter 1.3.2.2.1) 
and the dysconnection hypothesis (chapter 1.3.2.2.3) (Figure 2.1). We propose that 
DCM studies examining functional large-scale networks in combination with 
possible neurobiological mechanisms shape the understanding of schizophrenia as a 
cognitive brain network disorder (Figure 2.1).  
 
Figure 2.1 Understanding of schizophrenia as a cognitive brain network disorder – 
verbal/numeric “N-back” task (Reproduced from Dauvermann et al., 2014). 
 




the dopamine hypothesis. DA is a neuromodulator that may crucially affect Glu-
induced synaptic plasticity. Synaptic plasticity may be involved in the regulation of 
DA synthesis and release via other neurotransmitter systems. Specifically for 
nonlinear effects, it has been shown that DA acts as a neuromodulator mediating 
postsynaptic gain (Braver and Cohen, 1999; Friston et al., 2012). 
In a recent study, it has been reported that the combination of the DCM analysis of 
numerical “N-back” task in EST (Deserno et al., 2012) and generative embedding 
resulted in the dissection of three subgroups of EST based on the mechanistically-
inferred DCM findings (Brodersen et al., 2013). This exemplary study showed that 
DCM can be applied as a generative model of large-scale networks in individuals 
with schizophrenia. In summary, DCM is a promising approach for modelling 
synaptic plasticity; nevertheless in its current form it cannot reflect the full 




Preclinical neurobiological and computational findings reveal the relevance of 
synaptic plasticity and gating mechanism for learning and cognitive function. 
Furthermore, evidence of dopaminergic, glutamatergic and interactions between DA 
and Glu among other neurotransmitter systems for the modulation of synaptic 
plasticity, gating mechanism and therefore cognitive function such as working 
memory has been reported. 
In schizophrenia research, it has been shown that alterations of dopaminergic and 




mechanism and consequently in cognitive deficits such as working memory deficits 
in individuals with schizophrenia. In other words, cognitive symptoms in 
individuals with schizophrenia could be explained by the alterations of 
dopaminergic and glutamatergic transmission and therefore by the dopamine 
hypothesis and glutamate hypothesis of schizophrenia. 
FC findings of working memory in individuals with schizophrenia have advanced our 
knowledge of cognitive function in humans at the level of functional large-scale 
networks (chapter 1.4.3). However, it is not wholly understood what altered FC during 
cognition neurobiologically means in schizophrenia. EC findings from verbal/numeric 
working memory in people with schizophrenia, here specifically modelling functional 
large-scale networks with DCM, have shown indications of linkage between clinical 
network-based working memory (large-scale networks) and preclinical neurotransmitter 
modulation of cognitive function. A strength of DCM lies in interpretation of altered 
synaptic plasticity based on the inference of mechanistic information. We emphasise 
that the interpretation of altered neurotransmitter circuits should be considered carefully 
because DCM is likely to underestimate the processing complexity in neurobiological 
circuits. 
We outline one main limitation of the reviewed DCM studies, which lies in the 
implementation of the bilinear approach of DCM for the assessment of activity-
dependent synaptic plasticity underlying working memory function. One possible 
solution to this problem could be the application of nonlinear DCM (Stephan et al., 
2008; Stephan and Friston, 2010). 
Nonlinear DCM for fMRI is an advanced approach for increasing the biological 




modulation of neuronal connections) (Friston and Dolan, 2010; Daunizeau et al., 
2011a, Daunizeau et al., 2011b). In nonlinear  DCM,  the  modulation  of connection  
strengths  by  experimental  inputs  is  supplemented  by direct  modulation  of 
neural activity in one or more network regions (Friston et al., 2003; Stephan et al., 
2008). The computations for gating in neural networks use the multiplicative 
computation of nonlinear modulation (Salinas and Sejnowski, 2001; Volman et al., 
2010). Accordingly, nonlinear DCM can be used for inferring that the strength of a 
connection is modulated by activity of other neuronal populations (Stephan et al., 
2007, Stephan et al., 2008). 
Based on the preclinical neurobiological and computational evidence for altered 
synaptic plasticity and gating mechanism implicating cognitive symptoms in 
schizophrenia, we apply nonlinear DCM to two fMRI data sets in individuals with 
schizophrenia. In this, we focus on modelling the connection strengths of the 
thalamo-cortical connection during verbal fluency (chapter 3) and the meso-cortical 
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FA and FC measures during the fMRI HSCT were investigated in subjects at high 
genetic risk of schizophrenia as part of the EHRS study. Previous findings of FA 
(Whalley et al., 2004) and FC (Whalley et al., 2005) elucidated the state and trait 
effects in subjects at high familial risk of schizophrenia in contrast to healthy 
controls. These fMRI findings demonstrated significantly reduced activation of the 
MD thalamus in the HR subjects when compared to healthy controls (Whalley et al., 
2004). This finding of reduced activation in HR subjects was further supported by 
reduced FC measures between the IFG and the MD thalamus only in the HR group 
(Whalley et al., 2005). These findings suggested that subjects at high familial risk of 
schizophrenia would be more vulnerable (due to the genetic loading) to develop 
schizophrenia than healthy controls. In addition, a following study considered the 
relationship between reduced FC in HR subjects and increased PFC folding (Harris 
et al., 2007), which was interpreted as a possible trait marker of the vulnerability of 
the illness (Dauvermann et al., 2012). These FC analyses in the EHRS cohort applied 
correlation based methods to analyse the fMRI data, which do not allow 
interpretations of causality or feedback mechanisms. 
 
EC findings from cognitive tasks such as working memory in people with 
schizophrenia using DCM for fMRI (Friston et al., 2003) enable the modelling of 
functional large-scale networks. It has been proposed that these studies may lead to 





The DCM approach employed in the current research project was designed to 
investigate possible biophysical factors underlying the reduced FC between the IFG 
and the MD thalamus with linear and nonlinear DCM in subjects at high familial risk 
of schizophrenia. It was considered that altered connection strength between the IFG 
and the MD thalamus could lead to a better understanding of altered connectivity in 
schizophrenia (Krystal et al., 2003; Negyessy and Goldman-Rakic, 2005). Altered 
connection strength with nonlinear modulation of the thalamo-cortical connection 
during verbal fluency in HR subjects in contrast to healthy controls as assessed with 
nonlinear DCM may lead to a better understanding of schizophrenia. 
 
At the beginning of this chapter, we summarise findings from fMRI studies during 
covert verbal fluency in individuals with schizophrenia and healthy controls, which 
are subdivided into FA, FC and EC findings (chapter 3.3.1). The reported FA and FC 
findings of the HSCT as part of the EHRS are described in detail to provide 
background to the DCM analyses, which extend the FA and FC findings (3.3.2). In 
the next step, the complete processing steps and results of the fMRI HSCT data 
including pre-processing, statistical analyses and DCM analyses are described 
(chapters 3.4.4 and 3.4.5). In particular, the heuristic search protocol for the 
application of bilinear and nonlinear DCM for the HSCT is presented (chapter 
3.4.5.2). Finally, the results are discussed in context of possibly altered synaptic 






3.2 Overall aim 
The main aim of the current study of the EHRS data was to investigate possible 
biophysical mechanisms underlying fMRI data in covert verbal fluency with DCM, 
which could explain reduced IFG and thalamic BOLD response (Whalley et al., 
2004) and reduced FC between the IFG and the MD thalamus in the HR subjects in 
contrast to healthy controls (Whalley et al., 2005). Altered EC measures between the 
MD thalamus and the IFG may reflect disrupted synaptic plasticity and gating 
mechanisms of the thalamo-cortical connection (chapter 2.2.2.1). 
 
DCM is a translational brain modelling framework with physiologically interpretable 
dynamic system models, which are fitted to the fMRI data to provide estimates of 
pathophysiological mechanisms of a neuronal group. Gating at the neuronal level 
that provides a more precise estimation of how the rate of change of activity in one 
region influences the rate of change in other regions (Friston, 2009; Friston et al., 
2003; Stephan et al., 2008). The main advantage of nonlinear DCM over bilinear 
DCM is anchored in the differentiation between nonlinearities in the BOLD signal at 
the level of neuronal or haemodynamic mechanisms (Friston et al., 2003; Stephan et 
al., 2007; Stephan et al., 2008) by combining neuronal state equations with a 
haemodynamic feedforward network. Specifically, in nonlinear DCM (Stephan et al., 
2008) inhibitions of a neuronal group or neuronal connection can be modelled. In 
addition, nonlinear DCM assesses selective changes in each region, which can be 
used to model effects exerted by neurotransmitters like Glu. In other words, the 
modelling of activity-dependent gating of connections may allow indirect 




A heuristic search protocol was developed for the application of nonlinear DCM for 
fMRI data and applied to the EHRS data. This protocol was designed to examine 
hypothesised altered connection strengths of the thalamo-cortical and cortico-
thalamic connections using nonlinear modulation and build upon previously reported 
HSCT findings (Whalley et al., 2004; Whalley et al., 2005). 
 
3.3 Background 
3.3.1 Theoretical background of functional magnetic 
resonance imaging studies and positron emission 
tomography studies of covert verbal fluency in healthy 
subjects and subjects with schizophrenia 
The HSCT (Burgess and Shallice, 1996; Burgess and Shallice, 1997) is an 
established neuropsychological task in clinical and cognitive neurosciences to assess 
components of executive functions of the frontal lobes in healthy participants and 
patients with neurological syndromes (such as frontal lobe lesions) or individuals 
with schizophrenia (Chan et al. 2008). The HSCT consists of two parts - verbal 
response initiation (Part A) and verbal response suppression (Part B) – which capture 
different components of executive functions (Burgess and Shallice, 1996). Thus, Part 
A and Part B are considered to assess different psychological constructs (Siqueira et 
al. 2010). Part A is a verbal fluency-like test in which poor verbal fluency is 
understood as a sign of ‘frontal initiation problems’ (Burgess and Shallice, 1996). In 
contrast, Part B is designed to measure response suppression (or inhibition) and 




patients with brain injuries (Burgess and Shallice, 1996). The combined application 
of Part A and Part B allow the comparison of two executive function components of 
initiation and suppression/inhibition in the same participants as a clinical tool. In 
clinical and cognitive neurosciences, studies have applied the HSCT in different 
variations such as (i) The original version as devised by Burgess and Shallice 
(Burgess and Shallice, 1996) to compare response initiation and response 
suppression/inhibition; (ii) Only Part A of the HSCT as a verbal fluency-like task; 
and (iii) Only Part B of the HSCT as a response suppression/inhibition task. 
In Part A, participants are given sentences with the last word missing and they are 
required to complete the sentences meaningfully. Due to the task’s constraint of 
measuring the search for words related to the activation of semantic networks by the 
presentation of the sentences (with the last word missing) (Chan et al. 2008), Part A 
is thought to be a verbal fluency-like neuropsychological task. 
In Part B, participants are presented sentences with the last word missing which are 
comparable to the sentences in Part A. In this section of the HSCT, participants are 
requested to complete the sentences with words that do not make sense semantically. 
Part B measures the complex executive functions of response suppression/inhibition 
and strategy development because of the task’s requirement to inhibit the 
spontaneous semantically meaningful completion of the task and the alternative work 
search (Chan et al. 2008). 
 
Findings from fMRI and PET studies during the HSCT (Part A and/or Part B) and 
comparable covert verbal fluency tasks are summarised for FA/rCBF, FC and EC in 




have used the HSCT and similar covert verbal fluency tasks in order to ensure the 
comparability of findings. For the FA findings, mostly PET studies are summarised, 
of which the majority examined rCBF in healthy controls only; one PET study 
investigated both EST and healthy controls. One fMRI study investigated BOLD 
response between HR subjects and healthy controls. FC findings from three fMRI 
studies, one in HR subjects, one in FES and one in EST are discussed. Finally, two 
DCM studies assessed EC measures during an overt version of the HSCT, one in 
healthy controls and one in ARMS subjects. 
 
3.3.1.1 Findings of functional activation studies 
The first PET studies on the HSCT have repeatedly reported robust left-hemispheric 
rCBF of the regions involved in the functional performance of response initiation and 
response suppression: the IFG, the MTG (Frith et al., 1991; Nathaniel-James and 
Frith, 2002), and the intraparietal gyrus/ IPS in healthy controls (Nathaniel-James et 
al., 1997; Collette et al., 2001). RCBF of the ACC was observed in addition to the 
previously mentioned regions by Nathaniel-James et al. (Nathaniel-James et al., 
1997). 
The seminal clinical PET study by Frith et al., 2005 showed no significant 
differences of rCBF between EST and healthy controls during the HSCT for the 
regions of the left DLPFC, ACC and the left STG (Frith et al., 1995). One fMRI 
study observed reduced BOLD response in the left IFG and left MD thalamus in HR 
subjects in contrast to healthy controls during the parametric contrast. Regions such 
as the ACC, left MTG and left IPS are activated during the task in both HR subjects 




3.3.1.2 Findings of functional connectivity studies 
Three clinical fMRI studies assessed FC during covert verbal fluency using different 
FC methods at the HR stage, first-episode stage and established stage of the illness. 
In the first study in HR subjects, the authors applied a seed-based cross-correlation 
analysis to the HSCT task which was run in two ways to investigate potential effects 
of task activation from the HSCT data: (i) With variance related to task effects 
removed from the data (denoted as ‘removed variance’); and (ii) Without variance 
related to task effects modelled from the data (denoted as ‘modelled variance’) 
(Whalley et al., 2005). The first version of the connectivity analyses allowed the 
identification of regions without effects of task-related activation, whereas the 
second version comprises the task effects. Three sets of altered FC findings were 
observed: Firstly, reduced FC between right medial prefrontal regions and left 
cerebellar regions (with ‘modelled variance’ and ‘removed variance’) in HR subjects 
in contrast to healthy controls; secondly, increased FC between left parietal and left 
prefrontal regions (with ‘modelled variance’ and ‘removed variance’) in HR subjects 
in contrast to healthy controls; thirdly, reduced FC between the left IFG and the left 
MD thalamus (with ‘modelled variance’) in HR subjects only (Whalley et al., 2005). 
Boksman et al., 2005 investigated the functional network of the PFC during a similar 
covert verbal fluency task to the HSCT in never-treated FES (Boksman et al., 2005). 
PPIs between the activity of voxels in the right AC and any regions with significant 
covariance with the activity of the right AC were run. Within-group PPI analyses 
revealed significant FC between the right AC and the left temporal lobe including the 
left ITG in healthy controls. In contrast, in individuals with FES a widespread 




bilateral CG, bilateral SFG, left IFG and left STG. No significant between-group 
results between healthy controls and FES were reported.  
The third study examined the hypothesis of disrupted fronto-temporal connectivity in 
schizophrenia during the HSCT in EST (Lawrie et al., 2002). A significantly lower 
correlation between the activity of left DLPFC and the activity of the left middle 
temporal cortex/superior temporal cortex was reported in EST in contrast to healthy 
controls. Furthermore, a significant association between the reduced FC measure and 
severity of auditory hallucinations were seen in EST (Lawrie et al., 2002). 
 
3.3.1.3 Findings of effective connectivity studies 
The first DCM study, which assessed EC measures during the HCST, employed 
bilinear DCM in healthy controls (Allen et al., 2008) and formed the basis for the 
following DCM study in ARMS subjects using the same experimental paradigm and 
DCM53 version (Allen et al., 2010; please see Table 3.1 for details). However, the 
Bayesian Model Selection (BMS) inference method is different between both studies. 
In the control DCM study, five models comprised of the left MTG and left MFG 
were compared among each other. The main finding was that the winning model was 
characterised by increased EC with task-dependent modulation (of response 
suppression in contrast to response initiation) for the connection from the left MTG 
to the left MFG (Allen et al., 2008). 
Allen et al., (2010) investigated increased fronto-temporal EC (intrinsic connectivity) 
as a potential measure of vulnerability of developing schizophrenia in ARMS 
subjects. The specification of the models of this study was based on (i) the FA 
                                                          
3 DCM5 version is implemented in SPM5 version. DCM5 and DCM8 methodology differ in terms of 
different model inversion techniques. In DCM8, model inversion is considered as a development from 




findings between ARMS subjects and healthy controls and (ii) the control DCM 
findings (Allen et al 2008). Therefore, the region of the ACC was included in 
addition to the left-hemispheric MTG and MFG. In total, 14 different models were 
compared against each other. Two main findings were reported: Firstly, no 
significant effect of task-dependent modulation for the fronto-temporal connection 
between ARMS subjects and healthy controls was observed. Secondly, ARMS 
subjects displayed increased intrinsic connectivity between the ACC and the MTG 
in comparison to healthy controls. Furthermore, the BMS approach revealed that 
the same network was equally likely to explain the given HSCT fMRI data in both 











Subjects – Phase of 
Schizophrenia 
HC – 
HR, FES, EST 
Medication Experimental Paradigm Networks – 
Model Space 
Number of models      
Regions 
DCM Settings – 
DCM version   
Sphere size  
Inference technique(s) 
Main Finding(s) 
Allen et al., 
2008 
 




DCM in SPM5; 
 
12 mm spheres; 
 
BMS as implemented in 
SPM5; 
 
Model evidence  
approximation of BIC and 
AIC 
Winning model 
characterised by    EC 
with task-dependent 
modulation for 
connection MTG to 
MFG. 







HCST 14 left- hemispheric 
models; 
MFG, ACC, MTG 
DCM in SPM5; 
12 mm spheres; 
Random effects BMS3 
   IC between ACC 
and MTG. 
Same winning model 
in both groups. 
    Increased in subjects with schizophrenia in contrast to HC; 
ACC, anterior cingulate cortex; AIC, Akaike Information Criteron; ARMS, Subjects with at risk mental state; BIC, Bayesian Information Criterion; BMS, 
Bayesian Model Selection; EC, effective connectivity; HC, healthy controls; HR, subjects at high risk of schizophrenia; HSCT, Hayling Sentence 
Completion Task; IC, intrinsic connectivity; MFG, middle frontal gyrus; MTG, middle temporal gyrus. 
1 Subjects at high clinical risk of schizophrenia/ARMS subjects 
2 At the time of scanning 




3.3.2 Background of the Edinburgh High Risk Study 
The EHRS examined young adults at enhanced genetic risk of schizophrenia due to 
familial reasons over the period at which they are at greatest risk of becoming ill. 
Recruitment was conducted over the first five years of the study (1994-1999), details 
of which have been described previously (Hodges et al., 1999; Johnstone et al., 
2000). Briefly, individuals with schizophrenia with a family history of schizophrenia 
and with unaffected relatives aged between 16-25 years were identified from 
psychiatric hospital case records in Scotland. Case-note diagnoses of schizophrenia 
were verified with the Operational Criteria Checklist (McGuffin et al., 1991). The 
unaffected relatives aged between 16 and 25 were then approached and invited to 
participate. These unaffected relatives provided the HR group for the EHRS study. 
The control subjects recruited for the study had no family history of schizophrenia. 
All subjects were well at recruitment and were antipsychotic naïve throughout the 
study. All subjects were supplied with detailed written information regarding the 
study and provided written informed consent. The study was approved by the 
Psychiatry and Clinical Psychology subcommittee of the Lothian research ethics 
committee. 
 
Functional imaging was added to the protocol during the second phase of the study 
(1999-2004). Full details of the sample and the respective FA results for the HSCT 
(Whalley et al., 2004) and the results for the FC measures (Whalley et al., 2005) have 





At the time of the scan, all HR subjects underwent the clinical interview, the Present 
State Examination (PSE; Wing et al., 1974). The results have been published 
previously (Whalley et al., 2004; Whalley et al., 2005). None of the subjects received 
the full diagnosis of psychosis. Twenty-seven HR subjects showed isolated transient 
or partial psychotic symptoms (HR+ subjects). Forty-two HR subjects did not report 
any psychotic symptoms (HR- subjects). None of the subjects were undergoing 
antipsychotic treatment, seeking professional support or saw themselves as unwell. 
Twenty-one healthy controls participated in the EHRS. Details on positive PANSS 
symptom measures (score > 2) for HR subjects, who participated in the HSCT fMRI 
task, have been reported previously (Whalley et al., 2007). Additionally, a detailed 
presentation of PSE scores at the time of the HSCT fMRI scan in the four subjects, 
who subsequently developed schizophrenia, and the mental state of these four 
individuals at the time of the diagnosis have been published (Whalley et al., 2006).  
In demographics tests on the EHRS data, there were no statistically significant 
differences in age, gender, handedness or mean IQ between the healthy controls and 
the HR subjects. There were also no significant differences between HR+ subjects 
and HR- subjects (Table 3.2; Whalley et al., 2004; Whalley et al., 2005). Behavioural 
performance results showed that all participants performed the tasks appropriately in 
the scanner. There were no significant differences in word appropriateness scoring 







Table 3.2 Demographic details of the previously published functional activation and 
functional connectivity findings from the EHRS (Reproduced from Whalley et al., 
2004). 
 Controls (n = 21) High risk without 
symptoms (n = 42) 
High risk with 
symptoms (n = 27) 
Age (years)  
mean (SD) 
26.8 (2.7) 26.8 (3.4) 25.1 (3.1) 
Gender 
(male:female) 
13:8 17:25 13:14 
Mean NART IQ (SD) 97.95 (24.02) 99.56 (18.12) 97.86 (10.60) 
Handedness (R:L:A) 19:2:0 39:2:1 21:4:2 
Genetic liability (1st 
degree; 2nd degree)* 
N/A 32:10 16:11 
*First or second degree relatives with schizophrenia. N/A = not applicable; R = right;  
L = left; A = ambidextrous. NART, National Adult Reading Test. 
 
 
3.3.2.1 Main fMRI findings from the second phase of the EHRS 
The main fMRI findings on the HSCT in subjects at high familial risk of 
schizophrenia have been previously published (Whalley et al., 2004; Whalley et al., 
2005) and are summarised in the following two subchapters for FA and FC results. 
 
3.3.2.2 Functional activation findings 
For the standard subtraction analysis (sentence completion versus rest) all groups 
displayed activation in regions commonly associated with self-generated word 
production tasks, i.e. dorsolateral and medial prefrontal regions (DLPFC and mPFC), 
MTG and the STG (Frith et al., 1995; Nathaniel-James et al., 1997; Lawrie et al., 
2002). HR+ subjects showed increased activation of the left IPL in contrast to the 
HR- subjects and healthy controls. Furthermore, for the parametric contrast (i.e. 
increasing activations with increasing task difficulty across the four difficulty levels 
of the HSCT), greater activations of inferior frontal regions in HR subjects were in 




prefrontal regions in EST in contrast to healthy controls  (Lawrie et al., 2002; 
Nathaniel-James and Frith, 2002). HR subjects showed reduced activation of the 
mPFC as well as the MD thalamus and cerebellar regions in comparison to healthy 
controls. 
 
3.3.2.3 Functional connectivity findings 
FC was assessed using a seed-based cross-correlation analysis approach as 
implemented in Statistical Parametric Mapping (SPM; The Wellcome Department of 
Cognitive Neurology and collaborators, Institute of Neurology, London, 
http//www.fil.ion.ucl.ac.uk/spm/). The results demonstrated that there were 
indications of negative correlations between medial prefrontal, thalamic and 
cerebellar regions in the HR+ and HR- subjects for seeds located both in the medial 
frontal gyrus and MD thalamus. Additionally, evidence of increased prefrontal-
parietal FC in both the HR+ and the HR- subjects in comparison to healthy controls 
was reported. As mentioned in the introduction, these FC results were further 
examined and revealed a significant association between the reduced prefrontal-
thalamic FC and increased prefrontal folding in HR subjects in comparison to the 
healthy controls (Dauvermann et al., 2012). 
 
3.4 Methods 
The analyses presented in this chapter pertain to the reported FC findings of the 
scans of 69 HR subjects and 19 healthy controls (Whalley et al., 2005). The pre-
processing, first and second level analyses of these subjects were reprocessed in 




For the current DCM study, the EPI processing of the HSCT data was redone to 
ensure compliance with the DCM analysis methodology. The DCM required settings 
for spatial smoothing and oversampling of voxel size have been applied 
(Dauvermann et al., 2013). In keeping with the previous analyses we applied 
established SPM first level and second level between group analyses employing the 
settings used in our previous analyses (Whalley et al., 2004). There were no 
differences noted between the previously reported results by Whalley et al., 2004 and 
the new second level results. 
 
3.4.1 Study populations 
The recruitment of the subjects for the EHRS has been reported previously (Whalley 
et al., 2004; Whalley et al., 2005; Johnstone et al., 2003). 
The subject inclusion for the current DCM study was initially based on the main FC 
study by Whalley et al., (2005). DCM has stringent requirements for subject 
inclusion (please see below). Two healthy controls and 23 HR subjects did not meet 
the requirements of sufficient BOLD response in all regions that were included in the 
models and were excluded. Full details on the final inclusion of subjects as well as 
demographic and clinical details of the groups were summarised in Table 3.3. Based 
on the PSE and the initial subject inclusion by Whalley et al., 2005, 20 subjects were 
allocated to the HR+ group and 26 subjects to the HR- group. The PSE measures 
were converted to PANSS measures using the rescaled PANSS system (Kay et al., 









HR- HR+ Four ill Test p-
Value 
Number 19 26 20 4 - - 
Mean Age 
(SD) 
26.9 (3.5) 25.8 (3.2) 26.1 (3.1) 22.8 (4.50) F = .518a .598 





96.74 (8.90) 98.58 (10.00) 97.95 (16.33) F = 1.175 .211 
Handedness 
(R:L) 
16:3 23:3 18:2 4:0 x2= 4.36c .099 
PSE Scored 
(0/1:2:3) 
19:0:0 26:0:0 0:16:4 0:0:4 - - 
HR-, high risk subjects without psychotic symptoms; HR+, high risk subjects with psychotic 
symptoms, Four ill, four HR subjects who became subsequently ill; NART, National Adult 
Reading Test; IQ, intelligence quotient; ANOVA, analysis of variance; PSE, Present State 
Examination; SD, Standard Deviation. 
a ANOVA 
b Pearson’s chi-square 
c Kruskal-Wallis Test 




3.4.2 Functional experimental details 
A summary of the results from the previous analyses applied to the HSCT data are 
detailed in chapter 3.3.2.1. Full details of these analyses and the experimental details 
have been previously reported (Whalley et al., 2004; Whalley et al., 2005).  
The response initiation condition (Part A) of the HSCT (Burgess and Shallice, 1996) 
was used as the experimental verbal fluency task in the scanner. Subjects were 
shown sentences with the last word missing and were asked to silently think of an 
appropriate word to complete the sentence reasonably, and press a button when they 
had done so. Sentences were used from the sentence completion norms by Bloom 
and Fischler (Bloom and Fischler, 1980). Based on the sentence completion context, 
four difficulty levels were defined to adapt the initiation section of the HSCT for 
application of an fMRI task. Examples of each difficulty level have been presented 




design alternating rest conditions with task conditions, where the task conditions 
reflected the four levels of difficulty. Those task conditions enabled the statistical 
analysis of differences in activation over parametric manipulations of task difficulty 
in sentence completion blocks. The participants received standardized instructions of 
the HSCT before they entered the scanner.  
Participants were presented with the same sequence of sentences as given in the 
scanner and were asked to remember the word they first thought of in the scanner 
immediately after the scanning session. Behavioural performance was assessed by 
means scores for word appropriateness score and RT for each difficulty level. Word 
appropriate scores were defined by the word frequency list of sentence completion 
norms (Bloom and Fischler, 1980). The detailed scoring system has been published 
previously (Whalley et al., 2004). 
 
3.4.3 Functional scanning procedure 
Details of the functional scanning procedure for the HSCT have been reported 
previously (Whalley et al., 2004; Whalley et al., 2005). The acquisition of the HSCT 
functional imaging data was carried out at the Brain Imaging Research Centre for 
Scotland (Edinburgh, Scotland, UK) on a GE 1.5 T Signa scanner (GE Medical, 
Milwaukee, USA). An EPI sequence was used to acquire the functional scans. The 
following parameters were used: axial orientation TR/TE=4000/40 ms; matrix 
64×128; FOV 22×44 cm 2 ; 38 slices; 5 mm slice thickness; no gap. A total of 204 
volumes were acquired. Visual stimuli were presented using a screen (IFIS, MRI 
Devices, Waukesha, WI, USA) placed in the bore of the magnet; corrective lenses 




3.4.4 Scan pre-processing and statistical analysis  
The DCM scan pre-processing including first and second level analysis stages for 
(voxel-wise) functional response comparisons were performed using SPM8 
running in Matlab (version 7.1; The MathWorks, Natick, MA, USA). The DCM 
analysis was performed under DCM8. It should be noted at the time of the DCM 
analysis for this study DCM10 was available. However, the DCM10 release from 
the SPM group was undergoing updates and not considered as a stable release. 
DCM has technical requirements for the haemodynamic response model, which 
lies at the conceptual basis of DCM (Friston et al., 2003; Stephan et al., 2007; 
Stephan et al., 2008). The haemodynamic model minimally adjusts differences 
between the predicted and measured BOLD series (Friston et al., 2003; Stephan et 
al., 2007; Stephan et al., 2008). In DCM8, slice timing has been incorporated into 
the model specification step to enable the use of DCM with longer TRs than 1000 
ms (Kiebel et al., 2007). Parameters for spatial smoothing and oversampling the 
voxel size of the acquisition parameters from the functional scanning procedure 
have been applied. All other settings were kept as applied in the previous analyses 
(Whalley et al., 2004). 
 
3.4.4.1 Spatial pre-processing 
Following the previous analyses (Whalley et al., 2004), the first four volumes were 
discarded to ensure that no noise at the beginning of the magnetisation could distort 







The realignment processing step registers the EPI time series for each single subject 
to the first volume in the acquisition series to remove movement artefacts and create 
the mean image. The process is the estimation of 6 parameters of the rigid-body 
affine transformations in 3D resulting in the minimisation of the sum of squared 
differences between each volume and the reference image. In the following co-
registration, these created transformations are applied to the images which corrects 
for the degree of movement during the scan acquisition corresponding to the 
translation and rotation in the x-axis, y-axis and z-axis. 
 
3.4.4.1.2 Normalisation 
The normalisation algorithms are based on the least squares approach and the linear 
combination of the template image to the ends of (i) the acquisition of averages from 
within/inter subject comparisons in stereotactic normalisation and (ii) accurate 
matching of FA and structural anatomy. A mean image taken from the realignment 
processing step was used as the subject image for the normalisation of each subject’s 
scan set into the standardised MNI space. The MNI standard space was defined by 
the SPM8 EPI template. The normalization used linear affine regularisation with 
nonlinear deformations and oversampled with sinc interpolation to voxels sized 1 x 1 
x 1 mm3. 
 
3.4.4.1.3 Spatial Smoothing 
This processing step minimises noise and artefacts from the distribution of residuals 




mm3 full width half maximum (FWHM) Gaussian filter. This step is relevant for the 
first level statistical analysis, from which the parametric contrast based on the 
progressive difficulty level was extracted. 
 
3.4.4.1.4 Visual Inspection 
The images were visually inspected at two time points during the pre-processing to 
ensure good image quality and correctly run pre-processing. The first time point was 
at the alignment step by inspection of the movement parameters smaller than 3 mm. 
The second inspection was based on noise in the scans after the smoothing step. 
Following previous subject exclusion (Whalley et al., 2004), five subjects due to 
image noise in the scans were excluded on the basis of these qualitative tests. 
 
3.4.4.2 Statistical analysis 
We applied the established first and second level analyses employing settings used in 
the previous analyses (Whalley et al., 2004; Whalley et al., 2005). From the second 
level analysis we generated statistical parametric maps of the T statistics at each 
voxel SPM (1), which characterised differences in increased activation of regions 
with increasing task difficulty (i.e. the four difficulty levels of the HSCT). 
 
3.4.4.2.1 First level analysis 
The statistical first level analysis was performed using the general linear model 






  XY          [3.1] 
 
Y = observed response, i.e. EPI time series data 
β = regression weights or parameters to be estimated for each of the explanatory variables in the 
design matrix  
X = linear combination of explanatory variables (i.e. covariates or regressors) 
 = residual error 
 
Each SPM column in the design matrix resembles the effects specified in the model. 
In this study, at the single subject level the data was modelled with five conditions 
(the four difficulty levels and the rest condition). Each of these conditions was 
modelled by a boxcar convolution with the haemodynamic response function (HRF) 
as implemented in SPM8. The HRF convolution enables the smooth and delayed 
transition between the conditions. The individual’s set of movement estimates 
created in the realignment pre-processing step was also entered in the GLM to fit the 
subject’s movement as possible ‘covariates of no interest’. 
The settings applied for the estimation of the design matrix followed the previously 
published settings (Whalley et al., 2004; Whalley et al., 2005): 
 Single subject filtering in the time domain: 
 Low pass filter (Gaussian kernel, 4 s (FWHM)) 
 High pass filter (400 s cut-off) 
 Mask image 
A standard brain mask image applied to the first level analysis. 
The main aim for the statistical analysis was the examination of areas showing 
increased activation with increased sentence completion difficulty level because this 
parametric contrast lies at the basis of the DCM analyses. The settings for the 




Furthermore, the standard subtraction contrast analysis for all four sentence 
completion conditions versus rest condition was set [1 1 1 1 -4]. 
 
3.4.4.2.2 Second level analysis 
Contrast images of parameter estimates encoding condition-specific effects were 
entered into second level random effects analyses. ANOVA was used to determine 
group differences. For the second level random effects analyses we repeated the 
between group analyses for the current DCM study. As described previously, one of 
the main interests of the initial hypotheses of the EHRS was to investigate ‘trait’ 
effects and ‘state’ effects between healthy controls and the HR subjects as a group 
and within the HRall subjects subdivided into HR+ subjects and HR- subjects 
(Whalley et al., 2004; Whalley et al., 2005). ‘Trait’ effects were defined as 
differences between the healthy controls and all HR subjects. In contrast, ‘state’ 
effects resembled differences within the HR group comparing HR- subjects and HR+ 
subjects. The groups were matched on demographic measures. Thus, these measures 
were not included as possible confounders in the estimation of the model. 
For all second level analyses, the statistical maps were thresholded at the level of p = 
.001 uncorrected. We report regions that survive cluster-level correction for multiple 
comparisons across the whole brain at p < .05. All reported P - values in this thesis 
are at the corrected cluster level and the co-ordinates were converted from MNI to 
Talairach co-ordinates. The identification of regions was run using a combination of 
the Talairach Daemon (Lancaster et al., 1997; Lancaster et al., 2000) in combination 
with the Talairach brain atlas (Talairach and Tournoux; 1988). The results reported 




3.4.5 Functional integration – Bilinear and nonlinear Dynamic 
Causal Modelling for fMRI data 
The examination of underlying causality for the reduced FC between the IFG and the 
MD thalamus in HRall subjects in contrast to the healthy controls was the primary 
objective of this DCM study. To this end, the thalamo-cortical and cortico-thalamic 
connection strengths with nonlinear modulation were assessed using bilinear and 
nonlinear DCM for fMRI. 
The primary objective was to consider in what ways the HSCT task would indicate 
how subjects at high familial risk of schizophrenia would exhibit vulnerability to the 
development of the disorder that was not evident in healthy controls. Support for this 
hypothesis has been given by the previously reported findings of reduced FC 
measures between the IFG and the MD thalamus in the HR group in contrast to the 
healthy controls (Whalley et al., 2005). This ‘trait’ effect of high genetic risk of 
developing the disorder has been further supported by measures of increased PFC 
folding (Harris et al., 2007) and by the significant correlation between the reduced 
FC measures and increased prefrontal cortical folding in the same cohort 
(Dauvermann et al., 2012). These findings motivated the current the DCM study to 
the end of investigating the causal factors, which may underlie these findings by 
applying nonlinear DCM to the HSCT fMRI data of the EHRS. 
Methodological issues for the application for the DCM approach were considered 
regarding the employment of the DCM8 version run for the current DCM study. The 
DCM analyses for bilinear and nonlinear DCM were run in DCM8 as implemented 
in SPM8. The main reasons for the employment of DCM8 for the current study and 




theoretical and pragmatic grounds: Firstly, the definition of prior densities and 
parameterisation of the models for fMRI used in DCM8 in the version 3684 and 
therefore the mechanistic interpretation of the underlying distributed neuronal 
mechanisms is widely accepted in the research community. Secondly, the initial 
DCM analyses for the current DCM study were performed using DCM8. Thus, all 
analyses were completed using the DCM8 approach in SPM8 version, including the 
DCM analyses for the fMRI working memory data in subjects with established 
schizophrenia and healthy controls (chapter 4). 
 
In the following chapter 3.4.5, we describe the methods applied for the EHRS DCM 
study. In subchapter 3.4.5.1, the subject and ROI selection as the standard procedure 
for the preparation for the DCM is described. Chapter 3.4.5.2 gives the devised 
heuristic search protocol for the application of nonlinear DCM for fMRI data is 
introduced and explained. Then in chapter 3.4.5.3, we describe the post-hoc analysis 
performed for the connection strengths with nonlinear modulation and psychotic 
symptoms. 
 
3.4.5.1 Subject and ROI selection 
In this DCM study of the EHRS cohort, a different subgroup of HR subjects were 
examined than those noted in the previously published EHRS papers on FC measures 
(Whalley et al., 2005; Dauvermann et al., 2012). This was necessary because DCM 
has stringent requirements for the subject and region selection. In addition to the 
selection of the fMRI scans (Whalley et al., 2004), the condition of activation in each 




In detail, the second level analysis in the initial sample of 21 healthy controls and 69 
HR subjects identified robust left-lateralized activations in the IPS, IFG, MTG, ACC 
and the MD thalamus as previously reported (Whalley et al., 2004). ROIs located in 
all five regions were selected for the DCM analyses. The selection of the IPS, IFG, 
MTG and the ACC ROIs is consistent with other functional imaging studies of the 
HSCT in studies in healthy controls (Allen et al., 2008; Collette et al., 2001; Frith et 
al., 1991; 1995; Nathaniel-James and Frith, 2002; Nathaniel-James et al., 1997) and 
in a study of HR subjects (Allen et al., 2010). Our previous reports demonstrated 
deficits in FC between the MD thalamus and the IFG in HR subjects when they were 
compared to healthy controls (Whalley et al., 2005; Dauvermann et al., 2012). Thus, 
we included the MD thalamus in the large-scale network used for our DCM study. 
Also it has been established that altered synaptic plasticity of the connection from the 
MD thalamus to the PFC may underlie cortical dysfunction in schizophrenia 
(Negyessy and Goldman-Rakic, 2005). 
The five ROIs were defined by extracting the eigenvectors (i.e. time series) from 
each subject's individual activation map thresholded at p < .05 uncorrected at the 
closest maxima within a distance of 8 mm of the group peak voxel (for the IPS, IFG 
and MTG) and within 6 mm of the group peak voxel respectively (for the ACC and 
MD thalamus). This rationale ensured that the functional regions included in the 
DCM models were consistent across subjects (Stephan et al., 2007). In cases where 
the subject did not show activation in all five ROIs that satisfied the criteria, data 
from these subjects were excluded (2 healthy controls and 23 HR subjects). The final 
subject selection included 19 healthy controls and 46 high risk subjects. This 




(Dauvermann et al., 2013). The ROI locations detailed in Table 3.4 are given in 
accordance with the standard Talairach and Tournoux atlas (Talairach and Tournoux, 
1988) which was used by Whalley et al., (2005). The co-ordinates were in keeping 
with the previously reported co-ordinates (Whalley et al., 2005). 
 
Table 3.4 Coordinates of the five ROIs (Reproduced from Dauvermann et al., 2013). 
 Coordinates in Talairach Space 
IPS, BA40 -42 -48, 48 
IFG, BA47 -50, 18, -4 
MTG BA21 -50, -37, -5 
ACC, BA32 0, 22, 34 
MD Thal -8, -13, 6 
ACC, anterior cingulate cortex; IFG, inferior  
frontal gyrus; IPS, intra parietal sulcus; MD Thal,  
mediodorsal thalamus; MTG, middle temporal gyrus. 
 
3.4.5.2 Heuristic study protocol for bilinear and nonlinear Dynamic 
Causal Modelling 
We adopted an approach that would allow us to model nonlinear biological responses 
expected for the HCST by the means of nonlinear DCM for fMRI, specifically for 
the bidirectional connection between the IFG and the MD thalamus. 
In order to ensure that the established DCM methods for determining whether linear 
and nonlinear modelling could be applied to the EHRS data in a structured process, 
we developed a heuristic search protocol to optimise the DCM architecture. We used 
this protocol to test DCM methods on the experimental groupings that had been 
previously employed in the analyses of the EHRS data and to evaluate group 
differences in the EHRS study. The heuristic protocol splits the DCM processing into 




(i) In phase 1, bilinear DCM was used in order to test the structure for the HSCT 
across all subjects;  
(ii) In phase 2, nonlinear DCM was applied to model the nonlinear mechanisms 
of the thalamo-cortical and cortico-thalamic connections; and  
(iii) In phase 3, connection strengths with nonlinear modulation within the 
winning models were assessed. 






Figure 3.1. Protocol for the application of Nonlinear DCM for fMRI (Reproduced from 
Dauvermann et al., 2013). 
This protocol is subdivided into three phases which allow the modelling of connection 
strength with nonlinear modulation. The protocol was run for each grouping: (i) Healthy 
controls and all high risk subjects, (ii) Healthy controls, high risk subjects without psychotic 
symptoms and high risk subjects with psychotic symptoms, (iii) Healthy controls, high risk 
subjects without psychotic symptoms, high risk subjects with psychotic symptoms and four ill 
subjects who subsequently developed schizophrenia. 
 
To ensure that the DCM based analyses were consistent across the contrast groupings 




grouping, the DCM analyses were applied to healthy controls (n=19) and HRall 
subjects (n=46). In the second grouping, the DCM analyses were applied to healthy 
controls (n=19), HR− (n=26) and HR+ (n=20). In the third grouping, the DCM 
analyses were applied to healthy controls (n=19), HR− (n=25), HR+ (n=17) and the 
four ill HR subjects (n=4), i.e. those subjects who subsequent to scanning developed 
schizophrenia. 
1) In phase 1, bilinear DCM was used in order to select the structure for the 
HSCT large-scale network across all subjects. This analysis contained 
modulations for the activity-dependent neuronal interactions between the five 
regions of the network. The analysis steps are depicted in the protocol 
(column 1; Figure 3.1). The optimal model of this analysis was entered into 
phase 2. 
2) In phase 2, nonlinear DCM was applied to model the connection strengths 
with activity-dependent modulation of the reciprocal neuronal projection 
between the MD thalamus and the IFG. In order to ensure the modelling of 
the gating (i.e. nonlinear models), two preconditions were met: 
(i) The specification of the nonlinear models was based on the optimal 
bilinear model. Therefore, the bilinear model and the nonlinear 
models differed only in the single parameter of nonlinearity from each 
other. 
(ii) The implementation of Model Space Partitioning (MPS) and Family 
Inference was used to compare the bilinear and nonlinear models, 
which indicated that the chosen nonlinear model family outperformed 




protocol (column 2, Figure 3.1). The winning models of the BMS 
analysis entered the third phase. 
3) In phase 3, the connection strengths with nonlinear modulation within the 
winning model family were assessed using the posterior densities over 
connection strengths as assessed with Bayesian Model Averaging (BMA). 
This step allowed inference of the connection strengths with nonlinear 
modulation of the bidirectional projection between the IFG and the MD 
thalamus. The analysis steps are depicted in the protocol (column 3, Figure 
3.1). 
 
The theoretical implementations of bilinear DCM (Friston et al., 2003), nonlinear 
DCM (Stephan et al., 2008) and Family Level Inference (e.g. MSP, BMS at the 
model family level and BMA; Penny et al., 2010) have been reported previously. The 
application of bilinear DCM, MSP, Family Inference and BMA has been shown to 
produce reliable results (Seghier et al., 2011). 
Theoretically, the inference computations (i.e. Inference on nonlinear DCM, 
Inference Level at the family level with BMS allow for the testing of an infinite 
number of models (Penny et al., 2010)). However, we considered a limited but 
plausible model space that was comprised of eight bilinear models and four nonlinear 








3.4.5.2.1 Phase 1: Bilinear Dynamic Causal Modelling   
3.4.5.2.1.1 Theoretical background 
The SPM based DCM application has been designed for the assessment of 
interregional EC and the modulation of this connectivity by experimentally induced 
changes (Friston et al., 2003). DCM allows one to infer neuronal function 
mechanistically by the means of estimation of how the neural activity in one region 
changes the neural activity in another region. The ensuing responses are then entered 
into a biophysical model of haemodynamic responses at each region or voxel 
(Friston, 2009; Friston et al., 2003). Hidden neural dynamics are described by 
coupled differential equations and linked to predicted BOLD responses. The bilinear 
neuronal state equation Eq. [3.2] describes the timing and the place of the onset of 
the inputs as well as the modulation of the neuronal states and endogenous 
connectivity changes, given m known inputs (Friston et al., 2003; Stephan et al., 
2007): 







































     [3.2] 
x = neuronal state 
m = number of inputs 
ui = ith input 
A = matrix A 
B = matrix B 
C = matrix C 
In DCM the neuronal states, which represent the neuronal population activity of the 
modelled brain regions, change in accordance with the system's connectivity and 
experimentally controlled inputs. In Eq. [3.2], matrix A represents the endogenous 




denotes the modulation of those connections by the experimental manipulation (here, 
the measured changes in EC induced by the four difficulty levels of the HSCT); 
matrix C reflects driving inputs, which represent extrinsic parameters that change the 
neuronal state of brain regions within the model (here, visual presentation of the 
sentences with the last word missing). The bilinear effects were driven by box car 
stimulus functions encoding task difficulty, whereas the driving inputs were driven 
by box car stimulus functions encoding the main effect of task (Dauvermann et al., 
2013). 
 
3.4.5.2.1.2 Model space of bilinear models 
The original objective of DCM was to enable generative biophysical modelling. In 
order to meet this aim, the models examined must meet stringent neurobiological and 
neurocellular evidence, which enables the biophysical interpretation of the modelling 
approach. Thus, the details for the DCMs are derived from preclinical and clinical 
(i.e. subjects at high risk of schizophrenia and subjects with schizophrenia) 
biological, cellular, chemical and imaging studies. 
There are four conditions defined for the current DCM study of the EHRS data: 
(i) Each region within the large-scale network must have been reported in PET 
and fMRI studies during the covert verbal fluency task in healthy controls 
and in subjects with schizophrenia (chapter 3.3.1). 
(ii) Each connection between the regions of the network must have been 
established in the functional involvement during the performance of the 
covert verbal fluency task in healthy controls and in subjects with 




(iii) The experimental conditions of the covert verbal fluency task must be known 
to be involved in the performance of the covert verbal fluency task in healthy 
controls and in subjects with schizophrenia (chapter 3.3.1). 
(iv) Evidence for gating mechanisms for the thalamo-cortical and cortico-
thalamic connection in schizophrenia must exist in the literature (chapter 
2.2.2.1). 
 
In the EHRS DCM analyses we employed eight linear models, which were based 
upon a review of published findings. Details of this review are given below and this 
review is the basis of the specification of the EHRS model space. Evidence for the 
bidirectional connections between the MD thalamus and IFG (matrix A) was based 
on (Abitz et al., 2007; Kolluri et al., 2005; Lewis and Lieberman, 2000; Onn and 
Wang, 2005), and for the bidirectional connections between the MD thalamus and 
the ACC (matrix A) we considered findings from (Lee et al., 2007; Lewis and 
Lieberman, 2000; Onn and Wang, 2005; Welsh et al., 2010). For modelling the 
experimental manipulations, well established PET studies and fMRI in healthy 
subjects performing the HSCT were used (Collette et al., 2001; Frith et al., 1991, 
1995; Nathaniel-James and Frith, 2002; Nathaniel-James et al., 1997) as well as FC 
results in HR subjects of schizophrenia (Whalley et al., 2005). Specifically, two 
previous DCM studies on the task in healthy subjects (Allen et al., 2008) and HR 
subjects of schizophrenia (Allen et al., 2010) enabled the modelling of the matrices B 
and C. 
In phase 1, eight linear DCMs were modelled for each subject. Firstly, the models 




(matrix A). Specifically, the eight models are subdivided into two groups: (i) 
Endogenous connection from the IPS to the IFG (Figure 3.2; Models 1–4) and (ii) 
endogenous connection from the IPS to the MTG (Figure 3.2; Models 5–8). 
The models are specified in terms of the bilinear effect of the parametric (difficulty) 
of the task. Thirdly, the processing of visual stimuli was modelled by the driving 




    
  
Figure 3.2. Model space of linear models (Reproduced from Dauvermann et al., 2013). 
Models 1 to 4 are characterised by the endogenous connections from IPS to IFG. 
Model 1 is specified by driving inputs into the IPS and the MD Thal and modulatory input onto the connection from the MTG to the IFG. 
Model 2 is specified by driving input into the IPS and modulatory inputs onto the connection from the MTG to the IFG and from the MD Thal to the ACC. 
Model 3 is specified by driving input into the IPS and modulatory inputs onto the connection from the MTG to the IFG and from the MD Thal to the IFG. 
Model 4 is specified by driving input into the IPS and modulatory inputs onto the connection from the MTG to the IFG and from the IFG to the MD Thal. 
 
Models 5 to 8 are denoted by the endogenous connection from IPS to MTG. 
Model 5 is specified by driving inputs into the IPS and the MD Thal and modulatory input onto the connection from the MTG to the IFG. 
Model 6 is specified by driving input into the IPS and modulatory inputs onto the connection from the MTG to the IFG and from the MD Thal to the ACC. 
Model 7 is specified by driving input into the IPS and modulatory inputs onto the connection from the MTG to the IFG and from the MD Thal to the IFG. 




3.4.5.2.1.3 Random effects Bayesian Model Selection 
The phase 1 structure of the heuristic protocol Figure 3.1 is setup to identify the 
model that provides the most probable explanation of the fMRI data using the 
random effects BMS process as implemented in SPM8. We estimated the model 
evidence with the negative free energy (Stephan et al., 2009b). This measure takes 
into account not only the relative fit of competing models but also their relative 
complexity (cf. number of free parameters) (Stephan et al., 2009b). After the 
estimation of the model evidence, we computed the model evidence at the group 
level (Penny et al., 2004) by applying a hierarchical Bayesian approach (Stephan et 
al., 2009b) in order to correct for outliers. The application of the posterior 
exceedance probability estimates the criterion for the conditional likelihood of the 
model given the data at random (Stephan et al., 2009b). In Eq. [3.3], the exceedance 
probability (φk) is the likelihood that model k is more likely than any other model (of 
the K models tested), given the group data. 








      [3.3] 
φk = exceedance probabilities (Xp); sum to one over all models tested 
 
3.4.5.2.2 Phase 2: Nonlinear Dynamic Causal Modelling 
3.4.5.2.2.1 Theoretical background 
Bilinear DCM allows for the inference of dynamic biophysical processes at the 
neuronal level that translate neuronal activity of regions into predicted BOLD 
measurements (Stephan et al., 2008). Nonlinear DCM represents an extension of 
bilinear DCM, where the modulation of connection strengths by experimental inputs 




(Friston et al., 2003; Stephan et al., 2008). In other words, nonlinear DCM allows for 
the modelling of the interaction between two regions through a third region. Thus, 
nonlinear DCM is more representative of how biological systems work. This 
corresponds to an activity-dependent modulation of synaptic efficacy, which models 
the short-term plasticity we are interested in. The well-established computations for 
gating in neural networks is the multiplicative computation of nonlinear modulation 
(Salinas and Sejnowski, 2001; Volman et al., 2010). Nonlinear DCM (Stephan et al., 
2007, 2008) can be used to examine whether the connection strength of a connection 
is modulated by activity of other neuronal populations. To model nonlinear 
interactions within the network, the bilinear state equation Eq. [3.2] extends the 
Taylor series to set matrix D to be second order in the neuronal states (Stephan et al., 
2008; Eq. [3.4]). 












































































   [3.4] 
xj = jth neuronal state 
ui = ith input 
A = matrix A 
B = matrix B 
C = matrix C 
D = matrix D 
 
Matrices A, B and C were modelled as described in bilinear DCM (see section 
3.3.6.2.1.2) on Model space of bilinear models). Matrix D resembles the gating of a 
connection between two regions by the activity of a third region. Therefore, 




connections of interest are the connection from the IFG to the MD thalamus and the 
connection from the MD thalamus to the IFG) depends on the activity of other 
neuronal populations (here, the focus of the study was on the MD thalamus and the 
IFG; Alelú-Paz and Giménez-Amaya, 2008; Kolluri et al., 2005). Thus, the nonlinear 
modulation of the network interactions can be allocated to an explicit neuronal 
population (Stephan et al., 2007; Stephan et al., 2008). 
 
3.4.5.2.2.2 Model space of nonlinear models 
The constraints used in phase 2 for the nonlinear DCM were established in the 
bilinear modelling conducted in phase 1.  The constraints on the A, B and C matrices 
were recovered from the optimal Model 7 from the bilinear DCM analyses. This 
model served as the “basic” structure of the nonlinear models. In phase 2, our 
primary aim was to model the connectivity with nonlinear modulation of the 
reciprocal neuronal projection between the MD thalamus and the IFG. The nonlinear 
DCMs were specified on the basis of neurobiological evidence for nonlinear 
mechanisms in neuronal functions, including cognitive tasks for evidence on altered 
cortico-thalamic and thalamo-cortical connections (Alelú-Paz and Giménez-Amaya, 
2008; Kolluri et al., 2005) in schizophrenia. Figure 3.3 shows the four different 
nonlinear models that were used to identify the gating of the bidirectional 
endogenous connection between the IFG and the MD thalamus. Two out of the four 
nonlinear models were specified by the nonlinear modulation from the MD thalamus 
onto both endogenous connections between the IFG and the MD thalamus. The other 
two further models were specified by the nonlinear modulation from the IFG onto 






Figure 3.3. Model space of nonlinear models (Reproduced from Dauvermann et al., 
2013). 
Model_MDThal_MDThal_IFG and Model_MDThal_IFG_MDThal are characterised by the 
nonlinear modulation from the MD Thal onto the bidirectional connection between the MD 
Thal and the IFG. Both models are specified upon the winning bilinear model and form 
model family 2. 
Model_MDThal_MDThal_IFG is specified by the nonlinear modulation from the MD Thal onto 
the connection from the MD Thal to the IFG. 
Model_MDThal_IFG_MDThal is specified by the nonlinear modulation from the MD Thal onto 
the connection from the IFG to the MD Thal. 
Model_IFG_MDThal_IFG and Model_IFG_IFG_MDThal are characterised by the nonlinear 
modulation from the IFG onto the bidirectional connection between the MD Thal and the IFG. 
Both models are specified upon the winning bilinear model and form model family 3. 
Model_IFG_MDThal_IFG is specified by the nonlinear modulation from the IFG onto the 
connection from the MD Thal to the IFG. 
Model_IFG_IFG_MDThal is specified by the nonlinear modulation from the IFG onto the 








3.4.5.2.2.3 Model Space Partitioning – Family Level Inference - 
Random effects Bayesian Model Selection 
In phase 2, we applied the established Bayesian inference approach of Family Level 
Inference and BMA (Penny et al., 2010). Family Level Inference allows the 
comparison of models of different characteristics (i.e. bilinear and nonlinear models) 
at the family level. Family Level Inference removes uncertainty about aspects of 
model characteristics by focusing on the criterion of interest (Penny et al., 2010). To 
this end, the models differed from each other in the nonlinear aspect. 
Here, the model space was partitioned into three model families: 
(i) Model Family 1: bilinear model 
Model Family 1 contained the optimal bilinear model (Figure 3.2; Model 7). 
(ii) Model Family 2: nonlinear models — MD thalamus 
Model Family 2 contained the two nonlinear models with nonlinear 
modulation from the MD thalamus (Figure 3.3; 
Model_MDThal_MDThal_IFG and Model_MDThal_IFG_MDThal). 
(iii) Model Family 3: nonlinear models — IFG 
Model Family 3 contained the two nonlinear models with nonlinear 
modulation from the IFG (Figures 3.3; Model_IFG_MDThal_IFG and 
Model_IFG_IFG_MDThal). 
 
It is hypothesised that the for the EHRS study that different subject groups use 
different coping strategies to solve the HSCT. Family Level Inference provides an 
approach for random effects analyses (Penny et al., 2010) that can account for these 




families that contain different number of models (Penny et al., 2010). Random effect 
BMS at the family level uses a Gibbs sampling method (with 1,000,000 samples) and 
a Dirichlet distribution to compute the family frequencies of each model family in 
the population and defining a prior over these likelihoods and the exceedance 
probabilities. In Eq. (3), the exceedance probability (φk) is the likelihood that a 
model family k represents the analysed time sequences (of K families compared), for 
the given the fMRI task (Penny et al., 2010). It has been previously shown that this 
approach is reliable (Seghier et al., 2011). 
 
3.4.5.2.3 Phase 3: Bayesian Model Averaging – Theoretical 
background 
In phase 3, we applied BMA over the winning models identified from the BMS at the 
family level in the phase 2 processing. BMA assesses the full posterior density on 
parameters by weighting the evidence to the contribution of each model to the mean 
effect (Penny et al., 2010). Posterior density means that models with the highest 
evidence maximize their contribution to the evidence, while models with weak 
evidence minimize their contribution to the evidence. These results can be computed 
for posterior means of connectivity on single subject level. 
 
The significance of connection strength with nonlinear modulation for the four 
nonlinear DCMs (Figure 3.3) was computed by the fraction of samples in the 
posterior density that differed from zero. Significant effects are reported at a 
posterior probability level of 0.95. This approach has been shown to produce reliable 




over the bidirectional connections between the MD thalamus and the IFG by pooling 
evidence from different groups of subjects, in a way that accounts for uncertainty 
about the particular model generating the data. 
Apart from the examination of the connection strength with nonlinear modulation, 
the connection strengths for endogenous connections, connections with modulatory 
inputs and connections of direct inputs were assessed with the same procedure. 
 
3.4.5.3 Correlations between clinical measures and parameter 
estimates of connection strengths with nonlinear modulation 
The final component of the heuristic protocol evaluates the individual posterior 
densities of the connection strengths. The connection strengths with nonlinear 
modulation are entered into a statistical analysis where within-group correlations 
between the connection strengths with nonlinear modulation and the clinical 
symptoms assessed using the individual rescaled PANSS scores as an explorative 
approach. The correlations were run on the individual symptoms as assessed with 
PANSS in three separate analyses: (i) Positive symptoms (P1 – P7); (ii) negative 
symptoms (N1 – N7); and (iii) general symptoms (G1 – G16) (Kay et al., 1987). In 
order to estimate the sampling error of the original subpopulations, bivariate Pearson 
correlation with Bootstrapping and Confidence Intervals of 95% were constructed 
(Cohen, 1988; Efron and Tibshirani, 1993). Furthermore, the correlations were 
corrected for multiple comparisons. These analyses were run in the healthy controls, 
HRall and HR+ but not in the four ill subjects because of the small number of this 






3.5.1 Demographic and clinical details 
There were no significant differences in mean age, gender, mean intelligence 
quotient (NART IQ) or handedness between the groups (Table 3.3). 
 
3.5.2 Functional activation 
The localisation results are presented as between group results for the parametric 
contrast and the sentence completion versus baseline contrast for both the main ‘trait’ 
effect and ‘state’ effect in order to ensure that the processed EPI scans in SPM8 
reproduced the previously reported between group differences (Whalley et al., 2004). 
 
3.5.2.1 Main ‘trait’ effect  
For the examination of the ‘trait’ effect, healthy controls were compared with HRall 
subjects. The between group results for the parametric contrast are displayed in Table 
3.5. 
 
3.5.2.1.1 Parametric contrast 
The results for the between group differences for the parametric contrast revealed 
increased activation with increasing task difficulty in healthy controls compared to 











Extent Peak height 
coordinates 
Region Z score 
Parametric Contrast: Healthy Controls (n=21) < HRall subjects (n=69) 
 
n/s     




156 18, 43, 2 
1, 60, 56 






245 -3, -73, -8 
-10, -73, -11 
-18, -76, -14  






294 8, -13, 6 
-8, -17, 11 
16 -12 8 
R/L sub-lobar: thalamus 3.90 
Reported p values are thresholded at p < .05 FWE corrected cluster level, extent threshold = 
50 voxels. Coordinates represent the three maxima within the same cluster. 
 
3.5.2.1.2 Sentence completion versus rest 
For the sentence completion versus rest contrast, no statistically significant group 
differences were observed between the healthy controls and all HR subjects. 
 
3.5.2.2 ‘State’ effects 
For the ‘state’ effects, healthy controls and HR- subjects in one group versus HR+ 
subjects were compared. The between group results for the sentence completion 
versus rest contrast are displayed in Table 3.6. 
 
3.5.2.2.1 Parametric Contrast 
No significant group differences between healthy controls/HR- subjects and HR+ 






3.5.2.2.2 Sentence completion versus rest 
Increased activation in the left parietal lobe was observed in HR+ subjects versus HR 
subjects and healthy controls. There were significant results for the opposite contrast. 
 




Extent Peak height 
coordinates 
Region Z score 





387 -42, -48, -48 
-45, -39, 60  
-37 -43, 30 
L parietal: inferior parietal 
lobule, BA 40 
4.46 
Sentence completion versus rest: Healthy Controls and HR- subjects > HR+ subjects 
 
n/s     
Reported p values are thresholded at p < .05 FWE corrected cluster level, extent threshold = 
50 voxels. Coordinates represent the three maxima within the same cluster. 
 
3.5.3 Functional integration – Dynamic Causal Modelling 
The DCM results for the grouped analyses follow the three phases of the DCM 
protocol given in Figure 3.1. In the first phase, the optimal model for the HSCT 
identified the general structure of the network. In the second phase, this structure was 
further interrogated to reveal the model families that best explain the expected group 
separation in our cohort. In the third phase, the nonlinear modulation was assessed 
within the two winning model families resulting from the analyses in phase 2. The 





3.5.3.1 Bilinear Dynamic Causal Modelling and Bayesian Model 
Selection at the group level 
The application of phase 1 processing in the DCM protocol provided the exceedance 
probabilities of the eight linear models labelled M1 to M8 across the three subject 
groupings are presented Figure 3.4. In Figure 3.4a, the BMS results are shown for the 
first grouping of healthy controls and all HR. In Figure 3.4b, the BMS results are 
shown for the second grouping of healthy controls, HR− and HR+. In Figure 3.4c, 
the BMS results are shown for the third grouping of healthy controls, HR−, HR+ and 
the four ill subjects who subsequently developed schizophrenia. This random effects 
BMS analyses showed that Model 7 (M7) outperformed all other models for the 
tested groupings. Model 7 demonstrated Xp of 0.63 in healthy controls and Xp=0.52 
in HRall (Figure 3.4a); Xp=0.59 in HR− and Xp=0.63 in HR+ (Figure 3.4b); and 
Xp=0.63 in the four ill subjects (Figure 3.4c). The likelihood of Model 7 is three 
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c  
Figure 3.4 Bayesian Model Selection at the Group Level for Bilinear Models 
(Reproduced from Dauvermann et al., 2013). 
Figure 3.4a. Bayesian Model Selection at the group level for healthy controls and all high risk 
subjects 
First grouping of the BMS analysis for healthy controls and HRall. Model 7 is the optimal 
model in both healthy controls and HRall.  
Figure 3.4b. Bayesian Model Selection at the group level for healthy controls, high risk 
subjects without psychotic symptoms and high risk subjects with psychotic symptoms. 
Second grouping of the BMS analysis for healthy controls, HR- and HR+. Model 7 is the 
optimal model in healthy controls, HR- and HR+. 
Figure 3.4c. Bayesian Model Selection at the group level for healthy controls, high risk 
subjects without psychotic symptoms, high risk subjects with psychotic symptoms and the 
four ill subjects 
Third grouping of BMS analysis for healthy controls, HR-, HR+ and four ill subjects. Model 7 
is the optimal model in healthy controls, HR-, HR+ and the four ill subjects. 
BMS, Bayesian Model Selection; HC, healthy controls; HR-, high risk subjects without 
psychotic symptoms; HR+, high risk subjects with psychotic symptoms; Four ill subjects, four 
HR subjects who became subsequently ill; eight bilinear models (Figure 3.2) are labelled M1 
to M8; M7, Model 7 (Figure 3.2); Xp, exceedance probability. 
 
Model 7 is illustrated in Figure 3.2. It contains one unidirectional connection from 
the IPS to the MTG and reciprocal endogenous connections between all the other 
regions. The BMS results from Model 5 to Model 8 demonstrate that the 
unidirectional connection from the IPS to the MTG is more likely than the 




Model 3 and particularly Model 7 show that the task-dependent modulation was 
optimal for the forward connection between the MTG and the IFG and the forward 
connection between the MD thalamus and the IFG. Model 7 is similarly structured to 
the optimal model found in the HSCT study reported by Allen et al., (2010) although 
this study did not include the MD thalamus. 
We note that the exceedance probability in the implementation of Model 7 is 
consistent across the tested groups. The exceedance probabilities for Model 7 vary 
from a minimum of 0.58 to a maximum of 0.63 across all subject groupings. We also 
note similar consistency in exceedance probabilities for the other tested bilinear 
models. This consistency in BMS exceedance probabilities in healthy controls and 
HR subjects was also reported by Allen et al., (2010). 
 
3.5.3.2 Nonlinear Dynamic Causal Modelling and Bayesian Model 
Selection at the model family level 
The results of phase 2 are presented for the repeated grouping analyses. Three model 
families were compared against each other. The partitioning of the model space was 
the same for each grouping (see section on Model Space Partitioning – Family Level 
Inference – Bayesian Model Averaging). We compared the different model families 
using the random effects BMS approach at the family level to reveal the optimal 
model family across the three groupings in healthy controls and the high risk 
subjects. 
The BMS analysis over the model families resulted in different Xp values being 
recorded between the healthy controls and the HR subjects (Figure 3.5). The main 




summarises and compares the three groupings. The exceedance probabilities for the 
two winning Model Families 2 and 3 were summarised (for a similar approach see 
Penny et al., 2010; Seghier et al., 2011). 
(i) The two winning model families 2 and 3 outperform the model family 1 in 
every group. In other words, both model families 2 and 3 are more likely than 
model family 1 to explain the HSCT fMRI data. 
(ii) Model families 2 and 3 accounted for a total of Xp=0.95 in healthy controls 
and Xp=0.99 in HRall in the first run (Figure 3.5a). 
(iii) Model families 2 and 3 accounted for a total of Xp=0.95 in healthy controls, 
Xp=0.99 in HR− and Xp=0.99 in HR+ in the second run (Figure 3.5b). 
(iv) Model families 2 and 3 accounted for a total of Xp=0.95 in healthy controls, 
Xp=0.95 in HR−, Xp=0.99 in HR+ and Xp=0.86 in the four ill subjects in the 
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Figure 3.5. Bayesian Model Selection at the Model Family Level (Reproduced from 
Dauvermann et al., 2013). 
Figure 3.5a. Bayesian Model Selection at the model family level for healthy controls and all 
high risk subjects 
First grouping of the BMS analysis for healthy controls and HR all. The winning model 
families are Model Families 2 and 3 in both healthy controls and HRall. 
Figure 3.5b. Bayesian Model Selection at the model family level for healthy controls, high 
risk subjects without psychotic symptoms and high risk subjects with psychotic symptoms 
Second grouping of the BMS analysis for healthy controls, HR- and HR+. The winning model 
families are Model Families 2 and 3 in healthy controls, HR- and HR+. 
Figure 3.5c. Bayesian Model Selection at the model family level for healthy controls, high risk 
subjects without psychotic symptoms, high risk subjects with psychotic symptoms and the 
four ill subjects. 
Third grouping of the BMS analysis for healthy controls, HR-, HR+ and four ill subjects. The 
winning model families are Model Families 2 and 3 healthy controls, HR-, HR+ and the four 
ill subjects. 
BMS, Bayesian Model Selection; HC, healthy controls; HR-, high risk subjects without 
psychotic symptoms; HR+, high risk subjects with psychotic symptoms; Four ill subjects, four 
HR subjects who became subsequently ill; Xp, exceedance probability. Red Column: Model 
Family 1 - Bilinear Model 7; Blue Column: Model Family 2 - Nonlinear Models with nonlinear 
modulation from MD Thalamus: Green Column: Model Family 3 - Nonlinear Models with 
nonlinear modulations from IFG. 
 
In both model families 2 and 3, the nonlinear modulations onto both reciprocal 




The results of the three groupings demonstrated that the distribution of likelihoods of 
the model families 2 and 3 differentiated between the groupings of HR subjects. In 
the first grouping, the HRall showed a different distribution of exceedance 
probabilities to healthy controls. In the second run, the finding revealed that the 
distribution of the HR+ seemed to resemble the distribution of the HRall. In the third 
run, the additional subgroup of four ill subjects demonstrated that the pattern of 
greater likelihood of model family 2 than model family 3 as it was observed in  HR+ 
was repeated in the four ill subjects. 
 
3.5.3.3 Bayesian Model Averaging – Posterior densities of connection 
strengths 
The results for the posterior densities of connection strengths follow the outlined 
structure: Firstly, the connection strengths with nonlinear modulation are presented 
before endogenous connection strengths, connection strengths for modulatory inputs 
are reported. 
 
3.5.3.3.1 Connection strength with nonlinear modulation 
The result of the significant connection strengths with nonlinear modulation for the 
Model MDThal_MDThal_IFG (Figure 3.3) demonstrated reduced connection 
strengths with nonlinear modulation in HR+ and the four ill subjects but not in 
HRall.  
In order to investigate the posterior probabilities of the connectivity with nonlinear 
modulation, we assessed the connection strengths from model family 2, nonlinear 




the two winning models resulted in different posterior probabilities of the nonlinear 
modulation in the Model MDThal_MDThal_IFG (Figure 3.3; Figure 3.6). 
(i) The connection strength with nonlinear modulation was reduced in HRall, 
HR+ and the four ill subjects across the three groups; this parameter was 
significantly lower in the HR+ and the four ill HR subjects in contrast to the 
healthy controls (posterior probability 0.95). 
(ii) The connection strength with nonlinear modulation was not significantly 
different between the healthy controls and the HRall (Figure 3.6a). 
(iii) The connection strength with nonlinear modulation was significantly reduced 
in the HR+ in contrast to healthy controls (posterior probability 0.95; 
Figure Table 3.6b). 
(iv) The connection strength with nonlinear modulation was significantly reduced 

















Figure 3.6. Bayesian Model Averaging Results for the Thalamo-cortical Connection 
with Nonlinear Modulation from the MD Thalamus - Model_MDThal_MDThal_IFG 
(Reproduced from Dauvermann et al., 2013). 
Figure 3.6a. Average of posterior densities of connection strength with nonlinear modulation 
for healthy controls and all high risk subjects 
First grouping of the BMA analysis for healthy controls and all high risk subjects. The 
connection strength with nonlinear modulation was not significantly different. 
Figure 3.6b.  Average of posterior densities of connection strength with nonlinear modulation 
for healthy controls and high risk subjects with psychotic symptoms.  
Second grouping of the BMA analysis for healthy controls and HR+. The connection strength 
with nonlinear modulation was significantly reduced in HR+ in contrast to healthy controls. 
Figure 3.6c.  Average of posterior densities of connection strength with nonlinear modulation 
for healthy controls, high risk subjects with psychotic symptoms and the four ill subjects. 
Third grouping of the BMA analysis for healthy controls, HR+ and four ill subjects. The 
connection strength with nonlinear modulation was four ill subjects in contrast to the healthy 
controls. 
Average of posterior densities of connection strength with nonlinear modulation (in Hertz), 
(all significant at posterior probability threshold p > .95). BMA, Bayesian model averaging; 
HC, healthy controls; HR+, High Risk subjects with psychotic symptoms; four ill subjects, 4 
subjects who subsequently became ill. 
 
3.5.3.3.2 Endogenous connection strength 
The average of the posterior densities of the endogenous connection strengths from 











HR- subjects HR+ subjects Four ill subjects 
IPS -> MTG 
 
0.22 (0.25) 0.19 (0.23) 0.24 (0.22) 0.20 (0.25) 
IFG -> ACC 0.02 (0.08) 0.02 (0.10) 0.04 (0.13) 0.03 (0.16) 
 
ACC -> IFG 0.02 (0.09) 0.02 (0.11) 0.04 (0.12) 0.03 (0.14) 
 
IFG -> MTG 0.05 (0.15) 0.08 (0.08) 0.08 (0.13) 0.03 (0.13) 
 
MTG -> IFG 0.05 (0.11) 0.09 (0.06) 0.04 (0.13) 0.11 (0.15) 
 
IFG -> MDThal 0.01 (0.10) 0.01 (0.09) 0.04 (0.10) 0.03 (0.12) 
 
MDThal -> IFG 0.01 (0.09) 0.01 (0.08) 0.04 (0.10) 0.03 (0.23) 
 
ACC -> MTG 0.10 (0.10) 0.09 (0.06) 0.11 (0.14) 0.01 (0.12) 
 
MTG -> ACC 0.03 (0.05) 0.12 (0.05) 0.11 (0.11) 0.06 (0.11) 
 
ACC -> MDThal 0.00 (0.04) 0.03 (0.05) 0.03 (0.07) 0.02 (0.09) 
 
MDThal -> ACC 0.12 (0.15) 0.06 (0.05) 0.05 (0.10) 0.02 (0.11) 
 
MTG -> MDThal 0.03 (0.04) 0.10 (0.11) 0.13 (0.08) 0.08 (0.13) 
 
MDThal -> MTG 0.08 (0.12) 0.08 (0.11) 0.00 (0.12) 0.01 (0.14) 
 
Mean (SE) 
HC, healthy controls; HR-, high risk subjects without psychotic symptoms; HR+, high risk 
subjects with psychotic symptoms; Four ill subjects, four HR subjects who became 
subsequently ill. 
 
3.5.3.3.3 Connection strength with modulatory inputs 
The averages and standard deviations of the posterior densities of connection 
strengths with modulatory inputs across the three groupings are presented in Table 




Table 3.8 Average of posterior densities of connection strength of modulatory inputs (in Hertz). 
Model MDThal_MDThal_IFG 
 
HC HR- subjects HR+ subjects  Four ill subjects  
 “Low difficulty level” 
 
    
















“Low medium difficulty level” 
 
    
















“High medium difficulty level” 
 
    
















“High difficulty level” 
 
    

















HC, healthy controls; HR-, high risk subjects without psychotic symptoms; HR+, high risk subjects with psychotic symptoms;  









3.5.3.4 Correlations between clinical measures and posterior 
densities of connection strength with nonlinear modulation 
In the post-hoc analysis of symptom correlations, we examined whether the finding 
of reduced EC could underlie the clinical symptoms as assessed with the individual 
symptoms of the rescaled PANSS in the HR+. A significant correlation was found 
between the individual connection strength with nonlinear modulation of 
Model_MDThal_MDThal_IFG (Figure 3.2a) and the individual rescaled PANSS 
symptom ‘delusion’ (P1; Kay et al., 1987) in HR+ (r = −.246; p = .041; 95 % CI 
(−0.543; −0.024)). This finding met significance with corrections for multiple 
comparisons. The significant association in HR+ supported the more pronounced 
reduction of this connection strength with nonlinear modulation in the four subjects 
(Table 3.5c), who showed delusions at the time of transition to the illness. 
Furthermore, the correlation in HR+ in addition to the significant relationship in 
HRall (r=−.201; p=0.05; 95% CI (−0.446; 0.02); significant with corrections for 
multiple comparisons) confirms the BMS results on the model family level (Figure 
3.5a in HRall and Figure 3.5b in HR+). The distribution of the likelihood of the 
model families 2 and 3 between HRall, HR− and HR+ (Figure 3.5a and Figure 3.5b) 
can therefore be explained by the lower connection strength with nonlinear 
modulation (in the Model MDThal_MDThal_IFG) as a state-marker in the HRall and 
HR+ groups.  
There were no significant associations between the individual PANSS symptom 
‘hallucination’ (P3; hallucinatory behaviour; Kay et al., 1987) and the connection 
strength with nonlinear modulation in HR+ or HRall. Furthermore, we did not 




(positive, negative and general symptoms; Kay et al., 1987) and nonlinear EC 
measures in HR+ or HRall. Lastly, we do not report the correlation results for the 
healthy controls due to the inadequately small number of healthy controls for the 
correlation analyses, who showed positive, negative and general symptoms as 
assessed with PANSS. 
 
3.6 Discussion 
We applied nonlinear DCM to fMRI data for the HSCT in subjects at high familial 
risk of schizophrenia. For the HSCT, nonlinear DCM allowed us to model 
connection strength with nonlinear modulation and assess the interactions between 
neuronal populations in the MD thalamus and the IFG. Our results demonstrate that 
the connection strength with nonlinear modulation of the thalamo-cortical connection 
is reduced in HR+. This could result in reduced prefrontal-thalamic FC and cortical 
dysconnectivity and both is in keeping with and extends our previous findings of FC 
on this cohort (Whalley et al., 2005). In addition, we see further reductions of 
connection strength with nonlinear modulation in the four subjects who subsequently 
developed schizophrenia in our HR cohort although this should be considered 
preliminary given the small subject number in this group. Furthermore, we found 
significant negative correlations between connection strength with nonlinear 
modulation and the PANSS symptom severity of delusion in HR+ and the HRall. 
This indicates that the presence of active symptomatology in HR+ (and to a lesser 
extent in the HRall) may be a factor for the state-related differences between HR− 
and HR+. None of the subjects reported the presence of psychotic symptoms at more 




well. None were on antipsychotic medication. Thus, our findings are not confounded 
by the effect of medication. 
 
Our results of reduced connection strength with nonlinear modulation in the HR+ 
and four ill HR subjects are in keeping with studies, which propose that nonlinear 
models can resemble reduced gating and provide a better explanation to the fMRI 
data than linear models. The finding of reduced connection strength with the 
thalamo-cortical projection via the MD thalamus in the HR+ and the four ill subjects 
supports the hypothesis of disrupted synaptic plasticity, which is gated by nonlinear 
biophysical processes (Chance et al., 2002; Deng and Klyachko, 2011; Destexhe, 
2009; Negyessy and Goldman-Rakic, 2005). Our results support previous findings of 
disrupted synaptic plasticity of the thalamo-cortical connection (Krystal et al., 2003; 
Negyessy and Goldman-Rakic, 2005) resulting in cortical dysconnectivity in 
schizophrenia (Balu and Coyle, 2012; Byne et al., 2009; Goff and Coyle, 2001; 
Lewis and Lieberman, 2000; Pakkenberg et al., 2009; Sodhi et al., 2011; Watis et al., 
2008). 
 
Consistent with previous FC and EC studies using verbal fluency tasks, functional 
connections between the left IPS and left prefrontal regions, left IFG and left 
thalamus (Whalley et al., 2005), left IFG and ACC, left STG/MTG and ACC 
(Boksman et al., 2005; Allen et al., 2008; Allen et al., 2010) and left MFG and left 
MTG (Allen et al., 2008; Allen et al., 2010). In FC studies, altered functional 
connections between the left IFG and left thalamus, left parietal and left prefrontal 




dependent functional coupling between the right AC and left IFG as well as left STG 
in FES (Boksman et al., 2005) and negative correlations between the left DLPFC and 
left middle temporal cortex/superior temporal cortex in EST in contrast to healthy 
controls (Lawrie et al., 2002). Furthermore, supporting evidence for task-dependent 
modulation (of response suppression in contrast to response initiation of the HSCT) 
from the left MTG to the left MFG in healthy controls (Allen et al., 2008) and from 
the left MFG to the left MTG in ARMS subjects and healthy controls (Allen et al., 
2010) was reported from two DCM studies. Lastly, intrinsic connection strength was 
increased in ARMS subjects in contrast to healthy controls (Allen et al., 2010).        
For the bilinear models, the optimal model 7 in this study was similarly specified to 
the winning model in healthy controls and ARMS subjects and resulted in no 
significant group differences as previously reported (Allen et al., 2010). These 
findings suggest that (i) the task-dependent modulation from the MTG to MFG may 
reflect successful response initiation of the HSCT in all participants and (ii) in 
comparable cognitive coping of the HSCT in ARMS subjects and HR subjects 
despite significant group differences in FA (Whalley et al., 2004; Allen et al., 2010), 
FC between IFG and thalamus (Whalley et al., 2010) and EC between MTG and 
ACC (Allen et al., 2010). Given comparable behavioural performances between the 
study populations, we propose that the previously reported group differences at the 
FA and FC level may reflect altered cortical function (Schlösser et al., 2008) or a 
compensation to impaired function (Tan et al., 2006). We speculate that the lack of 
significant group differences in task-dependent modulation at the level of bilinear 
models may be due to the complex structure of the networks consisting of five 




in addition to the endogenous connections, connections with modulatory input and 
driving inputs. This finding may reflect one of the limitations of deterministic DCM, 
which does not account for unknown variables in the models. In terms of the main 
result of nonlinear models, we propose that the modelling of the nonlinear 
modulation in addition to the ‘structure’ of the bilinear models may have provided 
additional information, which led to greater probabilities in explaining the given 
fMRI data. On the neurocognitive level, we speculate that the reduced connection 
strengths with nonlinear modulation in HR+ subjects and four ill subjects may reflect 
a compensatory mechanisms, which is related to the severity of the transient 
‘delusion’ symptom. Currently, the knowledge of neurocognitive mechanisms 
underlying gating mechanisms in cognitive processes in humans is limited and 
clearly needs further research. 
 
It has been proposed that cortical dysfunction in verbal fluency tasks could be 
mediated by thalamic glutamatergic disruption (Fusar-Poli et al., 2011) and/or 
alterations of the thalamo-cortical neuronal projection (Byne et al., 2009; Lewis and 
Lieberman, 2000; Pakkenberg et al., 2009; Sodhi et al., 2011; Watis et al., 2008). In 
more detail, supporting evidence for increased BOLD response of the right DLPFC 
in ARMS/UHR subjects in contrast to healthy controls in the HSCT4 was reported, 
which was negatively related with lower thalamic Glu levels in ARMS subjects 
(ARMS, Fusar-Poli et al., 2011; UHR, Allen et al., 2014). Furthermore, it was shown 
that not only Glu concentrations from the thalamus in UHR subjects were reduced in 
contrast to healthy controls but also that thalamic Glu concentrations were negatively 
                                                          





associated with the severity of total positive symptoms in UHR in non-remission in 
contrast to UHR subjects in remission after 18 months (Egerton et al., 2014). In 
subjects at enhanced familial risk of schizophrenia, no significant group differences 
in thalamic Glu concentrations were reported (Yoo et al., 2009), however, increased 
Glx/Cr concentrations in the right medial frontal lobe in subjects at enhanced familial 
risk when compared to healthy controls have been found (Tibbo et al., 2004). 
Additional MRS studies in familial risk of schizophrenia did not find significant 
group differences in Glu/Glu-related levels in the left DLPFC/AC/left thalamus 
between HR subjects at familial risk and healthy controls (Yoo et al., 2009; 
Lutkenhoff et al., 2010). 
Furthermore, alterations of glutamatergic neurotransmission leading to the 
pathophysiology of schizophrenia as part of the glutamate hypothesis of 
schizophrenia have been suggested (Coyle, 2006; Coyle et al., 2010; Javitt, 2010). In 
terms of glutamatergic neurotransmission, NMDA receptor-dependent modulation of 
the thalamo-cortical connection may be disrupted in schizophrenia (Balu and Coyle, 
2012; Gray and Roth, 2007; McCormick and Bal, 1997; Romanides et al., 1999; 
Watis et al., 2008). It is noted that not only glutamatergic alterations are involved but 
alterations of interactions between DA and Glu among other implicated 
neurotransmitters are implicated (Cronenwett and Csernansky, 2010). One example 
of indirect relationship between cortical dysconnectivity and dopaminergic 
alterations has been presented by increased BOLD response of the bilateral PFC and 
greater PFC-midbrain FC in UHR, who subsequently developed schizophrenia in 
contrast to UHR, who did not subsequently develop schizophrenia (Allen et al., 




modulation of the thalamo-cortical connection during the HSCT suggest that altered 
glutamatergic and/or dopaminergic transmission of the MD thalamus could underlie 
the reduced gating of the task. We speculate that the difference in connection 
strengths with nonlinear modulation may be linked to clinical symptoms in HR+ 
subjects rather than behavioural performance since only clinical symptoms were 
significantly different between the groups. However, we acknowledge the lack of 
measures of Glu and DA concentration in the MD thalamus in this study. 
 
There are general limitations of bilinear and nonlinear DCM and specific limitations 
of this study. The temporal resolution of fMRI is limited, which leads to an inability 
to consider conduction delays in inputs and interregional interactions (Friston et al., 
2003) in contrast to DCM for EEG/MEG (Daunizeau et al., 2011a; Stephan and 
Friston, 2010; Friston and Dolan, 2010). DCM requires strict subject and ROI 
inclusion criteria (Stephan et al., 2007), which results in exclusion of more subjects 
compared to the usual fMRI analyses, leading to a smaller sample size for this study 
than for our previous analyses (Whalley et al., 2005; Whalley et al., 2004). Also 
DCM8 does not allow a direct assessment of alterations of excitatory glutamatergic 
subpopulations (Marreiros et al., 2008) in the models or an explicit neuronal 
population (Daunizeau et al., 2009). Thus, we cannot definitely state that 
glutamatergic neurotransmission is implicated in the lower connection strength with 
the gating in the high risk subjects. It is noted that underestimation of processing 
complexity of neurobiological networks is likely not only with bilinear DCM but 
also with nonlinear DCM (Dauvermann et al., 2014). The nonlinear dynamical 




represent the random or stochastic noise of neuronal activity (Saarinen et al., 2008) 
and hidden neuronal and physiological processes (Li et al., 2011). Our DCM 
analyses of subjects who subsequently develop schizophrenia were limited to four 
individuals. Because of the small size in this group in the DCM analysis it is not 
possible to consider the DCM results to have predictive validity although the four 
individuals can be treated as single-subject results (Stephan et al., 2007). For 
predictive studies using DCM results, the DCM-based generative embedding 
approach using support vector machines (Brodersen et al., 2011; Brodersen et al., 
2013) is an additional approach. Finally, the DCM analyses in this study were run in 
DCM8 limiting us to deterministic and one-state DCM. 
 
3.7 Conclusion 
Our results show that gating mechanism at the neuronal population level of the MD 
thalamus could be altered and may contribute to or be an underlying cause for the 
development of psychotic symptoms. This study suggests that nonlinear DCM could 
further our understanding of altered connectivity in subjects at high familial risk 
stage of schizophrenia. 
 
The methodological approach of this study has been adopted for the investigation of 
possibly altered gating mechanism in working memory in subjects with established 












4 Dynamic Causal Modelling for fMRI in 





















Findings from FC studies during verbal/numeric working memory in individuals 
with schizophrenia have increased insight into altered large-scale networks 
underlying working memory deficits (chapter 1.4.3). EC studies have reported 
altered connection strengths during cognitive tasks in people with schizophrenia 
when contrasted to healthy controls. These results may offer a biophysical 
interpretation of altered large-scale networks and possibly altered neurotransmission 
in schizophrenia (chapter 2.2.4.3). However, it is possible that the complexity of 
neurobiological networks is underestimated in DCM in its current implementation. 
 
Findings from the application of nonlinear DCM of the EHRS study showed that the 
connection strengths with nonlinear modulation of the thalamo-cortical connection 
during verbal fluency was significantly reduced in subjects at high familial risk of 
schizophrenia in comparison to healthy controls. These findings were interpreted as a 
possible marker of disrupted synaptic plasticity and glutamatergic transmission at the 
high risk stage of schizophrenia (chapter 3.6). 
 
In this study, we assessed the connection strength of nonlinear modulation of the 
bidirectional connection between the DLPFC and the VTA/SN area during verbal 
working memory in healthy controls and EST. The role of the VTA/SN area and the 
meso-cortical connection in dopaminergic neurotransmission and working memory 
has received extensive evidence from preclinical research (chapter 1.3.1, chapter 
1.3.2) and computational modelling of preclinical findings (chapter 2.2.2.2). The 




have been partly formulated on the basis of the findings on dopaminergic alterations 
of the VTA and the meso-cortical connection in animal models of schizophrenia. In 
humans, research on the functional role of the VTA in working memory is rare due 
to technical difficulties of neuroimaging techniques such as fMRI/PET (such as field 
strength for fMRI; Tomasi et al., 2007) and ethical reasons of invasive in vivo 
investigation of neuronal and cellular mechanisms in humans. With improvement of 
technical aspects (such as higher field strength of MRI scanners, improved EPI 
sequences; improved DA transporter ligands for PET) and modelling of parametric 
working memory loads/high working memory loads, recent fMRI studies provided 
evidence for the implication of the VTA/SN area in working memory and/or 
dopaminergic modulation in healthy controls (fMRI, Murty et al., 2011; D’Ardenne 
et al., 2012; Xu et al., 2013; Yu et al., 2013; PET, Mehta et al., 2008) and in EST 
(fMRI, D’Aiuto et al., 2014). We applied the heuristic search protocol for nonlinear 
DCM for fMRI (chapter 3.4.5.2) to the verbal “N-back” task in healthy controls and 
EST.  
 
The theoretical background for this study is based on the reviewed FA, FC and EC 
findings (of the DLPFC, IPS and ACC) during the verbal/numeric “N-Back” task in 
individuals with schizophrenia and healthy controls (chapters 1.4.2, 1.4.3 and 
2.2.4.3), the established functional role of the VTA in working memory and 
dopaminergic modulation in basic neuroscience (chapter 1.3.1, chapter 1.3.2 and 
chapter 2.2.2.2) and novel findings of the functional role of the VTA in working 
memory in humans by findings of FA, FC (fMRI, Murty et al., 2011; D’Ardenne et 




occupancy in clinical and cognitive neurosciences (PET, Mehta et al., 2008). The 
heuristic search protocol for the application of nonlinear DCM for fMRI (chapter 
3.4.5.2) was applied to the “N-Back” task of this study. Therefore, the chapters 
referring to the DCM scan processing and results (chapter 4.3.7 and chapter 4.4.4) 
follow the outline as given in the appropriate methods and results from chapter 3 
(chapter 3.4.5 and chapter 3.5.3). Lastly, the findings are discussed in context of 
possibly altered synaptic plasticity and gating mechanism in schizophrenia (chapter 
4.5). 
 
4.2 Overall aim 
The aim of the current study was to examine potentially altered neurobiological 
mechanisms underlying verbal working memory in fMRI data with nonlinear DCM 
for EST and healthy controls. Altered EC measures from nonlinear modulation may 
resemble disrupted synaptic plasticity and gating mechanisms of the meso-cortical 
connection during verbal working memory in schizophrenia (chapter 2.2.2.2). For the 
current study, it was hypothesised that EST would show altered connection strength 
with nonlinear modulation of the meso-cortical connection and/or cortico-mesal 
connection during the verbal “N-back” task compared to healthy controls. 
 
In chapter 3, we presented the application of nonlinear DCM to the EHRS study. We 
found evidence for altered activity-dependent synaptic plasticity processes, which are 
thought to be of nonlinear nature. These nonlinear processes or gain modulations 
(Abbot et al., 2007; Rothman et al., 2009; Salinas and Sejnowski, 2001; Shu et al., 




and Abbot, 1996; Salinas and Sejnowski, 2001). Furthermore, it has been proposed 
that gating processes during working memory may be altered in schizophrenia 
(Wang et al., 2010). 
 
As described in the previous chapter of the DCM EHRS study, nonlinear DCM for 
fMRI assesses inhibitions of a neuronal connection and provides a means to model 
nonlinearities in fMRI tasks (Stephan and Friston, 2010; Stephan et al., 2008). Thus, 
the heuristic search protocol from the DCM EHRS study was applied to the “N-
back” task. The DCM specification followed the same guidelines as outlined in 
chapter 3.4.5.1 and 3.4.5.2. Therefore, the model space was defined on the basis of 
the between-group FA results during the “N-Back” task. The bidirectional 
connection between the DLPFC and the ipsilateral VTA/SN area was modelled with 
connection strength with nonlinear modulation based on neurobiological findings of 
gating mechanism during working memory in schizophrenia (chapter 2.2.2.2). 
 
4.3 Methods 
For this study, verbal working memory fMRI data from EST and matched healthy 
controls were analysed with DCM for fMRI. These subjects were drawn from a large 
study, the SFMHS, which encompassed family members with the DISC1 
translocation (Blackwood et al., 2001), family members without the translocation, 
EST, patients with bipolar disorder, FEP and healthy controls. The SFMHS is a 





Recruitment for the DISC1 family encompassed areas of the Borders, Galloway, 
Dumfries, Glasgow and North Lanarkshire. EST and healthy volunteers were 
recruited from Edinburgh and Midlothian. The study was approved by the local 
Research Ethics Committee and institutional review board. All participants provided 
written informed consent. 
 
The EST and healthy controls subject selection for the DCM study was determined 
by the behavioural performance during the fMRI verbal “N-back” task. The level of 
task performance was assessed using the sensitivity index d’ as part of the signal 
detection theory (MacMillan and Creelman, 1991). The statistical analyses of the 
demographic, clinical and behavioural measures were conducted in SPSS (SPSS 
BMI 19.0). 
The scan pre-processing, statistical analysis for the FA and the DCM analyses were 
run in SPM8 (update revision number 3684) running in Matlab (version 7.1; The 
MathWorks, Natick, MA, USA). The DCM analyses were run using DCM8. 
Standard SPM processing was performed for the scan pre-processing and the 
statistical analyses. For the pre-processing, the same settings were applied as detailed 
in chapter 3.4.4.1. The methodological approach of the bilinear and nonlinear DCM 
analyses as described in chapter 3.4.5 was applied to the “N-Back” fMRI data. The 
model space was limited to interhemispheric models to account for: (i) Drop-out of 
EST and HC based on the lack of BOLD response of the VTA/SN area; and (ii) 





(i) Given the ‘novel’ role of the VTA/SN area in working memory in humans, it 
was possible that not every participant could be included for the DCM 
analyses with stringent requirement for subject and ROI selection (see 
chapter 3.4.5.1). In particular, it was not possible to foresee how many 
participants would show BOLD response of the VTA/SN area at the required 
threshold level.  
(ii) Nonlinear DCM for fMRI has not been applied to the “N-Back” task 
previously. Thus, we focused on the systematic investigation of the 
connection strengths with nonlinear modulation in inter-hemispheric models.  
 
4.3.1 Study populations 
EST and matched healthy controls were recruited as part of the SFMHS from spring 
2011 to winter 2013. Potential EST were identified through the research register of 
the Scottish Mental Health Research Register (http://www.smhrn.org.uk/), mental 
health services in Edinburgh, by contacting consultant psychiatrists throughout NHS 
in Edinburgh or hospital medical notes. Healthy participants were recruited through 
the Research Register as well through the social network of the patients and matched 
to the EST. The healthy volunteers had no family history of schizophrenia or any 
other major psychiatric illness. Exclusion criteria included history of severe brain 
injury, dependency or harmful use of alcohol or drugs for the last 12 months. MRI 
scanning safety was ensured. The study was approved by the South East Scotland 
Research Ethics Committee of the University of Edinburgh. All subjects provided 




In this chapter, DCM findings are presented from 18 healthy controls and 13 EST for 
the left hemisphere and 16 healthy controls and 15 EST for the right hemisphere. The 
different inclusion numbers of healthy controls and EST for the left and right 
hemispheres are based on the fact that no every healthy control or EST showed 
activation of the bilateral VTA/SN area or bilateral IPS (details are presented in 
chapter 4.3.7.1). Full details of demographic and clinical details of the included 
participants for the DCM analyses are displayed in Table 4.2. FMRI scans from a 
total number of 25 healthy controls and 26 EST were considered for the study. Two 
HC and eight EST were excluded because of poor behavioural performance during 
the “N-back” task. The cut-off for poor behavioural performance was set at d’ < 1.93 
which equals a hit rate < 85% and a FAlarm > 20%. “N-back“ fMRI data from 21 
healthy controls and 16 EST were statistically analysed, after scans of two healthy 
controls and two EST were discarded due to movement or poor scan quality. For the 
DCM analyses in the left hemisphere, three healthy controls and three EST were 
excluded, whereas five healthy controls and one EST were excluded for the right 
hemisphere due to lack of required activation of the bilateral VTA/SN area or 
bilateral IPS (details are presented in chapter 4.3.7.1). 
At the time of scan (or within a week of the scan) all subjects, both EST and healthy 
controls, underwent the clinical PANSS interview (Kay et al., 1987), the Scale for 
Assessment of Negative Symptoms (SANS (Andreasen, 1989) and the Global 
Assessment of Functioning (GAF; Hall, 1995). The rescaled PANSS scoring system 
and the standard scoring system for the SANS were used. A clinical diagnosis of 
established schizophrenia in accordance with DSM-IV-TR (American Psychiatric 




experienced clinicians. At the time of the scan, none of the EST had acute psychotic 
symptoms. All EST were on antipsychotic medication (Table 4.3). 
 
4.3.2 Functional experimental details  
EST and healthy controls performed the verbal “N-back” task (Kirchner, 1958) in the 
scanner. After pilot scans with healthy controls, who were naïve to the “N-back” 
task, it was considered that the “3-back” task was too difficult to perform for healthy 
volunteers and EST. Thus, the “2-back” task was chosen, which is in keeping with 
reported FA, FC and EC findings of the “N-back” task in schizophrenia studies. 
These studies repeatedly showed robust DLPFC BOLD responses in healthy controls 
and individuals with schizophrenia. 
Task instructions were given before entering the scanner and in the scanner. An 
instruction for each block was displayed at the beginning of the next condition. 
Stimuli were presented visually on a screen, which the subjects could see through 
goggles mounted on the head coil. The goggles contained corrective lenses, which 
could be adjusted when necessary. The subjects received both a left-hand and a right-
hand push button unit, which was synced with the experimental programme 
Presentation® provided by Neurobehavioural Systems (operating system Microsoft 
Windows http://www.neurobs.com/). The subjects were instructed to press their right 
index finger for target stimuli and their left index finger for non-target stimuli. 
The experimental paradigm was a block design (Broome et al., 2009), which 
consisted of three conditions: (i) Baseline condition (“0-back”), (ii) Low working 
memory load (“1-back”), and (iii) High working memory load (“2-back”). The 




time on the centre of the screen. For the “0-back” condition, subjects were instructed 
to press the right button when the letter “X” was presented and the left button for all 
other letters. For the “1-back” condition, the target stimulus was defined as the 
identical match between the current letter and the letter one turn back. For the “2-
back” condition, subjects were supposed to detect the target stimulus which was the 
same letter as the letter two turns back. The subjects were asked to respond as 
quickly as possible. 
The block conditions were ordered by increasing working memory load from “0-
back” (A) to “1-back” (B) to “2-back” (C). This block sequence was presented in 
three trials (A B C A B C A B C). During each block, stimuli were presented for 
1000 ms and each stimulus was preceded by 2000 ms of instructions. There were 14 
letters in each block with four target stimuli. The task lasted for 7.21 min.  
The block design enabled to analyses the fMRI data with a parametric contrast of 
increasing activation with increasing working memory load (“0-Back” versus “2-
Back”) and the standard subtraction analyses for (i) “0-back” versus “1-back” and  
(ii) “1-back” versus “2-back”. 
 
4.3.3 Scanning procedure 
Brain imaging was carried out at the Clinical Research Imaging Centre (CRIC) at the 
Queen’s Medical Research Institute (Edinburgh, UK) on a Siemens 3 Tesla whole-
body MRI Verio scanner (Siemens Medical Systems, Erlangen, Germany) using the 
matrix head coil with 12 elements. 
An initial localizer scan was performed to measure the interhemispheric angle and 




were acquired using T1-weighted, magnetisation prepared rapid acquisition gradient 
echo (MP-RAGE) images prescribed parallel to the AC-PC line, providing 160 
sagittal slices of 1.0 mm thickness, 256 x 256mm2 FOV, matrix size 256 x 256 mm2. 
Further scan parameters were TR = 2300 ms, TE = 2.98 ms, TI = 900 ms and a flip 
angle = 9°.  
EPI scans for the “N-back” task were acquired continuously during the experimental 
task (TR/TE = 1560/26 ms, matrix size of 256 x 256 mm2; FOV 256 x 256 mm2). 
Twenty six interleaved slices with 4 mm slice thickness were acquired within each 
TR period. Each EPI sequence encompassed 293 volumes of which the first 6 
volumes were discarded. 
 
4.3.4 Behavioural data 
During the scanning, the behavioural performance in terms of response times (RTs) 
and accuracy were recorded in logfiles written in Presentation. RTs and accuracy 
were assessed separately for the hemispheres because a different number of 
participants entered in the DCM analyses for both hemispheres. 
RTs were computed separately for the baseline condition “0-back”, both working 
memory conditions “1-back“ and “2-back” and for the overall performance across all 
conditions. Then, the RTs entered a GLM with group and sex as fixed factors and 
age and IQ as covariates. 
Accuracy of the behavioural performance was analysed with the sensitivity index d’ 
as part of the signal detection theory using the formula (MacMillan and Creelman, 





         [4.1] 
z = statistical Z value 
FAlarm = False alarm 
 
Hits and false alarm (FAlarm) rates of zero and one were adjusted as previously 
described (MacMillan and Kaplan, 1985). The task performance was separately 
calculated for the “1-back”, the “2-back” condition and the overall performance 
across all conditions. A higher d’ value denotes a higher accuracy in performance. 
The d’ values entered a GLM with group and sex as fixed factors and age and IQ as 
covariates. 
 
4.3.6 Scan pre-processing and statistical analysis 
The scan pre-processing, statistical analysis for the FA and the DCM analyses were 
run in SPM8. The DCM analyses were run using DCM8. 
Standard processing was performed for the scan pre-processing and the statistical 
analyses. For the pre-processing, the settings described in chapter 3.3.4 were applied 
with appropriate adjustments for the specific scanning in this data set. The DCM 
requirements for the pre-processing as detailed in chapter 3.4.4.1 for the parameters 
for spatial smoothing and oversampling the voxel size have been adopted for this 
study. The pre-processing was run using batch scripts to ensure the identical 
processing for each individual. 
For the current study, specific requirements have been defined in addition to the 




application of nonlinear DCM and to allow the interpretation of the EC results. The 
three requirements were: 
(i) Subject selection for the scan processing and DCM analyses based on the 
behavioural performance; 
(ii) Error condition in the GLM for the statistical scan analyses; 
(iii) Two pre-conditions for bilinear and nonlinear DCM analyses as part of the 
application of the heuristic protocol as outlined in chapter 3.4.5.2. 
 
(i) Subjects with comparable high behavioural performance between healthy 
controls and EST were selected. The criterion for inclusion was d’ value > 
1.93, which was congruent with a hit rate > 85% and a FAlarm rate of < 20% 
(see chapter 4.3.1). Therefore, the interpretation of the hypothesised altered 
connection strengths with nonlinear modulation will not be confounded by 
differences in task performance. 
(ii) FAlarm as identified during the behavioural analysis were modelled 
separately in each subject. This condition ensured the identification of the 
VTA/SN area in the parametric contrast (increased activation with increased 
working memory load; “0-Back” versus “2-Back”). 
(iii) The modelling of the error condition from the statistical analyses ensured the 
examination of the two pre-conditions for the DCM analyses: (i) The 
connection strength with driving inputs into the VTA/SN area could be 
modelled and assessed and (ii) the connection strength with nonlinear 
modulation of the bidirectional connection between the DLPFC and the 





4.3.6.1 Spatial pre-processing 
The first six acquisitions were discarded to ensure that the steady state of the 
magnetisation was fulfilled before the experimental paradigm started.  
 
4.3.6.1.1 Realignment 
The change in TR (1560 ms) and number of acquisitions (n = 293) in the EPI 
acquisition for the “N-back” task had been accordingly amended for the pre-
processing of the scans. 
The EPI time series for each single subject were registered to the mean in the series 
to remove movement artefacts and the mean image was created. The maximum level 
of movement for each individual was assessed based on the graphical output and the 
movement regressors written for the three orthogonal imaging planes. 
    
4.3.6.1.2 Normalisation 
The same settings from the EHRS were applied to the working memory data. The 
mean image was determined for the definition of the parameters. The images were 
normalised to an SPM8 EPI template and resampled using sinc interpolation to cubic 
sized voxels of 1 x 1 x 1 mm3 (please see chapter 3.4.4.1.2). 
 
4.3.6.1.3 Spatial smoothing 
Following the pre-processing protocol from the EHRS, the normalised scans were 
spatially smoothed with a 8 x 8 x 8 mm3 FWHM Gaussian filter to ensure the 




4.3.6.1.4 Visual inspection 
The same procedure for the visual inspection was performed as described in chapter 
3.4.4.1.4. Two healthy controls were excluded at this stage because of poor image 
quality (assumed to result from excessive scanner noise) as reported in the chapter 
4.3.1. Two EST were excluded at this stage of the analysis because of significant 
movement artefact of > 3 mm peak to peak.  
 
4.3.6.2 Statistical analysis 
The first level statistical analyses were run using batch scripts. The scripts were 
devised from the basis of SPM scripts. 
 
4.3.6.2.1 First level analysis 
In this study, at the single subject level the data was modelled with three “N-Back” 
conditions (“0-back”, “1-back” and “2-back”) in the first three columns. The fourth 
and fifth column correspond to the behavioural correct responses (hits) and incorrect 
responses (FAlarm). As previously described (chapter 3.4.4.2.1, each condition was 
modelled by a boxcar convolution with the hrf as implemented in SPM8. Similarly, 
the movement regressor for each individual was entered as ‘covariates of no interest’ 
within the GLM. 
The settings applied for the estimation of the design matrix followed the settings in 
chapter 3.4.4.2.1: 
 Single subject filtering in the time domain: 
 Low pass filter (Gaussian kernel, 4 s (FWHM)) 




Three contrasts were constructed to test areas of activation: 
(i) Parametric contrast/”0-Back” versus “2-Back”: Increasing activation with 
increasing working memory load under the assumption of linear memory load 
from “0-Back” to “2-Back”: ([-1 0 1]); 
(ii) Standard subtraction analysis: “0-back” versus “1-Back” ([-1 1 0]); 
(iii) Standard subtraction analysis: “1-back” versus “2-back” ([0 -1 1]). 
 
4.3.6.2.2 Second level analysis 
The contrast images of each individual for the parametric contrast (“0-back” versus 
“2-back”) and the conditions for low working memory load (“0-back” versus “1-
back”) and high working memory load (“1-back” versus “2-back”) were entered into 
a second level random effects analysis in order to infer on differential activations 
between the EST and the healthy controls. A one sample t-test was run to define the 
areas of activation within each of the group before a two sample t-test was used to 
determine differences in activation between the two groups. 
For both the within-group and the between-group analyses, statistical parametric 
maps were thresholded at the level of p = .001, uncorrected. Regions are reported 
that survived cluster-level correction for multiple comparisons across the whole brain 
at p < .05. Previous reports on FA of the VTA/SN area applied a threshold of p < .05 
FDR to the statistical maps (Genovese et al., 2002). We followed these settings for 
the VTA/SN area. The coordinates were converted and identified as previously 






4.3.6.2.2.1 Parametric contrast 
The main interest was to examine group differences of increasing activation with 
increasing working memory load (“0-back” versus “2-back”). 
Both groups were matched on age and gender (chapter 4.4.1). Nonetheless, for 
confidence reasons, these two factors were entered as covariates in the second level 
random effects for the within-group and between-group analyses. IQ has not been 
entered following the common approach in clinical studies. However, IQ has 
indirectly been corrected for when EST were selected based on the behavioural 
performance level in the “N-Back” task. 
 
4.3.6.2.2.2 Standard subtraction analyses 
For completion, the two subtraction contrasts for low and high working memory 
loads were tested for group differences in FA. Both EST and healthy controls were 
matched on age, gender and movement measures. As reported in chapter 4.3.6.2.1 
these factors were defined as covariates in the second level random effects analyses. 
IQ has not been entered. 
 
4.3.7 Functional Integration – Bilinear and nonlinear Dynamic 
Causal Modelling for fMRI data 
The bidirectional connections between the DLPFC and the VTA/SN area were 
modelled to investigate the possibility of altered connection strength with nonlinear 
modulation during verbal working memory between EST and healthy controls.  
Evidence from preclinical studies suggests that the meso-cortical connection and/or 




DLPFC in schizophrenia (chapter 2.2.2.2). Thus, the heuristic search protocol for the 
application of nonlinear DCM for fMRI (chapter 3.4.5.2; Figure 3.1; Dauvermann et 
al., 2013) was applied to the fMRI “N-Back” task to assess connection strength with 
nonlinear modulation of this bidirectional connection. 
 
The bilinear and nonlinear DCM analyses of the “N-Back” task were performed 
using DCM8 as implemented in SPM8 which was the identical version used for the 
DCM analyses and followed the previously presented outline of chapter 3.4.5. 
Specific changes in the application of the DCM methods in contrast to the EHRS 
DCM study are outlined specifically in the following subchapters:  
 Subject and ROI selection (chapter 4.3.7.1) 
 Model Space for the DCM analyses (chapter 4.3.7.2) 
o Model Space for Bilinear Models (chapter 4.3.7.2.1) 
o Model Space for Nonlinear Models (chapter 4.3.7.2.2.1) 
o Model Space Partitioning – Family Level Inference (chapter 
4.3.7.2.2.2). 
The DCM analyses were run separately for the groups and for the hemispheres. 
 
4.3.7.1 Subject and ROI selection 
The main finding from FA results for the between-group analysis for the parametric 
contrast was that EST showed significantly reduced activation of the DLPFC 
(BA9/BA46), the IPS (BA40), the dorsal ACC (dACC; BA32) and the VTA/SN area 
in contrast to the healthy controls (chapter 4.4.3.2.1). The VTA/SN area was 




ACC in working memory in humans to model the functional involvement of the 
midbrain region in working memory/dopaminergic modulation as widely accepted 
evidence in preclinical research (chapter 1.3.1, chapter 1.3.2 and chapter 2.2.2.2). 
The inclusion of the VTA/SN area further received support from recent fMRI and 
PET studies in humans that reported on the functional role of the VTA/SN area in 
working memory in healthy controls (Murty et al., 2011; D’Ardenne et al., 2012; Xu 
et al., 2013; Yu et al., 2013) and EST (D’Aiuto et al., 2014). The coordinates of the 
VTA/SN area are in keeping with previous studies on the VTA/SN area in working 
memory (Tomasi et al. 2007; Murty et al. 2011; D’Ardenne et al. 2012; Yu et al. 
2013; D’Aiuto et al. 2014). 
The time series of these four regions were extracted. The coordinates of the four 
ROIs are given in Table 4.1 according to the standard Talairach and Tournoux atlas 
(Talairach and Tournoux, 1988).  
The ROI selection followed the same procedure of the time series extraction as 
reported in chapter 3.4.5.1 (Dauvermann et al., 2013). Briefly, the four ROIs were 
selected by extracting the time series from the individual’s activation map of the 
parametric contrast thresholded at p < .05 uncorrected at the closest maxima within a 
standard distance of 8 mm of the group peak level for the IPS and DLPFC and 
adjusted distance of 6mm of the group peak level for the dACC and the VTA/SN 
area. These time series extraction rationales ensured the consistent selection of 
functional regions to be included for the DCM analyses across all subjects (Stephan 
et al., 2007). 
The subjects were selected on the basis of the requirement of activation in all four 




healthy controls and three EST, who did not show activation of the left VTA/SN area 
or the left IPS. For the right hemisphere, five healthy controls and three EST were 
excluded because of lack of BOLD response of the right VTA/SN area. Demographic 
details of the included subjects for the DCM analyses of each hemisphere are given 
in Table 4.2. Clinical details of the participants for both hemispheres are presented in 
Table 4.3. 
 
Table 4.1 Coordinates of the four ROIs for the DCM analyses. 
 Coordinates in Talairach Space (L/R) 
 
IPS, BA40 -44, -46, 42 49, -47, 30 
DLPFC, BA9/BA46 -46, 25, 31 41, 29, 17 
dACC, BA32 3, 36, 26 
VTA/SN area -9, -17, -6 7, -17, -3 
dACC, dorsal anterior cingulate cortex, DLPFC, dorsolateral  
prefrontal cortex, IPS, intra parietal sulcus, VTA/SN area, ventral  
tegmental area/substantia nigra area. 
 
4.3.7.2 Heuristic study protocol for bilinear and nonlinear Dynamic 
Causal Modelling 
The hypothesis of this study was that EST would show altered connection strengths 
with nonlinear modulation of the connection between the DLPFC and the VTA/SN 
area. To this end, we used the heuristic study protocol from the EHRS DCM study 
(chapter 3.4.5.2; Dauvermann et al., 2013) and applied it to the “N-Back” task of the 
SFMHS. The logic of the current DCM study was drawn from the EHRS DCM 
study. 
Briefly, the three phases of the protocol are outlined for the current DCM study on 
the fMRI “N-Back” task in healthy controls and EST:  
(i) In phase 1, bilinear DCM was run to test the structure of the “N-back” task 




(ii) In phase 2, nonlinear DCM was used to model the connection strengths with 
nonlinear modulation between the DLPFC and the VTA/SN (chapter 
4.3.7.2.2);  
(iii) In phase 3, the connection strengths with the nonlinear modulation for the 
bidirectional connection between the DLPFC and VTA/SN area within the 
winning models were assessed with BMA (chapter 4.3.7.2.3). 
The three phases of the DCM analyses were run separately for the left and right 
hemispheres. 
 
4.3.7.2.1 Phase 1: Bilinear Dynamic Causal Modelling 
The four conditions for biophysical modelling with DCM have been outlined in 
chapter 3.4.4. Those conditions were applied to the fMRI “N-Back” scans of this 
study.  
 
4.3.7.2.1.1 Model space of bilinear models 
Findings from preclinical neurobiological and clinical neuroimaging studies provide 
the basis of the specification for regions, connections and modulations for the linear 
DCMs. In total, the model space of bilinear models was comprised of nine DCMs. 
The involvement of the four regions of the DLPFC, IPS, AC (coordinates in Table 
4.1) for the “N-back” task in individuals with schizophrenia are well established. 
Clinical fMRI and PET studies during the “N-back” task repeatedly reported on the 
involvement of the DLPFC, IPS and AC in terms of FA, FC and EC measures during 
the “N-back” task in EST and healthy controls (chapters 1.4.2, 1.4.3, 2.2.4.3). For FA 




for the low and high working memory load were observed in EST when compared to 
healthy controls (chapter 1.4.2). FC studies provided further support for reductions in 
FC measures between (i) the DLPFC and IPS and (ii) the DLPFC and AC in EST in 
contrast to healthy controls (1.4.3). Altered EC measures during the verbal/numeric 
“N-back” task presented evidence for decreased EC (effect of task modulation) from 
the DLPFC to the PC in EST in contrast to healthy controls (2.2.4.3). 
The inclusion of the AC in the DCMs was based on the findings of its role in error 
monitoring and error conflict (Becerril et al., 2011; Wang et al., 2010; Brázdil et al., 
2007; Krawitz et al., 2011), which is implicated in working memory processes 
(Botvinick et al., 2001; Kerns et al., 2004). 
The VTA/SN area as the fourth region in the models was selected due its known 
functional role in working memory from preclinical (chapter 1.3.1, chapter 1.3.2) and 
computational modelling studies (chapter 2.2.2.2). Such studies reported evidence for 
dopaminergic alterations of the meso-cortical connection, glutamatergic alterations 
of the cortico-mesal connection and interactions between dopaminergic and 
glutamatergic alterations of the DLPFC – VTA/SN area – circuits. 
In recent years, clinical and cognitive neuroscientific studies showed that the 
VTA/SN area is functionally implicated in working memory function in healthy 
controls (FA, Tomasi et al. 2007; Murty et al., 2011; D’Ardenne et al., 2012; Yu et 
al., 2013) and EST (D’Aiuto et al., 2014) as well as functional networks in healthy 





The specification of the endogenous connections (matrix A), connections with 
modulatory input (matrix B) and effects of driving inputs (matrix C) follows 
evidence provided by preclinical neurobiological and clinical neuroimaging studies.  
Endogenous connections between the regions were specified by neurotransmitter 
projections such as dopaminergic projections from the VTA/SN area to the DLPFC 
(Au-Young et al., 1999; D’Ardenne et al., 2012; Gao and Wolf, 2007; Takahata and 
Moghaddam, 1998; Girault and Greengard, 2004) and glutamatergic projection from 
the DLPFC to the VTA/SN area. The bidirectional connection between the ACC and 
the VTA/SN area was defined on the basis of known dopaminergic projections (Onn 
and Wang, 2005). FC and EC findings were used to specify functional connections 
between the IPS and the DLPFC (FC, Tan et al., 2006; Rasetti et al., 2011; Quidé et 
al., 2013; EC, Deserno et al., 2012; Schmidt et al., 2013; Zhang et al., 2013), the IPS 
and ACC (FC, Meyer-Lindenberg et al., 2001; EC during a similar task, Brázdil et 
al., 2007) and the DLPFC and the ACC (Brázdil et al., 2007). 
 
Connections with modulatory input were defined by the experimental manipulation 
of the “N-back” task, namely the parametric modulation of the task (“0-back” versus 
“2-back”). Evidence for (parametric) working memory load effect and interactions 
effects with working memory load has been provided by fMRI studies during the “N-
back” task in healthy subjects and subjects with schizophrenia for (i) FA results of 
bilateral subregions of the PFC (including the DLFC), bilateral IPL, AC (fMRI 
studies, Callicott et al., 2000; Perlstein et al., 2001; Callicott et al., 2003; Thermenos 
et al., 2005; Tan et al., 2006; Rasetti et al., 2011; Guerrero-Pedraza et al., 2012; 




DLFC) and bilateral IPL (Tan et al., 2006; Rasetti et al., 2011; Quidé et al., 2013) 
and (iii) EC measures of  bilateral subregions of the PFC (including the DLFC) and 
bilateral IPL (Deserno et al., 2012; Schmidt et al., 2013; Zhang et al., 2013). Based 
on these clinical findings, the connection from the IPS to the DLPFC was specified 
by the parametric modulatory experimental input. 
 
Driving input or matrix C was defined by DCM studies, which reported evidence of 
effects of visual presentation of stimuli to the IPS (during a similar task, Brázdil et 
al., 2007; Wang et al., 2010). The role of the VTA/SN area in working memory has 
been reported previously (D’Ardenne et al., 2012). 
 
The nine DCMs differed in their unidirectional and bidirectional connections 
between the four regions (defined by matrix A). The specifications of the matrices B 





   
   
 
Figure 4.1 Model space of linear models. 
All nine models are characterised by bidirectional endogenous connections between the IPS and DLPFC, IPS and ACC and DLPFC and ACC. 
Furthermore, all models are defined by a modulatory input on the connection from the IPS to the DLPFC. All models receive driving two inputs: One 




The nine models differ in the specification of unidirectional or bidirectional endogenous connections: (i) Between the DLPFC and the VTA/SN area and 
(ii) between the ACC and VTA/SN area.  
Model 1 is specified by a bidirectional endogenous connection (i) between DLPFC and VTA/SN area and (ii) ACC and VTA/SN area. 
Model 2 is specified by a unidirectional endogenous connection from DLPFC to VTA/SN area and a bidirectional endogenous connection between ACC 
and VTA/SN area. 
Model 3 is specified by a unidirectional endogenous connection from VTA/SN area to DLPFC and a bidirectional endogenous connection between ACC 
and VTA/SN area. 
Model 4 is specified by a bidirectional endogenous connection between DLPFC and VTA/SN area and a unidirectional endogenous connection from 
VTA/SN area to ACC. 
Model 5 is specified by a unidirectional endogenous connection from DLPFC to VTA/SN area and a unidirectional endogenous connection from VTA/SN 
area to ACC. 
Model 6 is specified by a unidirectional endogenous connection from VTA/SN area to DLPFC and a unidirectional endogenous connection from VTA/SN 
area to ACC. 
Model 7 is specified by a bidirectional endogenous connection between DLPFC and VTA/SN area and a unidirectional endogenous connection from 
ACC to VTA/SN area. 
Model 8 is specified by a unidirectional endogenous connection from DLPFC to VTA/SN area and a unidirectional endogenous connection from ACC to 
VTA/SN area. 





4.3.7.2.1.2 Random effects Bayesian Model Selection 
BMS at the group level has been applied to models of both hemispheres in EST and 
healthy controls separately as outlined in chapter 3.4.5.2.1.3. 
 
4.3.7.2.2 Phase 2: Nonlinear Dynamic Causal Modelling 
The theoretical argumentation for the modelling of the connection strengths with 
nonlinear modulation follows the logic of the EHRS DCM study based on 
hypothesised altered connection strengths with nonlinear modulation in a parametric 
fMRI task. Thus, the definition of the model space of the nonlinear DCMs has been 
applied according to the protocol as outlined in chapter 3.4.5.2.2.2 (chapter 
4.3.7.2.2.1). Necessary changes concerning the partition of the model space into 
model family are presented. 
 
4.3.7.2.2.1 Model space of nonlinear models 
The model space of nonlinear models was comprised of four nonlinear models in 
congruence with chapter 3.4.5.2.2.2. In keeping with the BMS approach at the group 
level as outlined in phase 1 of the protocol (column 1; Figure 3.1), the optimal 
bilinear model for the EST and the healthy controls functions as the “basic” structure 
of the nonlinear DCMs. 
For both hemispheres, the winning linear model for EST was Model 1; whereas as 
Model 7 was the optimal model for healthy controls.5 Therefore, the nonlinear 
                                                          
5 For the right hemisphere in the healthy subjects, Model 7 was chosen to enter this phase of the DCM 
analyses instead of Model 8. As displayed in Table 4.15, the Xp of Model 8 (Xp = 0.23) was greater 
than the Xp for Model 7 (Xp = 0.16) or Model 2 (Xp = 0.18). Models 8 and 2 are characterised by a 
unidirectional endogenous connection from the DLPFC to the VTA/SN area, whereas Model 7 




models were defined separately for EST and healthy controls. However, the aim of 
modelling the bidirectional connection between the DLPFC and the VTA/SN area 
with nonlinear modulation remained the common goal for both groups. 
 
For EST, two nonlinear models were constructed on the structure of the winning 
Model 1 with the nonlinear modulation from the DLPFC to both connections 
between the DLPFC and the VTA/SN area (i.e. nonlinear models – DLPFC). Two 
further models were defined on the basis of Model 1 by connecting the nonlinear 
modulation from the VTA/SN area to the connections between the DLPFC and the 
VTA/SN (i.e. nonlinear models – VTA/SN; Figure 4.2). 
                                                                                                                                                                    
Model 7 was selected instead of Model 8 in order to enable the modelling of the bidirectional 






Figure 4.2 Four nonlinear models for subjects with established schizophrenia. 
The nonlinear models are specified on the basis of the winning Model 1 in EST. The 
endogenous connections, modulatory input and driving inputs are defined as in Model 1 
(Figure 4.1). 
Model 1_DLPFC_VTA/SN_DLPFC and Model 1_DLPFC_DLPFC_VTA/SN are characterised 
by the nonlinear modulation from the DLPFC on the bidirectional connection between 
VTA/SN area and DLPFC. Both models are specified upon the winning bilinear model and 
form model family 2. 
Model 1_DLPFC_VTA/SN_DLPFC is specified by the nonlinear modulation from DLPFC to 
the connection from VTA/SN area to DLPFC. 
Model 1_DLPFC _DLPFC_VTA/SN is specified by the nonlinear modulation from DLPFC to 
the connection from VTA/SN area to DLPFC. 
Model 1_VTA/SN_VTA/SN_DLPFC and Model 1_VTA/SN_DLPFC_VTA/SN are 
characterised by the nonlinear modulation from the VTA/SN area on the bidirectional 
connection between VTA/SN area and DLPFC. Both models are specified upon the winning 
bilinear model and form model family 3. 
Model 1_VTA/SN_VTA/SN_DLPFC is specified by the nonlinear modulation from VTA/SN 
area to the connection from DLPFC to VTA/SN area. 
Model 1_VTA/SN_DLPFC_VTA/SN is specified by the nonlinear modulation from VTA/SN 
area to the connection from VTA/SN area to DLPFC. 
 
For healthy controls, two nonlinear models were constructed on the basis of winning 
Model 7 with the nonlinear modulation from the DLPFC to the connections between 
the DLPFC and the VTA/SN area (i.e. nonlinear models – DLPFC). Two further 
models were defined on the basis of Model7 with nonlinear modulation from the 
VTA/SN area to the connections between the DLPFC and the VTA/SN area (i.e. 








Figure 4.3 Four nonlinear models for healthy controls. 
The nonlinear models are specified on the basis of the winning Model7 in healthy controls. 
The endogenous connections, modulatory input and driving inputs are defined as in Model 7 
(Figure 4.1). 
Model 7_DLPFC_VTA/SN_DLPFC and Model 7_DLPFC_DLPFC_VTA/SN are characterised 
by the nonlinear modulation from the DLPFC on the bidirectional connection between 
VTA/SN area and DLPFC. 
Model 7_DLPFC_VTA/SN_DLPFC is specified by the nonlinear modulation from DLPFC to 
the connection from VTA/SN area to DLPFC. 
Model 7_DLPFC _DLPFC_VTA/SN is specified by the nonlinear modulation from DLPFC to 
the connection from VTA/SN area to DLPFC. 
Model 7_VTA/SN_DLPFC_VTA/SN and Model 7_VTA/SN_VTA/SN_DLPFC are 
characterised by the nonlinear modulation from the VTA/SN area on the bidirectional 
connection between VTA/SN area and DLPFC. Both models are specified upon the winning 
bilinear model and form model family 3. 
Model 7_VTA/SN_DLPFC_VTA/SN is specified by the nonlinear modulation from VTA/SN 
area to the connection from VTA/SN area to DLPFC. 
Model 7_VTA/SN_VTA/SN_DLPFC is specified by the nonlinear modulation from VTA/SN 









4.3.7.2.2.2 Model Space Partitioning – Family Level Inference – 
Random effects Bayesian Model Selection 
The previously described BMS inference approach at the model family level phase 2 
of the protocol (column 2, Figure 3.1) has been applied to the current data set. The 
BMS analysis was separately run for both groups and each hemisphere. An example 
is shown for EST: 
(i) Model Family 1: bilinear model 
Model Family 1 contained the optimal bilinear model (Figure 4.1). 
(ii) Model Family 2: nonlinear models – DLPFC 
Model Family 2 contained the two nonlinear models with nonlinear 
modulation from the DLPFC (Figure 4.2). 
(iii) Model Family 3: nonlinear models – VTA/SN area 
Model Family 3 contained the two nonlinear models with nonlinear 
modulation from the VTA/SN area (Figure 4.2). 
 
The exceedance probabilities for the two winning model families 2 and 3 were 
summarised as described in chapter 3.4.5.2.2.3. 
 
4.3.7.2.3 Phase 3: Bayesian Model Averaging 
The objective of the BMA analysis was to assess posterior densities of the 
connection strength with nonlinear modulation for the meso-cortical and cortico-
mesal connection in the winning models from the previous step of the BMS 
approach. BMA has been applied to the winning models from the BMS analysis at 





The results of demographic and clinical details, behavioural performance and EC 
analyses are presented separately for the left and right hemispheres because different 
numbers of participants were included for the analyses in each hemisphere. For the 
left hemisphere, 18 healthy controls and 13 EST entered the DCM analyses, whereas 
16 healthy controls and 15 EST were included for analyses in the right hemisphere.  
 
4.4.1 Demographic and clinical details 
The demographic details (Table 4.2) and clinical details (Table 4.3) are given for the 
final subject inclusion for the DCM analyses. Those DCM analyses were performed 
separately for the left and the right hemispheres. The results of significance levels are 
comparable between the two hemispheres.  
In summary for both hemispheres, both EST and healthy controls did not differ from 
each other in mean age, sex or handedness (Table 4.2). There was a significant 
difference for IQ between the groups (left hemisphere: t = 2.234, df 16, p = .034; 
right hemisphere: t = .043, df 16, p = .007). Healthy controls showed a significantly 
greater IQ than EST. 
All EST were treated with a range of FGA and SGA with varying doses. Three EST 
received secondary antipsychotic medication and ten EST took additional medication 




Table 4.2 Demographic details for subjects included in the DCM analyses. 
 Healthy controls 
(L/R) 
 
EST (L/R) Test 
(L/R) 
p – Value 
(L/R) 
Number 18 16 13 15 _ _ _ _ 

































































1 Data missing. 









EST (L/R) Test 
(L/R) 
p – Value 
(L/R) 
Number 18 16 13 15 - - - - 
Illness Onset  
(in years; mean (SD) 
N/A N/A 19.92 (3.10) 21.47 (6.14) - - - - 
Illness Duration  
(in months; min – max 
(>99)) 
N/A N/A min 80 to max > 99 min 60 to max > 99 - - - - 
Total PANSS Score1, 
mean (SD) 








Total Positive Score, 
mean (SD) 








Total Negative Score, 
mean (SD) 








Total General Score, 
mean (SD) 








Total SANS Score, 
mean (SD) 




p = .01 p < 
.001 




N/A N/A 515.00 (410.06) 475.00 (400.55) - - - - 










- - - - 
Antipsychotic medication 
additional4 
N/A N/A (a) 2; 
(b) 1  
(a) 2; 
(b) 1 
- - - - 










GAF, Global Assessment of Functioning 
1 Rescaled total PANSS scores. 
2 to 100 mg CPZ.  
3 (a) Aripiprazole, (b) Clozapine, (c) Depixol (depot), (d) Olanzapine, (e) Risperidone/Risperidone Consta depot. 
4 (a) Amilsulpride, (b) Chlorpromazine. 




4.4.2 Behavioural performance 
The results of RTs (Table 4.4) and behavioural accuracy (Table 4.5) for healthy 
controls and EST are given. The results are briefly summarised for both hemispheres. 
RTs were longer with increasing working memory load for both EST and healthy 
controls. However, there were no statistically significant differences between the two 
groups for the three experimental conditions nor across all conditions (“2-back” for 
the left hemisphere: F =1.527, df 25, p = .228; “2-back” for the right hemisphere: F 
=2.195, df 25, p = .151). There were no significant main effects for group and sex or 
for the interaction effect between group and sex. 
 
Table 4.4 Response times during the “N-back” task in the scanner. 
 Healthy controls 
(L/R) 
 
EST (L/R) Test 
(L/R) 
p – Value 
(L/R) 









































































RT, response time. 
  
The sensitivity indices did not reveal a significant difference across the task 
conditions between the two groups (“2-back” for the left hemisphere: F =1.527, df 
25, p = .228; “2-back” for the right hemisphere: F =2.195, df 25, p = .151). There 
were no significant main effects for group and sex or for the interaction effect 
between group and sex. However, there was a significant effect of IQ (for the left 




.003) and a significant effect of age (for the left hemisphere: F =4.718, df 1, p = .040; 
for the right hemisphere: F =4.437, df 1, p = .045). 
 
Table 4.5 Task accuracy of behavioural performance during the “N-back” task in the 
scanner. 
 Healthy controls 
(L/R) 
 
EST (L/R) Test 
(L/R) 
p – Value 
(L/R) 
Number 18 16 13 15 _ _ _ _ 
























































d’, sensitivity index.   
 
4.4.3 Functional activation 
The results for the within-group and between-group analyses are subdivided into the 
parametric contrast (“0-back” versus “2-back”) as the main contrast of interest for 
the following DCM analyses. For completeness, the findings of the two standard 
subtraction analyses for the low working memory load and the high working memory 
load are presented. 
 
4.4.3.1 Within - group results 
4.4.3.1.1 Parametric contrast 
Both groups displayed two main regions of increasing activation with working 
memory load (i) the DLPFC (BA46/BA9) (bilateral for healthy controls; here left, x 
= -47, y = 33, z =26) and right hemisphere for EST; x = 33, y = 30, z = 34) and (ii) 




hemisphere for EST; x = -43, y = -40, z = 43). Further details are contained in Table 
4.6 for healthy subjects and Table 4.7 for EST. The BOLD responses of the DLPFC 
(BA46/BA9) for healthy subjects are given in Figure 4.4 and for EST in Figure 4.5.  




Extent Peak height 
coordinates 




3388 -47, 33, 26 
30, -50, 56 
46, 37, 23 
L frontal: middle frontal 





3357 47, -40, 43 
32, -62, 36 
33, -64, 47 
R parietal: inferior 





1735 32, -56, 38 
-35, -71, -30 
-12, -80, -21 
R parietal: superior 





5061 57, -29, -8 
47, -24, -12 
59, -45, -11 
R temporal: middle 





605 -31, -51, 65 
-11, -61, 66 
-20, -61, 66 
L parietal: superior 
parietal lobe, BA7 
4.36 
1Reported p values are thresholded at 0.001FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
2 Reported p values are thresholded at 0.001 uncorrected cluster level, extent threshold = 






Figure 4.4 Parametric Contrast for healthy controls (n = 21). Left middle frontal gyrus, 
BA46. 
Reported p values are thresholded at 0.001 FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
 




Extent Peak height 
coordinates 
Region Z score 
< .0011 
 
1153 33, 30, 34 
26, 10, 50 
R frontal: middle 





1112 -43, -40, 43 
-12, -56, 55 
-35, -38, 62 
L parietal: inferior 




1842 49, -41, 44 
41, -40, 44  
R parietal: inferior 




650 -45, -68, 1 L occipital: middle 




293 -13, -7, 1 L sub-lobar: lentiform 
nucleus  
3.73 
1Reported p values are thresholded at 0.001FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
2 Reported p values are thresholded at 0.001 uncorrected cluster level, extent threshold = 





Figure 4.5 Parametric Contrast for EST (n = 16). Right middle frontal gyrus, BA9. 
Reported p values are thresholded at 0.001FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
 
4.4.3.1.2 Summary of standard subtraction analyses 
For completeness, the within-group results for the low working memory load (“0-
back” versus “1-back”; (Table 4.8; Table 4.9) and the high working memory load 
(“1-back” versus “2-back”; (Table 4.10 and Table 4.11) are presented. We report 
selected results which are thresholded to at p < .001 FWE corrected cluster level with 
extent threshold = 600 voxels and z > 6. BOLD responses of the regions such as the 
DLPFC and IPL overlap with the within-group results of the parametric contrast (“0-
back” versus “2-back”).  
For the low working memory load, both groups demonstrated activations in regions 
commonly reported for this task condition as shown for the DLPFC (BA46) (left 
hemisphere for healthy controls; x = -44, y = 34, z = 19; and right hemisphere for 










Extent Peak height 
coordinates 




1790 44, -42, 58 
47, -41, 42 
39, -43, 45 
R parietal: inferior 





2815 -44, 34, 19 
-36, 54, -4 
-27, 5, 34 
L frontal: middle 





2004 24, 50, -6 
41, 44, 17 
44, 34, 23  
R frontal: superior 




966 57,  -34, -13 
49, -24, -14 
R temporal: middle 
temporal gyrus, BA21 
4.98 
Reported p values are thresholded at 0.001FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
 




Extent Peak height 
coordinates 




7865 -37, 44, 35 
-35, -55, 55 
-39, -45, 42 
L frontal: superior 





5254 -39, 6, 32 
-36, 16, 16 
-39, 32, 28 






5221 46, 18, 24 
46, 31, 15 
45, 12, 33  
R frontal: middle 





1436 -50, -63, -5 
-47, -68, -1 
-44, -72, 7 
L occipital: middle 
occipital gyrus, BA19 
4.37 
Reported p values are thresholded at 0.001 FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
 
For the high working memory load, both healthy controls and EST displayed the 
activated region of the MFG/SFG (BA8) (right hemisphere for healthy controls; x = 






Table 4.10 Selection of results for the high working memory load for healthy controls 




Extent Peak height 
coordinates 




2869 27, 14, 47 
24, 38, 28 
-24, 2, 39 






8562 30, -52, 39 
-44, -38, 42 
47, -39, 42 
R parietal: superior 





1670 52, -55, -2 
57, -44, -10 
45, -53, -5  
R temporal: middle 




1508 -2, -24, 29 
6, -28, -22 
L limbic: cingulate gyrus, 
BA24 
4.06 
Reported p values are thresholded at 0.001FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
 




Extent Peak height 
coordinates 




3144 -17, -58, 51 
36, -58, 54 
-28, -51, 62 




5326 2, 34, 46 
-36, 8, 24 
-22, 14, 48 
R frontal: superior frontal 





4342 26, 19, 7 
55, 17, -2 
49, 25, -2  
R sub-lobar: putamen 5.06 
.0152 
 
516 -14, -8, 0 
-10, -8, 0 






1517 -20, 59, 3 
-24, 53, -3 
-21, 46, -6 





695 27, 30, 33 
26, 389, 34 
R frontal: middle frontal 
gyrus, BA9 
4.15 
1Reported p values are thresholded at 0.001FWE corrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
2 Reported p values are thresholded at 0.001 uncorrected cluster level, extent threshold = 








4.4.3.2 Between - group results 
4.4.3.2.1 Parametric contrast 
Results of the group differences for the parametric contrast (“0-back” versus “2-
back”) showed greater increased activation with increasing working memory load in 
the healthy controls compared to the EST in the regions involving the bilateral 
DLPFC (BA9/46) (x = -46, y = 25, z = 31; p = .036; x = 41, y = 29, z = 17; p = .044 
(Figure 4.6; both at p < .001, FWE corrected cluster level. Other regions included the 
IPS (BA40) (x = 49, y = -47, z =30; p = .022; at p < .01 uncorrected cluster level) 
and the ACC (BA32) (x = 3, y = 36, z = 26; p = .0243; at p < .01 uncorrected cluster 
level; (Table 4.12). The bilateral midbrain region VTA/SN was significantly 
activated in healthy controls in contrast to the EST (left hemisphere, x = -9, y = -17, 
z = -6; p = .047 (Figure 4.7; right hemisphere, x = 7, y = -17, z = -3; p = .049; both at 
p < .05 FDR corrected cluster level). 
There were no group differences for increased activation for EST in contrast to 
healthy controls. Not all of these regions were noted for the within-group results, 
however those activated regions were evident at a lower threshold of p = .005. As 
expected from the sensitivity index d’ results (chapter 4.4.2), no interaction effects 




 Table 4.12 Between-group random effects analysis for the parametric contrast. 
P value Extent Peak height 
coordinates 
Region Z score 
Healthy Controls < EST 
 
n/s     




1097 -52, -22, -12 
-60, -17, -12 
L temporal: middle 









345 41, 29, 17 R frontal: middle frontal 




1344 49, -47, 30 R parietal: inferior 









1836 -13, -2, 8 
-13, -7, 4 















1 Reported p values are thresholded at p < .001 FWE corrected cluster level, extent threshold 
= 200 voxels. Coordinates represent the three maxima within the same cluster. 
2 Reported p values are thresholded at p < .01 uncorrected cluster level, extent threshold = 
200 voxels. Coordinates represent the three maxima within the same cluster. 
3 Reported p values are thresholded at p < .05 FWE corrected cluster level, extent threshold 
= 200 voxels. Coordinates represent the three maxima within the same cluster. 
4 Reported p values are thresholded at p < .05 FDR corrected cluster level, extent threshold 






Figure 4.6 Between-group random effects analysis for the parametric contrast. Left 
MFG, BA9. 
Reported p values are thresholded at p < .001FWE corrected cluster level, extent threshold 
= 200 voxels. Coordinates represent the three maxima within the same cluster. 
 
 
Figure 4.7 Between-group random effects analysis for the parametric contrast. Left 
Midbrain, VTA/SN. 
Reported p values are thresholded at p < .05 FDR corrected cluster level, extent threshold = 





In summary, increased activations with increased working memory load were found 
in healthy controls in contrast to EST in regions consistently reported during the “N-
back” task: (i) DLPFC (left, Callicott et al., 2000; bilateral, Tan et al., 2006), (ii) IPS 
(right, Callicott et al., 2000) and (iii) AC (right, Callicott et al., 2000). Other fMRI 
studies during working memory reported significant differences between healthy 
subject and patients with schizophrenia of the dACC (BA32; Becerril et al., 2011; 
Wang et al., 2010; Brázdil et al., 2007). Furthermore, healthy controls compared to 
EST displayed significantly greater working memory load related to increased 
activation in the bilateral VTA/SN area. This finding replicates previously reported 
BOLD responses for the midbrain region during working memory in healthy subjects 
(D’Ardenne et al., 2012; Düzel et al., 2008; Murty et al., 2011). 
 
4.4.3.2.2 Summary of standard subtraction analyses 
For the low working memory load, healthy controls showed increased activation in 
the left MTG (BA21) in comparison to EST (Table 4.13). There were no other 
significant group differences.  
 
Table 4.13 Between-group random effects analysis for the low working memory load. 
P value Extent Peak height 
coordinates 
Region Z score 
Healthy Controls < EST 
 
n/s     
Healthy Controls > EST 
 
.014* 1755 -66, -22, -15 
-57, -19, -14 
-59, -17, -8 
L temporal: middle 
temporal gyrus, BA21 
4.48 
*Reported p values are thresholded at p < .01 uncorrected cluster level, extent threshold = 






Healthy subjects displayed increased activation of the left precuneus and the left 
ACC in contrast to EST (Table 4.14). No other group differences were observed. 
Table 4.14 Between-group random effects analysis for the high working memory load. 
P value 
 
Extent Peak height 
coordinates 
Region Z score 
Healthy Controls < EST 
 
n/s     





1879 -5, -55, 49 
-11, -50, 45 
-14, -58, 44 
L parietal: precuneus 3.77 
 < 0.0012 
 
 
5683 -7, -7, 30 
21, 24, 31 
-42, 28, 25 
L limbic: cingulate 
gyrus, BA24 
3.17 
1Reported p values are thresholded at 0.01 uncorrected cluster level, extent threshold = 200 
voxels. Coordinates represent the three maxima within the same cluster. 
2 Reported p values are thresholded at p < .05 FWE corrected cluster level, extent threshold 
= 200 voxels. Coordinates represent the three maxima within the same cluster. 
 
4.4.4 Functional integration – Dynamic Causal Modelling 
The results of the bilinear and nonlinear DCM analyses are given separately for the 
findings for the left and right hemispheres following the phased protocol in Figure 
3.1. The outline of this results section is in keeping with the outline of the methods 
section. In the first step, the winning model for the “N-back” task for bilinear DCM 
is presented. Then the optimal bilinear model and four nonlinear models entered the 
next phase of determining the likelihood of linear and nonlinear models before the 
connection strength of the nonlinear modulation was assessed and compared between 








4.4.4.1 Bilinear Dynamic Causal Modelling and Bayesian Model 
Selection at the group level 
For the left hemisphere, the optimal model for the healthy controls was Model 7 (Xp 
= 0.24) whereas Model 1 was the winning model for the EST (Xp = 0.23) (Table 
4.15; Figure 4.8). 
Model 1 (see Figure 4.1) is characterised by bidirectional endogenous connections 
between (i) IPS and DLPFC, (ii) IPS and dACC, (iii) DLPFC and dACC, (iv) 
DLPFC and the VTA/SN area and (v) ACC and the VTA/SN area. Experimental 
manipulations are modelled by the connection from the IPS to the DLPFC, whereas 
the visual presentation of the stimuli and the individual errors during the working 
memory tasks are set on the IPS and the VTA/SN area, respectively. Model 7 (Figure 
4.1) differs from Model 1 only in the unidirectional connection from the ACC to the 
VTA/SN area instead of the bidirectional connection in comparison to Model 1. 
The Xps of the Models 1, 2, 7 and 8 ranged between Xp = 0.14 – 0.24 for the healthy 
controls and Xp = 0.13 – 0.23 for the EST, respectively. In more detail, Models 1 and 
2 were more likely to explain the given fMRI data in EST than in the healthy 
controls. In contrast, Models 7 and 8 displayed a higher probability in the healthy 
controls than in the EST. The main difference between the two pairs of DCMs are 
the specification of a bidirectional endogenous connection between the ACC and the 
VTA/SN area (Models 1 and 2; Figure 4.1) and a unidirectional endogenous 






Figure 4.8 Exceedance probabilities for the linear models in healthy controls and EST 
– Left hemisphere. 
Results for HC are based on Model 7 and results for EST are based on Model 1 (Figure 4.1). 
HC, healthy controls; EST; Xp, Exceedance probability. M1, Model 1; M7, Model. 
 
 
Figure 4.9 Exceedance probabilities for the linear models in healthy controls and EST 
– Right hemisphere. 
Results for HC are based on Model 7 and results for EST are based on Model 1 (Figure 4.1). 
HC, healthy controls; EST; Xp, Exceedance probability. M1, Model; M7, Model. 
 
For the right hemisphere, Model 8 is the optimal model in the healthy controls (Xp = 
0.23) with Model 7 displaying the third greatest likelihood of Xp = 0.16, whereas 
Model 1 is the optimal model for the EST (Xp = 0.20) (Figure 4.9). Models 1, 7 and 




in healthy controls than in EST. In comparison, Models 1 and 2 outperformed 
Models 7 and 8 and were more likely to explain the fMRI data in EST than in healthy 
controls. The structure of Model 1 (optimal model in EST) and Model 8 (optimal 
model in healthy controls) are differently characterised by endogenous connections: 
Model1 is defined by bidirectional endogenous connections between (i) the DLPFC 
and the VTA/SN area and (ii) the ACC and VTA/SN area. In contrast, Model 8 is 
described by unidirectional endogenous connections from (i) the DLPFC to the 
VTA/SN area and (ii) from the ACC to the VTA/SN area. 
 





Healthy controls  
 
 
– Left hemisphere 














0.18 0.15 0.23* 0.20* 
Model 2 
 
0.14 0.18 0.20 0.19 
Model 3 
 
0.04 0.04 0.05 0.07 
Model 4 
 
0.10 0.08 0.06 0.08 
Model 5 
 
0.08 0.07 0.08 0.09 
Model 6 
 
0.02 0.03 0.03 0.03 
Model  7 
 
0.24* 0.16 0.16 0.14 
Model 8 
 
0.16 0.23* 0.13 0.15 
Model 9 
 
0.04 0.06 0.05 0.06 
* Model 7 is the winning model in healthy subjects in the left hemisphere. 
* Model 8 is the winning model in healthy controls in the right hemisphere. 
* Model 1 is the winning model in EST in both hemispheres. 
 
In summary for both the left and the right hemispheres, the results of both 
hemispheres across the healthy controls and EST reflected a similar pattern. Models 




both hemispheres with Xp values in comparable ranges. Furthermore, the likelihoods 
of the optimal models were comparable between both hemispheres within each group 
and between the groups. Despite these similarities, Models 7 and 8 showed greater 
Xp values for healthy controls for both hemispheres, whereas Models 1 and 2 showed 
greater likelihood for EST for both hemispheres.   
 
4.4.4.2 Nonlinear Dynamic Causal Modelling and Bayesian Model 
Selection at the model family level 
We report three main results for the BMS results at the model family level: (i) 
outperformance of nonlinear models over bilinear model, (ii) winning model family 
for the left hemisphere in healthy controls and EST and (iii) winning model family 
for the right hemisphere in health controls and EST. However, it is noted that the 
findings cannot be directly compared between the healthy controls and EST due to 
two different model structures used for the BMS analyses. Bilinear Model7 was 
modelled for the nonlinear models for healthy controls; in contrast, bilinear Model 1 
was the basis for the nonlinear models in EST.  
 
(i) For both the left and right hemispheres, the nonlinear model families 
outperformed the linear model family in healthy controls and EST (Figure 
4.10 and Figure 4.11; Table 4.16). Therefore, the pre-condition of greater 
likelihood of the nonlinear models over the linear model was met as 





For healthy controls, nonlinear model family 2 (nonlinear models – DLPFC) and 
nonlinear model family 3 (nonlinear models – VTA/SN) (left hemisphere, Xp = 0.90; 
right hemisphere, Xp = 0.89) outperformed the linear model family 1 (bilinear 
model) (left hemisphere, Xp = 0.10; right hemisphere, Xp = 0.11) (Figure 4.10 and 
Figure 4.11; Table 4.16). 
A similar picture was observed in EST. Nonlinear model family 2 (nonlinear models 
– DLPFC) and nonlinear model family 3 (nonlinear models – VTA/SN) displayed 
greater likelihoods (left hemisphere, Xp = 0.82; right hemisphere, Xp = 0.90) than the 
bilinear model family 1 (left hemisphere, Xp = 0.18; right hemisphere, Xp = 0.10) 
(Figure 4.10 and Figure 4.11; Table 4.16).  
 
(ii) The winning model family for the left hemisphere was model family 2 in 
healthy controls and EST with comparable likelihoods of Xp = 0.46 for 
healthy controls and Xp = 0.44 for the EST. Model family 3 was the second 
winning model family in both groups (Xp = 0.44 for the healthy controls and 
Xp = 0.38 for the EST; (Figure 4.10; Table 4.16). The likelihoods of model 








Figure 4.10 Bayesian Model Selection results at the model family level for the left 
hemisphere. 
Results for HC are based on Model 7 and results for EST are based on Model 1 (Figure 4.1). 
HC, healthy controls; EST; Xp, Exceedance probability. 
MF1, Model family 1, bilinear model 
MF2, Model family 2, nonlinear models – DLPFC 
MF3, Model family 3, nonlinear models – VTA/SN 
 
(iii) For the right hemisphere, healthy controls and EST showed the same winning 
model family 2 as the most likely model family for the given fMRI data (Xp 
= 0.45 for healthy controls, Xp = 0.56 for EST). Model family 3 was the 
second winning model family with in both groups with Xp = 0.44 for healthy 
controls, Xp = 0.34 for EST). The difference in probabilities between the 
model families 2 and 3 was marginally different in healthy subjects. 







Figure 4.11 Bayesian Model Selection results at the model family level for the right 
hemisphere. 
Results for HC are based on Model 7 and results for EST are based on Model 1 (Figure 4.1). 
HC, healthy controls; EST; Xp, Exceedance probability. 
MF1, Model family 1, bilinear model 
MF2, Model family 2, nonlinear models – DLPFC 
MF3, Model family 3, nonlinear models – VTA/SN 
 








– Left hemisphere 










– Left hemisphere 
EST 
 




Model family 1 0.10 0.11 0.18 0.10 
Model family 2 0.46* 0.45* 0.44* 0.56* 
Model family 3 0.44 0.44 0.38 0.34 
* Denotes the winning model family. 
Results for HC are based on Model 7 and results for EST are based on Model 1 (Figure 4.1). 
Model family 1, bilinear model. 
Model family 2, nonlinear models – DLPFC 
Model family 3, nonlinear models – VTA/SN 
 
In summary, the Xps of model families 2 and 3 in healthy subjects were similar for 
the right and the left hemispheres (Table 4.16). This finding is in keeping with the 
previous DCM results for nonlinear DCM in healthy controls on the verbal fluency 




chapter 3.4.3.2; Dauvermann et al., 2013). In contrast, in EST the Xps for model 
families 2 and 3 differed between the hemispheres (Table 4.16). Notably, the 
difference in likelihood of model family 2 in contrast to model family 3 for the right 
hemisphere was greater than for the left hemisphere. 
 
4.4.4.3 Bayesian Model Averaging – Posterior densities of connection 
strengths 
The findings of the posterior densities of connection strengths are presented 
separately for healthy controls and EST for the winning models of model family 2 
and both hemispheres. Connection strengths with nonlinear modulation, endogenous 
connection strengths and connection strengths with modulatory inputs are given. 
The results for the connection strengths cannot be directly compared between the 
groups because two different model structures underlie the BMS and BMA findings: 
Bilinear Model7 entered the BMS and BMA analyses for healthy controls, whereas 
bilinear Model1 was the optimal linear model for EST. 
 
4.4.4.3.1 Connection strength with nonlinear modulation 
The average connection strengths with nonlinear modulation for the connections 
between the DLPFC and the VTA/SN area are presented. 
The posterior densities of connection strengths with nonlinear modulation for the 
connection from the DLPFC to the VTA/SN area for the right and left hemispheres 
between healthy controls and EST were comparable (Figure 4.12). A similar picture 
was observed for the connection from the VTA/SN area to the DLPFC between the 
groups although negative values of connection strengths with nonlinear modulation 




hemisphere, negative values for the connection strengths with nonlinear modulation 
were observed only in EST (Figure 4.12). 
 
Figure 4.12 Average of posterior densities of connection strength with nonlinear 
modulation. 
Results for HC are based on Model 7_DLPFC_VTA/SN_DLPFC (Figure 4.3) and results for 
EST are based on Model 1_DLPFC_VTA/SN_DLPFC (Figure 4.2). 
 
4.4.4.3.2 Endogenous connection strength 
For healthy controls, the averages of posterior densities of endogenous connection 
strengths were similar between the left and right hemispheres. A similar pattern was 
observed for both hemispheres in EST (Table 4.17). However, a direct comparison is 



































IPS -> DLPFC 
 
0.34 (0.05) 0.28 (0.13) 0.25 (0.12) 0.22 (0.12) 
IPS -> ACC 
 
0.27 (0.09) 0.26 (0.11) 0.25 (0.12) 0.25 (0.12) 
DLPFC -> IPS 
 
-0.05 (0.07) -0.04 (0.09) 0.04 (0.12) 0.04 (0.12) 
DLPFC -> ACC 
 
0.15 (0.05) 0.12 (0.08) 0.16 (0.13) 0.14 (0.10) 
DLPFC -> VTA/SN 
 
0.15 (0.11) 0.14 (0.09) 0.14 (0.13) 0.12 (0.13) 
ACC -> IPS 
 
0.05 (0.04) -0.04 (0.10) 0.03 (0.10) 0.02 (0.10) 
ACC- > DLPFC 
 
0.10 (0.03) 0.06 (0.12) 0.10 (0.10) 0.08 (0.17) 
ACC -> VTA/SN 
 
0.10 (0.12) 0.10 (0.06) 0.12 (0.12) 0.11 (0.10) 
VTA/SN -> DLPFC 
 
0.01 (0.05) 0 (0.05) 0.04 (0.06) 0.04 (0.07) 
VTA/SN -> ACC 
 
n/a n/a 0.07 (0.08) 0.06 (0.08) 
Mean (SE) 
Results for HC are based on Model 7_DLPFC_VTA/SN_DLPFC (Figure 4.3) and results for 
EST are based on Model 1_DLPFC_VTA/SN_DLPFC (Figure 4.2). 
 
4.4.4.3.3 Connection strength with modulatory inputs 
The averages of posterior estimates of connection strengths with modulatory inputs 
lied in similar ranges between healthy controls and EST as well as between both 
hemispheres (Table 4.18). A comparison of connection strengths between the groups 








Table 4.18 Average of posterior densities of connection strengths with modulatory 























“0-back” 0.18 (0.06) 0.16 (0.09) 0.12 (0.10) 0.10 (0.11) 
“1-back” 0.04 (0.01) 0.02 (0.07) 0.17 (0.03) 0.05 (0.06) 
“2-back” 0.17 (0.04) 0.14 (0.04) 0.08 (0.09) 0.10 (0.11) 
Mean (SE) 
Results for HC are based on Model 7_DLPFC_VTA/SN_DLPFC (Figure 4.3) and results for 
EST are based on Model 1_DLPFC_VTA/SN_DLPFC (Figure 4.2). 
 
4.5 Discussion 
We applied bilinear and nonlinear DCM to fMRI data for the “N-back” task in EST 
and healthy controls. The main result of nonlinear DCM analyses was that the 
nonlinear models outperformed the linear models in healthy controls and EST 
separately. This finding was apparent in both groups and in both hemispheres despite 
two different functional networks in healthy controls and EST. Notably, the two 
nonlinear model families were equally likely between both hemispheres in healthy 
controls, whereas the probabilities of the two nonlinear model families varied 
between the two hemispheres in EST. The outperformance of nonlinear models over 
linear models suggests that the meso-cortical and/or cortico-mesal connection is 
gated in healthy controls and EST independently. This findings may support 
preclinical and computational findings of gated synaptic plasticity processes during 
working memory (chapter 2.2.2.2). We further propose that the gating mechanism 
may be intact in EST based on the similar averages of connection strengths.  
 
Currently, it is not understood what the neurocognitive and neuropsychological 




gating as assessed with nonlinear DCM for fMRI may lead to successful 
performance of working memory given the comparable performance levels in this 
study based on recent neuroimaging studies employing EEG reported findings on the 
relevance of intact sensory gating during working memory tasks (Lijffijtet al., 2009; 
Shimi and Astle et al. 2013; Huang et al., 2013). However, more research is needed 
to shed light on possible neurocognitive mechanisms of gating in working memory 
and its potentially altered effect in individuals with schizophrenia. We note that  the 
reported group differences of the parametric contrast (“0-Back” versus “2-Back”) 
may reflect altered cortical function (Schlösser et al., 2008) or a compensatory 
mechanism to impaired cognitive function (Tan et al., 2006) in EST in keeping with 
previous FA studies (Callicott et al., 2000; Tan et al., 2006; Deserno et al., 2012). 
 
The main result of the bilinear DCM analyses was that there were two different 
winning bilinear models for healthy controls and EST during the “N-back” task for 
both hemispheres due to the adaptation of the heuristic search protocol from the 
EHRS. We interpreted this finding as a possible indication for different underlying 
functional networks for the performance of working memory in EST and healthy 
controls. From a cognitive neuroscience perspective, the different functional 
networks may be an indication for altered functional connections between prefrontal 
and midbrain regions or a compensatory mechanism of these regions in EST. 
However, we cannot rule out that clinical symptoms or antipsychotic medication may 
have changed the functional networks. Controversial results of both ameliorating and 
worsening effects of antipsychotics on FA findings (da Silva Alves et al., 2008; 




al., 2012) and EC findings (Schlösser et al., 2003; Schmidt et al., 2013) during 
working memory performance in individuals with schizophrenia were reported. We 
cannot interpret the EC findings in terms of potential pharmacological effects since 
this study was not designed for such an investigation. In addition, EST in this study 
were treated with a variety of antipsychotic medications (FGA and SGA).  
 
It has been proposed that alterations of dopaminergic and glutamatergic 
neurotransmission could lead to the pathophysiology of schizophrenia as part of the 
glutamate hypothesis of schizophrenia (Coyle, 2006; Coyle et al., 2011; Javitt, 2010). 
In particular, interactions between dopaminergic and glutamatergic modulation via 
AMPA and NMDA receptors of the meso-cortical connection may be disrupted in 
schizophrenia (chapter 2.2.2.2). Due to the impossibility of comparing the 
connection strengths with nonlinear modulation between healthy controls and EST, 
we cannot interpret potentially altered neurotransmission in EST.  
 
A direct comparison of bilinear and nonlinear findings with previous DCM studies is 
limited because of differing functional networks being employed to assess the N-
back task. Additional factors that limit a comparison of bilinear DCM findings with 
three clinical DCM studies in “N-back” are the use of differing DCM versions 
(DCM10, Deserno et al., 2012; Schmidt et al., 2013; not reported DCM version, 






Specific methodological limitations are given for the DCM analyses of this study, 
which have not been previously discussed (chapter 2.2.4.3; chapter 3.6). Firstly, one 
limitation of the bilinear DCM analysis lies in the limited linear model space 
investigated in the current study. The number of models and the variability among 
the models was limited in contrast to previously tested model spaces of the “N-back” 
task in individuals with schizophrenia (Deserno et al., 2012; Schmidt et al., 2013). 
Furthermore, the models were limited to intrahemispheric DCMs only, whereas it 
can be assumed that working memory function happens interhemispherically. 
Secondly, only models containing the exact same regions within a model and the 
exact number of regions can enter a model comparison. Thus, currently implemented 
model comparison and Bayesian inference approaches in DCM (across all DCM 
versions) does not allow the comparison of different models between two groups. 
Thirdly, it is possible that the BOLD response of the VTA/SN area was not great 
enough to assess connection strengths with nonlinear modulation given the small 
VOI sphere of 6 mm in addition to the small numbers of the two population groups. 
This limitation of the lack of robustness of the VTA/SN area in this sample set is 
reflected in the number of healthy controls and EST due to lack of sufficiently 
activated bilateral VTA/SN region (and the bilateral IPS) and the intrahemispheric 
models. Greater BOLD response in the bilateral VTA/SN area would have allowed 
the extension of the model space to interhemispheric models and therefore more 
biologically plausible model space. Nonetheless, we note that the number of 






Future DCM analyses of working fMRI data in individuals with schizophrenia could 
be improved in several ways. Firstly, interhemispheric DCMs should be specified in 
the model space since FA, FC and EC findings report evidence for altered BOLD 
responses, FC and EC between healthy controls and EST in both hemispheres. 
Therefore, it can be assumed that functional networks underlying working memory 
may function interhemispherically and thus in a more complex way than it was 
hypothesised in this study. Secondly, potential pharmacological effects of 
antipsychotics in EST and their effects on connection strengths (with nonlinear 
modulation) could be investigated, for example by comparing different subgroups 
defined by type of antipsychotic medication (i.e. FGA or SGA), dose of medication, 
duration of antipsychotic treatment, mode of action of medication and possible 
additional medication treatment. Thirdly, DCM settings should be chosen to allow a 
comparison among several DCM studies including the same DCM version and 
comparable model space. Fourthly, for better temporal resolution in investigations of 
gating processes underlying functional networks, DCM for fMRI and EEG analyses 
could be combined.  
 
4.6 Conclusion 
Our results of different optimal model structures for healthy controls and EST may 
indicate different functional networks for the performance of the verbal “N-Back” 
task. The investigation of possibly altered functional large-sale networks before the 
onset of schizophrenia may lead to a better insight into the pathophysiology of 































The main objective of the work on the EHRS and SFMHS cohorts was the modelling 
of synaptic plasticity and gating mechanisms, which are thought to be implicated in 
cognitive tasks in schizophrenia: The connections considered in the modelling work 
included the thalamo-cortical connection and the meso-cortical connection. For the 
EHRS, the connection strength with nonlinear modulation of the thalamo-cortical 
connection during verbal fluency in subjects at high familial risk of schizophrenia 
and healthy controls was assessed with nonlinear DCM for fMRI. For the SFMHS, 
the meso-cortical connection during working memory in EST and healthy controls 
was analysed with nonlinear DCM. 
 
In this chapter, key DCM findings of the EHRS and the SFMHS are summarised and 
discussed in context of methodological aspects and future directions. Finally, 
concluding remarks of modelling fMRI data for long-term goals of development of 
diagnostic tools and treatment for individuals with schizophrenia are given.   
 
5.2 Key findings 
For the EHRS, the application of nonlinear DCM to verbal fluency fMRI data 
revealed that the connection strength with nonlinear modulation of the thalamo-
cortical connection was reduced in HR+ in contrast to healthy controls (chapter 
3.5.3.3.1). This finding was supported by significantly negative correlations between 
connection strength with nonlinear modulation and severity of the ‘delusion’ 
symptom in HR+ and HRall (chapter 3.5.3.4). We proposed that the findings of 




preclinical and computational studies of reduced gating of the thalamo-cortical 
connection. Furthermore, we suggested that the altered connection strengths with 
nonlinear modulation in HR+ in contrast to healthy controls may provide a 
mechanistic explanation of the previously reported reduced BOLD response of the 
DLPFC in HR when compared to healthy controls (Whalley et al., 2004) and reduced 
prefrontal-thalamic FC in HR (Whalley et al., 2005). The reduced connection 
strengths with nonlinear modulation were interpreted as indications of thalamic 
glutamatergic alteration in context of the glutamate hypothesis of schizophrenia 
(chapter 3.6). In summary, we assessed altered synaptic plasticity and altered gating 
mechanism of the thalamo-cortical connection in HR when compared to healthy 
controls by the means of connection strengths with nonlinear modulation. 
 
The work in this thesis is the first study to assess connection strengths with nonlinear 
modulation of fMRI data. The methodology and logic of the application of nonlinear 
DCM for fMRI from the EHRS was adapted for the investigation of hypothesised 
altered synaptic plasticity and gating mechanism of the meso-cortical connection 
during working memory in EST and healthy controls for the SFMHS. In contrast to 
the EHRS in which HR and HC showed the same optimal model, EST and HC were 
found to use two different optimal models in the SFMHS. 
 
For the bilinear DCM analyses of the working memory fMRI data of the SFMHS, 
two different optimal linear models were found for EST and healthy controls 
(chapter 4.4.4.1). We proposed that this finding may indicate that EST used a 




working memory task than healthy controls. As a consequence of this main result at 
the group level, the connection strengths at the model family level could not be 
compared between EST and healthy controls. Therefore, the hypothesis of altered 
connection strength with nonlinear modulation of the meso-cortical connection 
between the two groups was not possible (chapter 4.4.4.2). However, we speculated 
that the gating mechanism during working memory was intact in EST based on 
comparable averages of posterior densities of connection strengths with nonlinear 
modulation between the two groups. Taken together, we reported findings of 
possibly different functional large-scale networks underlying the functional 
performance of working memory between EST and healthy controls. 
 
5.3 Methodological considerations and future 
directions 
5.3.1 Suitability of Dynamic Causal Modelling for fMRI for 
modelling synaptic plasticity and gating mechanisms in 
individuals with schizophrenia 
Originally, DCM was invented for the analysis of fMRI data to assess EC measures 
(Friston et al., 2003) with the objective of increasing interpretability of connectivity 
measures. In the following years, it has been proposed that DCM could be a tool to 
assess synaptic plasticity processes underlying the neural responses (Stephan et al., 
2006; Stephan et al., 2009a). This assumption has been specifically phrased for the 




schizophrenia when compared to healthy controls as hypothesised by the dysconnection 
hypothesis of schizophrenia (Stephan et al., 2006; Stephan et al., 2009a). 
 
Since the original design of bilinear DCM for fMRI, nonlinear DCM (Stephan et al., 
2008) and two-state DCM (Marreiros et al., 2008) have been developed to account for 
greater biophysical plausibility. In nonlinear DCM, one can assess the strengths of a 
connection by activity of other neuronal populations (Stephan et al., 2007, Stephan et 
al., 2008). Two-state DCM offers to infer intrinsic connectivity of two neuronal 
states, i.e. neuronal populations, in one region within the network (Marreiros et al., 
2008). Here, we focus on nonlinear DCM. 
 
The main characteristic of nonlinear DCM is the implementation of second-order 
derivatives for the assessment of connection strengths with nonlinear modulation 
(Stephan et al., 2008; Stephan and Friston, 2010), which are comparable to equations 
used in preclinical and computational studies to assess altered synaptic plasticity 
processes such as gating mechanisms (Abbott et al., 1997; Chance et al., 2002; Salinas 
and Sejnowski, 2001). Further support for the computation of second-order differential 
equations comes from DCM for EEG/MEG. In the state equation for DCM for 
EEG/MEG, comparable second-order derivatives are applied to infer neuronal 
interactions of inhibitory and excitatory subpopulations (Kiebel et al., 2006; Chen et al., 
2008; Kiebel, 2012). 
 
Criticism towards limited biophysical plausibility of DCM for fMRI remains despite the 




nonlinear modulation of fMRI data, which is based on the limited temporal resolution 
of fMRI (Friston et al., 2003; Roiser et al., 2013) to measure biophysical mechanisms 
from EPI time series (Moran et al., 2011; Friston and Dolan, 2010; Daunizeau et al., 
2011a; Friston et al., 2012). 
 
A second limitation of DCM was considered in a review of the robustness of the 
statistical inference techniques used in DCM10 and DCM126 for all modalities (i.e. 
fMRI, EEG, MEG, steady-state responses, local field potentials) (Daunizeau et al., 
2011a). Criticism has been raised towards the use of the free energy principle for the 
derivation of approximate Bayesian inference, which results in the risk of unpredictable 
results of model evidence and posterior densities of connection strengths over repeated 
runs of analyses (Daunizeau et al., 2009; Daunizeau et al., 2011a). Two aspects of the 
free energy optimization procedure, which may affect unstable model evidence and 
posterior densities of connection strengths have been discussed: (i) The construct of 
“global maximum level” of free energy (Daunizeau et al., 2011a) and (ii) the use of the 
mean-field/Laplace approximation as part of the variational Bayesian scheme for 
inference (Daunizeau et al., 2009; Daunizeau et al., 2011a). The investigation of 
minimising the risks for the unstable results and possible solutions for more 
reproducible findings is ongoing. 
 
In summary, DCM is a useful tool for inferring synaptic plasticity processes, which 
may underlie neural responses when the robustness of the statistical inference is 
                                                          




ensured. We propose to combine DCM for fMRI and DCM for EEG/MEG to further 
increase the biological plausibility in addition to the application of nonlinear DCM. 
 
5.3.2 Investigating functional large-scale networks of fMRI 
data in context of the dopamine hypothesis and 
glutamate hypothesis of schizophrenia 
In a recent review, it has been proposed that DCM studies that modelled cognitive 
function in subjects with schizophrenia may be able to interpret EC findings on the 
basis of the dopamine hypothesis and glutamate hypothesis of schizophrenia 
(Dauvermann et al., 2014; numeric/verbal working memory, Deserno et al., 2012; 
Schmidt et al., 2013; verbal fluency, Dauvermann et al., 2013). 
These exemplary studies used DCM as a biophysical modelling approach to 
functional large-scale networks to report altered EC findings during a cognitive 
task in individuals with schizophrenia in contrast to healthy controls. The findings 
were interpreted in terms of altered synaptic plasticity processes and 
dopaminergic/glutamatergic transmission in individuals with schizophrenia when 
compared to healthy controls supporting the disconnection hypothesis of 
schizophrenia (Stephan et al., 2006; Stephan et al., 2009a). Thus, these results may 
show indications of linkage between clinical large-scale networks and preclinical 
neurotransmitter modulation of cognitive function. Altered synaptic plasticity during 
cognitive function (such as working memory and verbal fluency) can be interpreted 
with dopaminergic and glutamatergic mechanisms. We emphasise that the 
interpretation of altered neurotransmitter circuits should be considered carefully 






The main finding of the SFMHS was that EST and healthy control showed different 
functional large-scale networks during the “N-Back” task, which may reflect 
compensatory mechanisms in EST given the comparably high performance. Thus, 
different functional networks may be interpreted as different learning strategies 
between EST and healthy controls und therefore different synaptic plasticity. We 
discuss possible methodological aspects of the SFMHS, which may offer an 
explanation for the reported findings. Firstly, the comparison of connection strengths 
(with nonlinear modulation) between EST and healthy controls was not possible due to 
the application of the heuristic search protocol from the EHRS. The robust nature of 
the protocol developed for the EHRS showed that EST and healthy controls of the 
SFMHS resolved the working memory task by using different functional networks. 
Secondly, although the connection strengths could not be compared among the two 
groups we speculate that synaptic plasticity processes could be altered between the 
groups based on the two different functional networks. In general, the inference of 
connection strength as assessed with DCM is based on the premise that each specified 
model entering the model comparison may resemble a model of regions and 
connections known to be implicated during the examined brain function. Therefore, it 
can be assumed that different structures of functional networks may point at the 
possibility of different neurobiological networks between EST and healthy controls. 
Currently, DCM does not allow the comparison of different models among two groups. 
Lastly, EST were treated with antipsychotic medication, which may have ameliorated 




antipsychotic medication is unclear. 
 
5.3.3 Understanding of schizophrenia as a cognitive 
brain network disorder 
Our understanding of schizophrenia is in continuous development. Translation 
between preclinical and clinical research plays a crucial role in forming the notion of 
schizophrenia. 
The understanding of schizophrenia as a brain disorder has developed by 
observations of effects of antipsychotic treatment in patients with schizophrenia. In 
addition, preclinical systematic research of pharmacological effects on brain 
processes has revealed evidence of alterations of cellular, chemical and molecular 
mechanisms:  
(i) Findings of dopaminergic and glutamatergic transmission in animal models 
of schizophrenia contributed to the understanding of schizophrenia as a brain 
disorder.  
(ii) Findings of neurotransmitter circuits, mainly dopaminergic and glutamatergic 
circuits, were found to modulate working memory in animal models of 
schizophrenia in combination with computational studies (Durstewitz and 
Seamans, 2008). Such evidence contributed to shape the understanding of 
schizophrenia as a cognitive network disorder. 
However, the understanding of schizophrenia has not only been shaped by preclinical 
research but also by clinical research in individuals with schizophrenia, which has 
been and continues to be illuminated by preclinical neurobiological and 




contributed to forming our understanding of schizophrenia as a cognitive brain 
disorder. In addition, biophysical modelling of fMRI scans has led to the progress in 
our understanding of schizophrenia as a cognitive brain network disorder. 
 
For future research, we propose the combination of biophysical modelling of 
functional large-scale networks and other computational neuropsychiatric aspects, 
which are able to detect critical neurobiological processes and which are of clinical 
relevance for individuals with schizophrenia. Long-term objectives of predicting 
and improving clinical treatment in patients with schizophrenia may be met by 
considering investigation of the following neuropsychiatric factors: 
 Neurotransmitter systems 
 Behaviour 
 Clinical symptoms 
 Effects of antipsychotic medication 
 Clinical outcome. 
Research on these combined analyses in individuals at different phases of 
schizophrenia in comparison to healthy controls may lead to better insight into the 
nature or development of functional large-scale networks from the high risk stage 
over the course of schizophrenia. It is conceivable that altered functional large-scale 
networks are already apparent at the high risk stage before the onset of 
schizophrenia. Alternatively, functional large-scale networks could change after the 
onset of the illness based on altered neurobiological processes. 
Finally, we suggest study designs, which may lead to better insight into the 




neuroimaging techniques or modelling approaches of neuropsychiatric factors, for 
example: 
(i) Combination of biophysical modelling of functional large-scale networks with 
computation, for example:  
a. Brain function and brain circuit model (Anticevic et al., 2012); 
b. Brain function and behaviour (Murray et al., 2012); 
c. Brain function and effect of antipsychotic medication: 
(ii) Combination of biophysical modelling of functional large-scale networks with 
multimodal neuroimaging study designs, for example: 
a. FMRI and EEG/MEG study designs; 
b. FMRI and TMS study designs (D’Ardenne et al., 2012); 
c. FMRI and MRS study designs; 
d. FMRI and PET study designs;    
(iii) Combination of biophysical modelling of functional large-scale networks with 
models of sensory learning (a), reinforcement learning (b) and classification 
algorithms (c), for example: 
a. Sensory learning (den Ouden et al., 2009; den Ouden et al., 2010); 
b. Reinforcement learning (Montague et al., 2012); 
c. Machine learning approach (Brodersen et al., 2011; Brodersen et al., 
2013). 
 
Here, we discuss a possible future DCM for fMRI and MRS study design, which 
falls into the category of (ii) ‘Combination of biophysical modelling of functional 




can be seen as an additional study design to the existent DCM study in working 
memory in EST and healthy controls as part of the SFMHS (chapter 4).  
In the DCM part of the SFMHS, we assessed EC measures of functional large-scale 
networks during working memory in EST and healthy controls. In particular, we 
measured the connection strengths with nonlinear modulation of the meso-cortical 
connection. The main result was that EST and HC showed two different optimal 
models for the working memory task, which we interpreted as an indication for a 
compensatory mechanism and/or ‘learning’ strategy. However, due to the lack of a 
Glu measure in the participants, we could not comment on possible glutamatergic 
alterations and their effect on differing synaptic plasticity underlying the functional 
large-scale networks. 
Here, we suggest the following study design to investigate possible relationships 
between glutamatergic levels in prefrontal regions and connectivity measures in 
working memory in EST and HC. The study design consists of three parts, of which 
the second and third part supplement the first part (i.e. chapter 4): 
(i) Application of DCM for fMRI to “N-Back task” in EST and healthy controls; 
(ii) In vivo resting Glu level measurement by the means of Single-Voxel 
Spectroscopy/MRS in the same participants and the same scanning session in 
prefrontal regions such as the bilateral DLPFC and ACC, which are known to 
be implicated in working memory function. Furthermore, the regions of the 
DLPFC and ACC are specified as regions in the functional networks. 
(iii) Post-hoc analysis of relationships between (nonlinear) connection strengths 




The combination of modelling functional large-scale networks with assessment 
of glutamatergic concentrations in the same participants may lead to a better 
understanding of working memory and possibly related glutamatergic 
involvement in individuals with schizophrenia. 
 
5.4 Concluding remarks 
We have conducted modelling of functional large-scale networks and considered 
how they contribute to our understanding of schizophrenia as a cognitive brain 
network disorder. The DCM findings of the EHRS and the SFMHS enabled us to 
investigate functional networks during the performance of a cognitive task and to 
interpret the findings in context of neurobiological hypotheses of schizophrenia. 
For the EHRS, we reported findings of altered synaptic plasticity during verbal 
fluency between subjects at high familial risk of schizophrenia and healthy 
controls. For the SFMHS, we showed that EST and healthy controls used different 
functional networks during working memory. For future research, the combination 
of modelling fMRI scans and other neuropsychiatric factors can bring researchers 
closer to the common long-term objectives of developing imaging based diagnostic 
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Computational modeling of functional brain networks in fMRI data has advanced the under-
standing of higher cognitive function. It is hypothesized that functional networks mediating
higher cognitive processes are disrupted in people with schizophrenia. In this article, we
review studies that applied measures of functional and effective connectivity to fMRI data
during cognitive tasks, in particular working memory fMRI studies.We provide a conceptual
summary of the main findings in fMRI data and their relationship with neurotransmitter
systems, which are known to be altered in individuals with schizophrenia. We consider
possible developments in computational neuropsychiatry, which are likely to further our
understanding of how key functional networks are altered in schizophrenia.
Keywords: computational neuropsychiatry, schizophrenia, fMRI, dynamic causal modeling, cognition,
neurotransmitter, dopamine, glutamate
INTRODUCTION
Schizophrenia is a severe psychiatric disorder, which is initially
manifested through positive symptoms including delusions, hal-
lucinations, and disorganized thoughts. As the illness progresses
negative symptoms such as avolition, alogia, and apathy may occur.
Prior to diagnosis of illness, cognitive deficits can occur and illness
progression can also be associated with cognitive deficits (1, 2). It
is widely established that such cognitive deficits are considered a
core symptom of schizophrenia (3) and are associated with reduc-
tions in working memory performance. Working memory deficits
are one of the main neurocognitive impairments found in subjects
Abbreviations: AC/ACC, anterior cingulate/anterior cingulate cortex; ARMS, at-
risk mental state; BMS, Bayesian model selection; BOLD response, blood-oxygen-
level dependent response; D1 receptor, D1 subtype of the dopamine receptor; D2
receptor, D2 subtype of the dopamine receptor; D2/3 receptors, D2/3 subtype of
the dopamine receptor; DCM, Dynamic Causal Modeling; DMN, default-mode
network; DLPFC, dorsolateral prefrontal cortex; EC, effective connectivity; EST, sub-
jects with EST; FC, functional connectivity; FEP, subjects with first episode psychosis;
FES, subjects with first episode schizophrenia; GABA, γ-aminobutyric acid; GBC,
global-based connectivity; HR, subjects at high risk of schizophrenia; HR+, subjects
at high familial risk of schizophrenia with transient psychotic symptoms; HR−, sub-
jects at high familial risk of schizophrenia without transient psychotic symptoms;
HRill, subjects at high familial risk of schizophrenia who subsequent to scanning
developed schizophrenia; HSCT, Hayling sentence completion task IFG inferior
frontal gyrus; MFG, middle frontal gyrus; MRS, magnetic resonance spectroscopy;
NMDA, N -Methyl-d-aspartate acid; PC, parietal cortex; PET, positron emission
tomography; rCBF, regional cerebral blood flow; SPECT, single-photon emission
computed tomography; SPL, superior parietal lobe; STG, superior temporal gyrus.
with first episode schizophrenia (FES) (4, 5) and in people with
established schizophrenia (EST) (6). Similar deficits also occur
in individuals at high risk of schizophrenia [HR; Ref. (2)]. Fur-
thermore, recent evidence has been presented, which indicates a
relationship between severity of working memory deficits and the
severity of negative symptoms (7). The severity of working mem-
ory deficits that is evident at the first episode of schizophrenia can
predict the quality of life at the established stage of the illness (8, 9).
Two major neurotransmitter circuits have been implicated in
clinical and cognitive symptoms in subjects with schizophrenia:
these are the dopamine and glutamate neurotransmitter circuits.
Evidence has been presented for separate alterations/disruptions of
dopamine and glutamate as well as an interactive role between both
neurotransmitters1. The two main neurobiological hypotheses
in schizophrenia are based on the theories of altered dopamin-
ergic transmission (“dopamine hypothesis of schizophrenia”)
and altered glutamatergic transmission (“glutamate hypothesis
of schizophrenia”). It is thought that both dopamine and glu-
tamate modulate the dorsolateral prefrontal cortex (DLPFC) and
in schizophrenia alter the performance in cognitive processes such
as in working memory (10–13). Such work supports the notion
of schizophrenia as a brain disorder. FMRI and positron emission
tomography (PET) findings of altered functional activation and
functional connectivity (FC) during working memory have been
1It is noted that other neurotransmitter circuits are interacting with dopaminergic
and/or glutamatergic circuits such as serotonin and GABA (24, 29, 149).
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reported in people with schizophrenia when they are compared to
healthy controls (14, 15). Furthermore, PET studies have presented
evidence for indirect markers of altered dopamine transmission,
which was correlated with working memory performance (2, 16).
Alterations of indirect measures of glutamate concentrations have
been reported by proton magnetic resonance spectroscopy (MRS)
studies (17).
One subfield within the emerging field of computational neu-
ropsychiatry is based on modeling fMRI networks and the evi-
dence of (i) altered dopaminergic and/or glutamatergic transmis-
sion in (ii) cognitive function (i.e., working memory) in people
with schizophrenia. Therefore, the objectives are the investigation
of impaired cognitive function mediated by large-scale networks
in combination with underlying neurobiological circuits such as
dopamine and glutamate. Researchers in computational neuropsy-
chiatry examine and model altered cognitive brain function in
terms of functionally integrated regions [i.e., effective connectiv-
ity (EC)] (18), which may be mediated by genetic factors and
neurotransmitter circuits (19–21). Mechanistic responses can be
inferred from the computational modeling of cognitive brain func-
tion where the localized brain function is monitored through
the BOLD response (22). This modeling approach allows com-
putational neuropsychiatry to further our understanding of the
neurobiological processes, which underlie altered cognitive brain
function in individuals with schizophrenia. Thus, advancing our
knowledge of schizophrenia as a cognitive brain network disorder.
In this review, we summarize fMRI findings in verbal/numeric
working memory2 in context of (i) the understanding of schizo-
phrenia as a cognitive brain disorder (from clinical and cognitive
neurosciences) and (ii) the understanding of schizophrenia as
a cognitive brain network disorder (from computational neu-
ropsychiatry). We discuss these sets of findings in context of the
dopamine and the glutamate hypotheses of schizophrenia. We
consider two key research questions for the discussion of each
set of findings:
(i) To what extent do these sets of findings support the dopamine
hypothesis and/or the glutamate hypothesis in subjects with
schizophrenia?
(ii) Do the findings from computational neuropsychiatry lead to
a better understanding of schizophrenia than that obtained
from clinical and cognitive neurosciences?
The review is structured as followed: first, the dopamine and
glutamate hypotheses of schizophrenia are summarized (Section
Schizophrenia as a Brain Disorder). Second, exemplary findings
of verbal/numeric working memory deficits from fMRI studies
in subjects with schizophrenia are summarized. These findings
are discussed in context of the dopamine hypothesis and the glu-
tamate hypothesis of schizophrenia (Section Schizophrenia as a
Cognitive Brain Disorder). Third, we present a brief introduc-
tion to computational neuropsychiatry. We provide examples from
2In this review, we focus on the “2-back” task [verbal “2-back”, (104); numeric
“2-back”, (97)] to review/discuss brain function and PET findings of compara-
ble experimental paradigms, psychological/ cognitive domains/components and
activated brain regions.
computational neuropsychiatry and the application to the investi-
gation of cognitive brain large-scale networks in people with schiz-
ophrenia3. Finally, we consider current methodological limitations
of the methods (Section From Computational Neuropsychiatry
Towards Schizophrenia as a Cognitive Brain Network Disorder).
We outline potential future influences of computational advances
in schizophrenia that may shape our understanding of schizophre-
nia with the aim of developing more effective treatments for the
disorder (Section Understanding of Schizophrenia).
SCHIZOPHRENIA AS A BRAIN DISORDER
Neurobiological research into alterations of dopaminergic and/or
glutamatergic neurotransmission has paved the way for the under-
standing of schizophrenia as a disorder of the brain. The dopamine
hypothesis posits that dopamine function is altered in schizo-
phrenia and that this dysfunction may be the pathophysiological
pathway leading to clinical and cognitive symptoms (23, 24).
The glutamate hypothesis proposes that the altered dopaminergic
dysfunction may be secondary to aberrant glutamatergic dysreg-
ulation, which may contribute to clinical and cognitive symptoms
in schizophrenia (25–27).
DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA
The origin of the dopamine hypothesis of schizophrenia is based
on the discovery of antipsychotic drugs by Delay et al. (28) in
1952. Carlsson and Lindqvit reported the first findings of an
effect of antipsychotic drugs on the metabolism of dopamine (29).
The dopamine hypothesis posits that alterations of dopaminergic
receptors may underlie the clinical symptoms of schizophrenia
(30). Over last three decades, the dopamine hypothesis of schiz-
ophrenia has undergone reformulations in light of newly avail-
able preclinical and clinical findings. Here, we consider the three
main hypotheses: (i) the “dopamine receptor hypothesis,” (ii) the
“modified dopamine hypothesis of schizophrenia,” and (iii) the
“dopamine hypothesis: version III.”
The dopamine receptor hypothesis goes back to studies report-
ing antipsychotics affecting the affinity of dopamine receptors
(31–33). Further evidence for the hypothesis was presented with
increased synaptic monoamine levels during the induction of
psychotic symptoms (34). The focus of this hypothesis rests on
the excess of dopamine receptors. Thus, the clinical treatment is
aimed at blocking the dopamine D2 subtype of the dopamine
receptors (35).
The modified dopamine hypothesis of schizophrenia has been
formulated to integrate new findings (36). Preclinical and clini-
cal studies (i.e., post-mortem, metabolite, and dopamine receptor
neuroimaging studies) have advanced the understanding of rela-
tionships between affinity and occupancy of D2 and D1 subtypes of
the dopamine receptors and regional specificity (37). Furthermore,
it was assumed that findings of altered regional dopaminergic
receptor function from preclinical and indirect clinical studies
could be linked to clinical symptomatology in schizophrenia (36).
The hypothesis suggests that “hypofrontality,” as measured with
reduced regional cerebral blood flow (rCBF) in the PFC may indi-
cate low dopamine levels in the PFC (36). Findings from preclinical
3Exemplary studies on verbal fluency findings are presented.
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lesion studies proposed that prefrontal “hypodopaminergia” lead
to striatal “hyperdopaminergia” (38, 39). In addition, it is hypoth-
esized that prefrontal “hypodopaminergia” could cause negative
symptoms, whereas striatal “hyperdopaminergia” could lead to
positive symptoms (36).
The dopamine hypothesis: version III synthesizes published
findings on dopamine and its potential role in schizophrenia from
the main fields into one unifying hypothesis. The hypothesis aims
to provide a framework for findings from developments in clini-
cal research into genetic (risk) factors, environmental risk factors,
neurochemical and neuroimaging studies, and preclinical studies,
which may be related to increased presynaptic striatal dopamin-
ergic function in schizophrenia (23). The hypothesis is comprised
of four components: (i) The interaction of “hits” such as fronto-
temporal dysfunction, genes, stress, and drugs may lead to striatal
dopamine dysregulation (i.e., increased presynaptic dopamine
synthesis capacity) and therefore to psychosis. (ii) It is hypoth-
esized that the primary dopaminergic dysfunction is located at
the presynaptic dopaminergic level instead of the D2 receptor
level. (iii) The hypothesis assumes that the dopamine dysregu-
lation combined with cultural and societal factors could lead to
future clinical diagnosis of “psychosis” rather than schizophrenia.
(iv) It is proposed that the dopamine dysfunction could change the
perception and judgment of stimuli (possibly through aberrant
salience), which could result in cognitive deficits (40, 41).
Recent meta-analyses, which examined markers of striatal
dopamine alterations in schizophrenia, reported evidence of dif-
ferent types of elevated dopamine dysfunction. Supporting evi-
dence for the dopamine hypothesis has been shown by increased
striatal presynaptic dopaminergic function in medication-free
or medication-naïve patients with schizophrenia contrasted to
healthy controls (42) and increased striatal dopamine synthesis
capacity (43). Contradictory findings have however been reported
by Fusar-Poli and Meyer-Lindenberg (44), who found no dif-
ference in striatal dopamine active transporter density between
patients with schizophrenia and healthy controls.
In summary, while both the dopamine receptor hypothesis
and the modified dopamine hypothesis of schizophrenia have
their origins in the neurobiological investigation of the mode
of action of antipsychotics, the dopamine hypothesis: version III
aims at integrating advances in research of schizophrenia into
one unifying dopamine hypothesis. The scope of understanding
of dopaminergic dysregulation has become more defined, rang-
ing from the whole brain perspective, through the perspective of
regional specificity between (DL)PFC and striatum, to the current
perspective of elevated presynaptic striatal dopaminergic function.
The development of the dopamine hypothesis over the three ver-
sions has helped shape the understanding of schizophrenia as a
brain disorder.
GLUTAMATE HYPOTHESIS OF SCHIZOPHRENIA
The origin of the glutamate hypothesis of schizophrenia was based
on the discovery of psychotomimetic effects of ketamine and phen-
cyclidine, which elicited psychotic symptoms in healthy people.
Symptoms such as delusions and hallucinations experienced by
healthy individuals were compared to positive symptoms seen in
FES (45, 46). The glutamate hypothesis postulates a mechanistic
process of altered interacting glutamatergic and/or dopaminergic
neurotransmitter circuitries implicated in the pathophysiology of
clinical and cognitive symptoms in schizophrenia (47–50). In this
review, we consider three models of the glutamate hypothesis with
relevance to the investigation of altered working memory function
in people with schizophrenia: (i) the “N -Methyl-d-aspartate acid
(NMDA) receptor hypofunction model” of schizophrenia, (ii) the
“acute ketamine model,” and (iii) the “dysconnection hypothesis”
of schizophrenia.
The NMDA receptor hypofunction model of schizophrenia
posits that the subtype of the glutamate receptor is implicated in
multiple pathological brain mechanisms of schizophrenia rang-
ing across cellular, chemical, and neuronal levels (51–54). It has
been proposed that NMDA receptor hypofunction could under-
lie the pathophysiology of negative and cognitive symptoms in
schizophrenia (29, 51, 55, 56). Clinical trials with agents modulat-
ing NMDA receptor in addition to treatment with first-generation
antipsychotics (FGA; such as chlorpromazine, haloperidol, per-
phenazine) and second-generation antipsychotics (SGA; such as
clozapine and olanzapine) presented supporting evidence for
amelioration of negative and cognitive symptoms (51, 57, 58).
Evidence for the involvement of NMDA receptor hypofunction
through interactions among different neurotransmitters such as γ-
aminobutyric acid (GABAergic) interneurons (51) and dopamine
(59, 60) has also been reported.
Evidence for the glutamate hypothesis in humans is based on
clinical studies with ketamine in healthy subjects. Results suggest
that glutamatergic alterations could explain the pathophysiolog-
ical mechanisms resulting in positive symptoms predominantly
experienced by FES and those with first episode psychosis (FEP)
(45, 61). While findings from ketamine injection studies have aided
the understanding of glutamatergic signaling in the development
of delusions and hallucinations, evidence for altered glutamatergic
transmission in negative and cognitive symptoms is scarce. FMRI
findings from ketamine studies in healthy subjects propose that
altered glutamatergic signaling could be implicated in working
memory (12, 45, 62). These findings are in keeping with evi-
dence from glutamatergic animal models, which report aberrant
working memory function after the inhibition of glutamatergic
receptors (63–66).
The dysconnection hypothesis of schizophrenia posits that
altered NMDA receptor-mediated synaptic plasticity may be the
underlying pathophysiological mechanism in individuals with
schizophrenia (20, 21, 67). The authors propose that altered synap-
tic plasticity may explain both clinical symptoms and cognitive
deficits in people with schizophrenia neurobiologically by altered
NMDA receptor neuromodulation. Therefore, the dysconnection
hypothesis synthesizes neurobiological findings (i.e., dopamine
as one of the main neuromodulators leading to aberrant NMDA
receptor function) with clinical and cognitive neuroscientific find-
ings (i.e., cognitive impairment) in individuals with schizophrenia.
One of the main objectives of the dysconnection hypothesis is to
offer a new approach and therefore new interpretation of neuro-
physiological and neuroimaging data. This may be used to assist
in the understanding of altered cognitive function in people with
schizophrenia. For functional neuroimaging data, the biophysi-
cal modeling approach of dynamic causal modeling [DCM; Ref.
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(18)] has been proposed to infer biophysical processes (namely,
NMDA receptor-dependent synaptic plasticity) underlying the
blood-oxygen-level-dependent (BOLD) responses. In addition,
the authors provide arguments that the development of positive
symptoms such as delusions can be explained by a “failure of self-
monitoring mechanism” or “corollary discharge” (20). Abnormal
EC findings from EEG and fMRI studies across a range of cognitive
tasks in subjects with schizophrenia in contrast to healthy con-
trols have been reported (68–70). These lead to a new insight into
altered connectivity above those provided by FC studies, which
are formulated under different theoretical frameworks, specifi-
cally DCM findings enable the inference of biophysical processes
underlying neural responses (18, 19, 71).
In summary, the three hypotheses, the NMDA receptor hypo-
function model, the acute ketamine model, and the dysconnection
hypothesis, have motivated researchers to investigate biophysical
circuit processes implicated in glutamatergic and dopaminer-
gic interaction in negative symptoms and cognitive function in
schizophrenia. These circuit mechanisms are thought to under-
lie altered working memory function in schizophrenia. Research
on the NMDA receptor hypofunction model has its roots in the
pharmacological examination of antipsychotics, the development
of new agents, and its effects on clinical and cognitive symptoms
in preclinical and clinical research in schizophrenia. The focus of
researchers examining the acute ketamine model and the dyscon-
nection hypothesis lies on elucidating proposed neurobiological
processes of blockade of NMDA receptor underlying altered cog-
nitive brain function in schizophrenia. The study designs of both
versions differ in the investigation of (i) the pharmacological effect
of ketamine on altered cognitive brain function and clinical symp-
tomatology in healthy controls (the acute ketamine model) and (ii)
altered synaptic plasticity during altered cognitive brain function
in subjects with schizophrenia. Despite the different approaches,
researchers of both versions of the glutamate hypothesis share
the common aim of increasing our insight into schizophrenia by
the translation of neurobiological knowledge from basic research
to clinical research in schizophrenia. Furthermore, researchers
share the common methodological approach of large-scale net-
work analysis of fMRI data. Taken together, development over the
three versions of the glutamate hypothesis of schizophrenia have
presented promising evidence for shaping the understanding of
schizophrenia as a cognitive brain network disorder.
SCHIZOPHRENIA AS A COGNITIVE BRAIN DISORDER
Clinical and cognitive neuroscience studies have applied in vivo
neuroimaging techniques of fMRI, PET, and single-photon emis-
sion computed tomography (SPECT) to assess neurobiological
processes that underlie working memory function in people with
schizophrenia. Techniques such as PET and SPECT use injec-
tions of positron-emitting radionuclide as tracer (for PET) or
gamma-emitting radionuclide as tracer (for SPECT) in the liv-
ing brain. Although these nuclear medical imaging techniques are
non-invasive they require the administration of tracers. FMRI pro-
vides non-invasive in vivo imaging, which measures brain function
by means of the BOLD response (72).
In the last two decades, the fields of clinical and cognitive
neurosciences merged to provide a multidisciplinary approach to
research into schizophrenia. This approach has created the notion
of schizophrenia as a cognitive brain disorder (15, 73, 74).
EXAMPLES OF fMRI AND PET STUDIES INVESTIGATING ALTERED
WORKING MEMORY FUNCTION IN SUBJECTS WITH SCHIZOPHRENIA
Working memory tasks were initially investigated with fMRI in
healthy subjects (75–78). These initial findings led to the use of
fMRI as a tool for examining neurobiological markers that could
be related to working memory performance. The examination
of working memory function was extended to individuals with
schizophrenia.
Reported findings of brain function during working mem-
ory (among several domains and components of working mem-
ory tasks) in healthy controls have led to the understanding
that dopamine modulates working memory in healthy controls
(79–81). This evidence of dopaminergic involvement in working
memory was extended by the findings of altered dopaminergic
modulation in schizophrenia (74, 82). Subsequently, converging
findings were reported that regions such as DLPFC, anterior cin-
gulate cortex (ACC), and parietal cortex (PC) are activated in
working memory in both healthy controls and in subjects with
schizophrenia (83–86). However, in those with schizophrenia,
these regions exhibit increased or reduced functional activations
and FC between prefrontal and parietal regions as well as between
prefrontal and temporal regions in contrast to healthy controls.
Alterations in FC occur at all stages of the illness (87, 88): (i) in
HR subjects (89); (ii) in FES and FEP (90), and (iii) in subjects
with EST (91).
Systematic reviews and meta-analyses of working memory
fMRI studies in people with schizophrenia do not report con-
sistent findings (92–95). Some studies report increased activation
of the DLPFC, commonly referred to as “hyperfrontality,” how-
ever, others report decreased activation or “hypofrontality.” This
picture of differing functional activation in terms of the direc-
tion, extent, and/or pattern of BOLD responses was attributed to
the variation of domains and components of working memory
tasks (92–95). Also it was considered that methodological factors
in the applied analyses would contribute to these variations in
functional activation (93, 95, 96). In addition, differences in med-
ication could contribute to variation in the reported functional
activation between studies.
Here, we review exemplary fMRI studies using the numeric or
verbal “N-back” task in subjects with EST and healthy controls,
which reported functional activation and FC findings (Table 1).
The reviewed studies present group differences between subjects
with schizophrenia and healthy controls. In functional activa-
tion studies, evidence was reported for increased activation in
DLPFC, PFC, ventral PFC, medial frontal gyrus, and AC during
high working memory load in subjects with EST (89, 97–101).
However, reduced activation in prefrontal regions, such as ven-
tral PFC, DLPFC, AC, and parietal regions was found during high
working memory load in subjects with EST (97, 98, 102). One
study in FES found a reduction of activation in inferior frontal
gyrus (IFG), superior frontal gyrus, and AC during high working
memory load (103). We note three factors, which contributed to
difficulties in comparing the findings across the reviewed stud-
ies: (i) missing information of phase of schizophrenia (100), (ii)
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heterogeneous groups of subjects with EST (97, 101, 103), and
(iii) limited information on antipsychotic treatment (89, 97–101,
103). Fundamentally, none of the functional activation findings
was interpreted in context of the dopamine or glutamate hypothe-
sis. The lack of a clear understanding in terms of neural activation
and pathophysiological mechanism suggests there is a need for
studies examining wider prefrontal circuitry underlying working
memory deficits in schizophrenia (93, 95).
Functional connectivity studies applied voxel-based seed
approaches to the BOLD response (89, 100, 103), with the excep-
tion of one study, which applied an ROI-to-ROI approach (101).
Despite equivalent methodological approaches, the FC findings
are not entirely comparable due to the use of different seed loca-
tions. Findings of reduced connectivity involving subregions of
the PFC were found in FES and EST. Reduced FC findings in
subjects with schizophrenia and EST were reported in the major-
ity of studies: (i) Reduced prefrontal–parietal4 FC in subjects
with schizophrenia (100); (ii) Reduced prefrontal–hippocampal,
prefrontal–striatal, and within-PFC FC in EST (89); and (iii)
Reduced parieto-prefrontal FC and between putamen and ventro-
lateral PFC in EST (101). Further evidence for reduced FC between
medial frontal gyrus and putamen was found in FES (103). In con-
trast to most studies that report reduced FC in the early and late
phases of the illness, increased FC between the ventral PFC and
posterior PC was shown in subjects with schizophrenia (100). The
findings of both reduced and increased FC between subregions
of the PFC and the posterior PC may be related to variations in
behavioral response to task load for subjects with schizophrenia
(100). Similar difficulties in comparing the FC findings among
the studies are present as in the comparison of the functional acti-
vation studies due to unclear and missing information regarding
the illness phase, diagnosis, and medication treatment. Similarly,
no reference is made to the dopamine or glutamate hypothesis in
interpreting the FC findings.
In summary, findings presented by FC studies during the “N-
back” task have paved the way for the understanding of large-
scale functional networks in working memory. Furthermore, the
insight of brain alterations in subjects with schizophrenia has
advanced with FC from individually activated regions to con-
nectivity between brain regions. The perspective of circuit-based
neurobiology and cognitive brain function opens the doors for
translational research from preclinical and clinical research in
schizophrenia. However, FC is limited as the connection assess-
ments are based upon regional correlations and this approach does
not allow inferences of directions or causality between connected
regions (18).
Positron emission tomography and SPECT imaging in schiz-
ophrenia research are used to investigate indirect markers of
dopamine measures such as D2/3 receptors, presynaptic dopamin-
ergic function, dopamine synthesis capacity, dopamine release,
and dopamine transporters. Three [H215O] PET studies consis-
tently reported reduced rCBF in DLPFC and PC in verbal/numeric
“2-back” in subjects with EST in contrast to healthy controls (104–
106). Reduced prefrontal–hippocampal FC findings in subjects
4Reduced FC between the dorsal PFC and posterior PC.
with schizophrenia in contrast to healthy controls (105, 106)
confirmed the hypothesis of reduced functional connections in
working memory. Correlational PET studies provided support for
dopaminergic alterations and measures of the “2-back” task in
subjects with schizophrenia (2, 16).
In summary, fMRI and PET studies in the field of clinical
and cognitive neurosciences have been used to investigate brain
function during working memory in people with schizophrenia
(Figure 1). Both fMRI and PET findings have advanced the under-
standing of altered working memory performance and brain func-
tion in subjects with schizophrenia. This has led to better insight
into the interaction between altered working memory function
and experimental/clinical factors (such as cognitive domains of
working memory function, performance level, phases of illness,
clinical symptomatology, and effects of antipsychotic medication)
in individuals with schizophrenia.
EXAMPLES OF fMRI STUDIES INVESTIGATING ALTERED SPATIAL
WORKING MEMORY FUNCTION – GLUTAMATE HYPOTHESIS OF
SCHIZOPHRENIA
The role of the DLPFC in working memory deficits has been
associated with glutamatergic alterations and more specifically in
dopamine–glutamate interactions (10, 50, 51). Furthermore, it has
been reported that ketamine, a NMDA receptor antagonist, can
induce psychosis-like symptoms in healthy subjects (45). Here, we
briefly summarize the main functional activation and FC findings
of fMRI studies on the spatial “N-back” task in the context of the
glutamate hypothesis of schizophrenia (Table 2).
Anticevic et al. (12) presented ketamine-induced reduced func-
tional activation in task-activated regions (such as the DLPFC and
the precuneus) and task-deactivated regions of the default-mode
network (DMN). In addition, the combination of a spiking local-
circuit model of performance during the spatial “N-back” task and
the functional activation findings revealed that the modulation of
FIGURE 1 | Understanding of schizophrenia as a cognitive brain
disorder – verbal/numeric “N-back” task. afMRI; bPET, positron emission
tomography.
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ketamine alters the association between the task-activated and the
task-deactivated networks. Finally, it was shown that ketamine
modulates FC between the fronto-parietal and DMN networks.
In a recent study, Driesen et al. (62) provided further support for
ketamine-induced reduced prefrontal FC during the spatial “N-
back” task. Two FC approaches with the same seed regions were
employed, seed-based FC and global-based connectivity (GBC),
which revealed both decreased FC within the DLPFC. The seed-
based analysis resulted in reduced FC between DLPFC and mid-
dle frontal gyrus [MFG, IFG, and insula (among other regions)
under ketamine in contrast to saline]. The GBC analysis showed
decreased FC of the DLPFC under ketamine.
In summary, these studies on altered spatial working memory
function inform on the glutamate hypothesis, through the acute
ketamine model (Figure 2). In this, they have advanced the under-
standing of NMDA receptor-modulated brain function in healthy
subjects.
FROM COMPUTATIONAL NEUROPSYCHIATRY TOWARD
SCHIZOPHRENIA AS A COGNITIVE BRAIN NETWORK
DISORDER
Clinical and cognitive neurosciences have advanced the under-
standing of altered working memory function in subjects with
schizophrenia. FMRI studies in working memory among other
neuroimaging and electrophysiological techniques, have reported
on functional activation and FC findings in subjects with schizo-
phrenia. Both findings of functional activation and FC revealed
methodological, cognitive, and clinical factors related to our
understanding of altered working memory function in patients
with schizophrenia. In particular, FC findings mark the begin-
ning of the notion of “disconnection” and “dysconnection” (20,
21, 67, 107) in working with people with schizophrenia. FC is
defined as the statistical association or dependency among two or
more anatomically distinct time-series (107). FC findings cannot
be interpreted in terms of causal effects between connected regions
and thus, does not allow for a mechanistic inference of the BOLD
responses.
The modeling of functional large-scale networks5 during work-
ing memory function in schizophrenia could provide mechanistic
explanations for altered brain function in individuals with schiz-
ophrenia. The advantage of modeling functional large-scale net-
works in terms of EC over FC is that inferences can be drawn
on mechanistic processes, which are not directly observable in the
BOLD response.
COMPUTATIONAL NEUROSCIENCE AND COMPUTATIONAL
NEUROPSYCHIATRY
Marr proposes a theoretical framework for computational research
on the brain on three levels (1976). At the first level, researchers
should aim to gain knowledge of the high-level computations of
the brain such as working memory (“computational level”). At the
next level, the testing of the brain’s methods and algorithms for the
high-level working memory function is led by hypotheses derived
from the acquired knowledge and testing how appropriate an algo-
rithm such as Bayesian inference is for modeling the working
5As one subfield within computational psychiatry.
FIGURE 2 | Understanding of schizophrenia as a cognitive brain
disorder – spatial “N-back” task.
memory brain function (“algorithmic level”). Finally, when an
algorithm is found, which is valid and more likely than alterna-
tive algorithms to predict known brain function/behavior, then
the investigation of the biological implementation can be pursued
(“physical level”).
Computational neuropsychiatry is an emerging field within
computational neuroscience. Computational neuropsychiatry
aims to provide an explanatory bridge between altered cogni-
tive function and neurobiological mechanisms associated with
the development of mental illness (108, 109, Huys, unreferred
preprint). Computational neuropsychiatry in humans has been
defined by outlining a set of components, which include bio-
physical modeling and computational modeling (109). Differ-
ent types of computational models at different neural levels are
used dependent on the study hypothesis (108, Huys, unreferred
preprint).
COMPUTATIONAL NEUROPSYCHIATRY AND MODELING OF
FUNCTIONAL LARGE-SCALE NETWORKS IN SUBJECTS WITH
SCHIZOPHRENIA
Connectionist and neural network models in working mem-
ory/cognitive control in subjects with schizophrenia have added
to our understanding of both the brain function and the neuro-
biological mechanism underlying working memory (74, 76). The
strength of these models is based on the translational link between
human brain function (i.e., functional activation) and preclini-
cal neurobiological evidence (namely, dopaminergic modulation)
during working memory.
Following on from the work of Cohen and Braver, evidence for
the understanding of schizophrenia as a cognitive network disor-
der has been presented by both preclinical studies (8, 10, 110–113)
and human FC studies in working memory (89, 100, 101, 103).
Recent studies examining biophysical mechanisms underlying
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altered functional large-scale networks aim to bridge the gap
between the human functional network used in working mem-
ory and the preclinical neurobiological processes. Examples of
such computational neuropsychiatric studies, including EC dur-
ing working memory in subjects with schizophrenia, are reviewed.
In this, we focus on DCM studies investigating the numeric/verbal
“N-back” task in subjects with schizophrenia and healthy controls.
This is considered in the context of the dopamine and glutamate
hypotheses of schizophrenia. Both neurobiological hypotheses
have contributed to the formulation of research objectives in
computational neuropsychiatry (114) and the development of
computational modeling techniques of fMRI data in subjects with
schizophrenia (20).
Dynamic causal modeling for fMRI – examples of modeling
functional large-scale networks
Dynamic causal modeling for fMRI has been introduced as a
method to provide insight into the notion of “functional inte-
gration” during cognitive performance. “Functional integration”
has been advanced from the historic notion of “functional special-
ization” (115), which is defined by context-dependent interactions
among different brain regions (18, 116–118).
Dynamic causal modeling has been described as a biophysical
modeling of neuronal dynamic processes (18, 19)6, which can be
used as a method for the computation of synaptic plasticity from
fMRI task-based studies (20, 21). Together biophysical modeling
and Bayesian inference analysis form the framework for DCM (71,
117, 118). Thus, DCM is a modeling approach, which combines
defined network models (i.e., hypotheses) with Bayesian inver-
sion methods (19, 117). Specifically, DCM assesses inter-regional
EC through assessment of experimentally induced changes (18)
and therefore allows for mechanistic inferences from neuronal
function.
Bilinear DCM infers dynamics at the neuronal level by translat-
ing modeled neuronal responses into predicted BOLD measure-
ments (18). Non-linear DCM for fMRI (71, 119) is an advanced
approach for increasing the biological plausibility of DCMs by the
means of modeling “gain modulation” (i.e., non-linear modula-
tion of neuronal connections) (19, 117, 118). In non-linear DCM,
the modulation of connection strengths by experimental inputs is
supplemented by direct modulation of neural activity in one or
more network regions (18, 119). The computations for gating in
neural networks use the multiplicative computation of non-linear
modulation (120, 121). Accordingly, non-linear DCM can be used
for inferring that the strength of a connection is modulated by
activity of other neuronal populations (119, 122).
Findings of altered effective connectivity during working mem-
ory in subjects with schizophrenia. The first DCM studies in
healthy controls described large-scale networks in working mem-
ory and a similar task [continuous performance test; (123–125)].
A recent study in healthy controls built the linkage between EC
results and underlying dopaminergic modulation of large-scale
6We consider DCM as the generative model approach as introduced in the seminal
article by Friston et al. (18).
networks comprising of the DLPFC and PC during verbal memory
performance (126).
To date four DCM studies have examined the verbal/numeric
“N-back” task in subjects with schizophrenia using bilinear DCM
(127–130) (Table 3). These provide novel insights into reduced
task-dependent EC and increased task-independent EC measures
through modeling large-scale networks in schizophrenia.
In the first study, increased fronto-temporal intrinsic connec-
tivity was found to be associated with increased functional acti-
vation of the superior temporal gyrus (STG) during the numeric
“N-back” task in the subjects at the prodromal and at the acutely
psychotic stage of schizophrenia in contrast to the healthy controls.
This suggests a potential marker for vulnerability to the disorder
(127). Furthermore, progressively decreased intrinsic connectiv-
ity between the STG and the MFG in subjects at-risk mental state
(ARMS) and FES subjects in contrast to the healthy controls was
reported. This finding suggested that functional activation may
resemble increased task-independent EC between the PFC and
the STG. However, the results of the study are not comparable to
other DCM studies because (i) only one model was examined and
(ii) the biological plausibility of the EC measures is not clearly
accessible. No reference to the dopamine or glutamate hypotheses
was made.
The second study investigated the working memory-dependent
modulatory effect for the prefrontal–parietal connectivity in sub-
jects with EST and healthy subjects during the numeric “N-back”
task (128). The large-scale networks included the right DLPFC, the
PC, and the visual cortex with bidirectional connection between all
regions. The main finding was decreased task-dependent EC from
the DLPFC to the PC in the subjects with EST. Thus, this finding
could resemble evidence for the glutamate hypothesis of schizo-
phrenia, specifically the NMDA receptor hypofunction model and
the dysconnection hypothesis.
The third study examined possible vulnerability markers for
psychosis from the verbal “N-back” task in ARMS subjects, FES
subjects, and healthy subjects (129). This study examined reduced
task-dependent EC measures as well as relationships between con-
nectivity parameters and antipsychotic medication received by
subjects. In this study, EC in interhemispheric large-scale net-
works between the bilateral superior parietal lobes (SPL) and the
bilateral MFG was assessed. This study reported novel findings
of progressively decreased working memory and induced mod-
ulation of connectivity between the MFG and the SPL (from
healthy subjects to ARMS). Additionally, further decreased EC
of modulatory effects were observed in non-medicated subjects
with FEP contrasted to healthy controls. Evidence for ameliora-
tion of reduced EC between the MFG and the SPL in subjects with
FES, who received SGA medication, could reflect alterations of
dopaminergic regulation of NMDA receptor-dependent synaptic
plasticity of fronto-parietal connections. However, this interpre-
tation is limited by the lack of a control group of FES who are
treated with different types of antipsychotic medication. These
findings across different subpopulations of schizophrenia together
with the effect of antipsychotic medication may reflect support for
the NMDA receptor hypofunction model and the dysconnection
hypothesis.
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In the fourth study, Zhang et al. (130) explored EC measures
in terms of possible neurobiological markers in groups of subjects
with schizophrenia with high or low suicide risk and contrasted
these with healthy controls during the verbal “N-back” task. The
large-scale networks were defined by unidirectional and bidirec-
tional connections between the two regions of the medial PFC and
PC as well as working memory effects on these regions. This pilot
study presented novel findings in subjects with schizophrenia at
suicidal risk in terms of increased intrinsic connectivity from the
PC to the MFG in both groups with FES (in comparison to healthy
controls). This finding was interpreted as a possible association to
schizophrenia, in which increased intrinsic connectivity from the
MFG to the PC in the subjects with high risk of suicide could reflect
vulnerability of suicide. However, the results are not directly com-
parable to the other DCM studies because of the study population,
which focused on the issue of suicide. The findings were also not
interpreted in context of the dopamine or glutamate hypotheses.
We highlight main experimental and methodological limita-
tions in the four DCM studies, which impede the comparability
of findings (please see Table 3 for details). The main experimen-
tal limitation focuses on the discrepancies between the different
patient subpopulations. Two studies analyzed working memory
fMRI data of subjects with ARMS and FES in comparison to
healthy controls (127, 129), whereas one study modeled scans from
subjects with EST (128). Zhang et al. (130) reported findings of
a unique patient population of FES with high and low suicidal
risk. In terms of methodological issues, one limitation lies in dif-
ferent definitions of model spaces for the large-scale networks,
despite equivalence in the experimental tasks. Another limitation
is that the reviewed DCM studies employed deterministic DCM
for the comparison of the models. Deterministic models can pre-
dict processes perfectly if all inputs are known (131). However, at
this early stage of employing biophysical modeling approaches to
human brain function, we do not have a full understanding of the
brain responses to working memory. Future studies may employ
stochastic DCM as an extension (117, 118, 132). A further limita-
tion is that different DCM versions were applied across the four
studies, which impede the comparability of the findings. The pri-
ors are differently defined in the used DCM versions, which give
rise to a variation in model evidence between the studies (117).
Thus, it is possible that discrepancies in EC findings could be due
to the prior definition and may not be solely due to differences in
performance, brain function, or clinical aspects of subjects with
schizophrenia. Lastly, a general limitation of DCM for fMRI is
that maximally 10 regions within a large-scale network can be
modeled. This simplification results in difficulties of biophysical
modeling of tasks, which are likely to encompass more than ten
regions. Furthermore, not only the definition of different regions
and different numbers of regions but also different modulatory
inputs result in further extensions to the model space. Such model
spaces are difficult to validate and analyze.
The four DCM studies presented evidence for increased task-
dependent EC and increased task-independent EC findings during
verbal/numeric working memory in subjects with schizophrenia.
We discuss these EC findings in context of (i) the dopamine and
glutamate hypothesis and (ii) FC findings during verbal/numeric
working memory in subjects with schizophrenia.
The four studies modeled large-scale networks during the “N-
back” task in subjects with schizophrenia. However, only two out
of these four studies consider their DCM results in the light of bio-
physical processes (128, 129). The findings of reduced EC (namely,
the effect of task-modulation) of the prefrontal–parietal connec-
tion in subjects with schizophrenia in contrast to healthy controls
were interpreted biophysically and linked to the NMDA recep-
tor hypofunction model and the dysconnection hypothesis (128,
129). Both studies reported reduced EC findings of the prefrontal–
parietal connection during working memory, however, these find-
ings need to be considered carefully due to different experimental
designs (i.e., patient subpopulations, antipsychotic medication
treatment of FGA and SGA) and methodological implementation
(i.e., model space, DCM settings, and inference techniques).
Three of the DCM studies reported altered EC findings of
the prefrontal–parietal and parieto-prefrontal connections dur-
ing the “N-back” task in subjects with schizophrenia in contrast to
healthy controls. Deserno et al. (128) and Schmidt et al. (129) pre-
sented reduced EC (effect of task-modulation) of the prefrontal–
parietal connection in subjects with schizophrenia in contrast to
healthy controls, whereas Zhang et al. (130) found increased EC
(intrinsic connectivity) of the parietal–prefrontal connection. The
reduced task-dependent EC findings are in keeping with reduced
FC findings of these connections, although increased FC between
a different prefrontal subregion and the PC was reported (100).
The study by Crossley et al. (127) reported increased EC (intrin-
sic connectivity) of the prefrontal–temporal connection in subjects
at HR and FES (in contrast to healthy controls). Reduced FC
of the prefrontal–temporal connection during the “N-back” task
in subjects with schizophrenia has been previously reported in
PET studies (105, 106). However, the regions within the PFC and
temporal region differ between the studies.
Findings of altered effective connectivity during verbal fluency
in subjects with schizophrenia. Here, we discuss bilinear and
non-linear DCM studies, which have assessed large-scale networks
during verbal fluency [namely, the Hayling sentence completion
task (HSCT)] in subjects with schizophrenia and healthy controls
(Table 4). One bilinear DCM study in healthy controls investi-
gated the task-dependent modulation of response initiation and
response suppression in EC between left hemispheric temporal
and prefrontal regions (133). The main finding was a difference in
connection strength of the modulatory effect in response initiation
and response suppression.
Two clinical bilinear DCM studies have investigated EC mea-
sures during the HSCT in HR subjects and healthy controls: (i)
Subjects at high clinical risk of schizophrenia [ARMS; Ref. (134)]
and (ii) subjects at high familial risk of schizophrenia (135). Allen
et al. (134) investigated increased fronto-temporal EC (intrinsic
connectivity) as a potential measure of vulnerability of develop-
ing schizophrenia. Two main findings were reported: firstly, no
significant effect of task-dependent modulation on the fronto-
temporal connection between ARMS subjects and healthy controls
was revealed. Secondly, ARMS subjects displayed increased intrin-
sic connectivity between the ACC and the MTG in comparison
to healthy controls. Furthermore, the Bayesian model selection
(BMS) approach revealed that the same network was equally likely
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to explain the given HSCT fMRI data in both the ARMS subjects
and the healthy controls. No reference to the glutamate hypothesis
was made.
Dauvermann et al. (135) modeled EC measures in a similar
version of the HSCT that was used by Allen et al. (134). This
study was conducted in subjects at high familial risk of schizo-
phrenia and healthy subjects. The results reported by Allen et al.
(134) of a similar large-scale network in both HR subjects and
healthy controls was replicated7. This finding was also confirmed
by Dauvermann et al. (135), when the group of HR subjects was
subdivided into high risk subjects without transient psychotic
symptoms (referred to as HR−), high risk subjects with transient
psychotic symptoms (referred to as HR+) and high risk subjects
who subsequent to scanning developed schizophrenia [referred to
as HRill; please see Ref. (136, 137)]. Comparability between these
two studies is limited due to differences in the model space. The
model space in Dauvermann et al. (135) includes the IPS and the
mediodorsal thalamus, which are not incorporated in the model
space by Allen et al. (134). In addition, endogenous connections
and task-dependent modulations were accordingly changed [Ref.
(135); Table 4]. There was no reference to the glutamate hypothesis
of schizophrenia.
Limitations of bilinear DCM have been addressed through the
development of non-linear DCM for fMRI (119). This method
was applied in the genetic high risk study reported by Dau-
vermann et al. (135). The progress from the bilinear DCM to
the non-linear DCM as reported by Dauvermann is based on
the biophysical modeling of connection strength with non-linear
modulation during the HSCT response. The authors show that
relative to healthy controls there is reduced connection strength
with non-linear modulation of the thalamo-cortical connection
during the HSCT in HR+ subjects and a further reduction in
this connection strength in HRill subjects (135). The authors sug-
gest that reduced gain control may underlie the reduced strength
in the thalamo-cortical connection. Furthermore, the findings of
reduced connection strength with non-linear modulation of the
thalamo-cortical connection could reflect altered glutamatergic
neurotransmission, which may underlie a disruption of synaptic
plasticity in this thalamo-cortical connection [Ref. (135); Table 4].
Thus, the findings were interpreted in context of the NMDA
receptor hypofunction model and the dysconnection hypothesis.
Summary of studies modeling functional large-scale
networks – dynamic causal modeling for fMRI
Evidence from brain function in working memory in subjects with
schizophrenia at the level of functional large-scale networks (i.e.,
clinical and cognitive neurosciences) and neurobiological mech-
anisms in working memory in animal models of schizophrenia
(preclinical neurobiological research) in combination with com-
putational neuroscientific approaches has informed and enabled
research in computational neuropsychiatry.
Exemplary DCM studies in subjects with schizophrenia have
reported both increased and reduced EC findings during cogni-
tion in subjects with schizophrenia in contrast to healthy controls.
7It is noted, however, that the large-scale networks differed slightly from the previous
study.
These studies applied DCM as a biophysical modeling approach
to functional large-scale networks, which enabled the interpreta-
tion of EC findings on the basis of the glutamate hypothesis of
schizophrenia, namely the NMDA receptor hypofunction model
and the dysconnection hypothesis (128, 129, 135). We empha-
size that the findings support not only the glutamate hypoth-
esis but also the dopamine hypothesis. Dopamine is a neuro-
modulator that may crucially affect glutamate-induced synaptic
plasticity. Synaptic plasticity may be involved in a regulation
of dopamine synthesis and release via other neurotransmitter
systems. Specifically for non-linear effects, it has been shown
that dopamine acts as a neuromodulator mediating postsynaptic
gain (74, 138).
In a recent study, it has been reported that the combination
of the DCM analysis of numerical “N-back” task in EST (128)
and generative embedding resulted in the dissection of three
subgroups of EST based on the mechanistically inferred DCM
findings (139). This exemplary study showed that DCM can be
applied as a generative model of large-scale networks in indi-
viduals with schizophrenia. In summary, DCM is a promising
approach for modeling synaptic plasticity; nevertheless in its cur-
rent form it cannot reflect the full complexity in the processing
required for the implementation of tasks such as working memory
(Figure 3).
UNDERSTANDING OF SCHIZOPHRENIA IN DEVELOPMENT
Our understanding of schizophrenia is in continuous development
and with more preclinical and clinical findings being published this
understanding will advance further. A critical aspect of this under-
standing is the facilitation of multidisciplinary approach between
preclinical and clinical research in schizophrenia.
The original understanding of schizophrenia as a brain disorder
stems from observational clinical work, which led onto preclinical
FIGURE 3 | Understanding of schizophrenia as a cognitive brain
network disorder – verbal/numeric “N-back” task.
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investigation. Over time, the knowledge of alterations of cellular,
chemical, and molecular mechanisms has increased: (i) findings of
dopaminergic and glutamatergic modulation of working memory
(and clinical features) in animal models of schizophrenia con-
tributed to form the understanding of schizophrenia as a cognitive
brain disorder; (ii) findings of neurotransmitter circuit systems,
mainly dopaminergic and glutamatergic systems, were found to
modulate working memory in animal models of schizophrenia
in combination with computational studies (140), which plays a
role in shaping the understanding of schizophrenia as a cognitive
network disorder.
Understanding of schizophrenia has not only been shaped by
preclinical research but also by clinical research in subjects with
schizophrenia, which has been and continues to be illuminated by
preclinical neurobiological and computational work. The field of
clinical and cognitive neurosciences has contributed to forming
our understanding of schizophrenia as a cognitive brain dis-
order. Importantly, the multidisciplinary field of computational
neuropsychiatry (preclinical neurobiology, clinical and cognitive
neurosciences, and computational psychiatry) has allowed for
progress in our understanding of schizophrenia as a cognitive
brain network disorder.
SCHIZOPHRENIA AS COGNITIVE BRAIN NETWORK DISORDER
The use of computational neuropsychiatric research in developing
our understanding of schizophrenia as a cognitive brain network
disorder is at an early stage. Here, we focused on FC and EC studies
(DCM studies) during the verbal/numeric “N-back” task in sub-
jects with schizophrenia and healthy controls. We discuss these
FC and EC findings in context of two key research questions.
Consideration of these questions was seen as a means to inform
future schizophrenia research in the fields of clinical and cognitive
neurosciences and/or computational neuropsychiatry:
To what extent do these sets of findings support the dopamine
hypothesis and/or the glutamate hypothesis in subjects with
schizophrenia?
Studies reported both increased and reduced FC during the “N-
back” task in subjects with schizophrenia in contrast to healthy
controls. These findings have introduced the notion of human
large-scale networks underlying brain function during working
memory. The FC correlational analyses do not allow for the
inference of directions or weights of in functional connections.
Thus, from FC findings it is not practical to draw inferences on
neurobiological causal processing.
Studies, which applied DCM as a biophysical modeling
approach to functional large-scale networks, showed that reduced
EC findings could be interpreted in context of the NMDA receptor
hypofunction model and the dysconnection hypothesis.
In summary, FC findings cannot be interpreted in context
of the dopamine or glutamate hypothesis. For EC findings, the
computational neuropsychiatric approach of modeling large-
scale networks requires biophysically plausible networks, which
are hypothesis-driven from neurobiological and cognitive neu-
roscience in subjects with schizophrenia. EC findings have been
interpreted in the context of the glutamate hypothesis and the
dopamine hypothesis.
Do the findings from computational neuropsychiatry lead to a gain
in understanding of schizophrenia in comparison to the findings
from clinical and cognitive neurosciences?
Functional connectivity findings from cognitive and clinical neu-
roscience have contributed to the understanding of schizophrenia
as a cognitive brain disorder. The analysis of altered working
memory at the level of large-scale networks has advanced our
knowledge of cognitive function in humans. However, it is not
wholly understood what altered FC during cognition neurobio-
logically means in schizophrenia. EC findings from computational
neuropsychiatry, here specifically modeling functional large-scale
networks with DCM, have shown indications of linkage between
clinical network-based working memory (large-scale networks)
and preclinical neurotransmitter modulation of cognitive func-
tion. Altered synaptic plasticity during working memory can be
interpreted with dopaminergic and glutamatergic mechanisms.
We emphasize that the interpretation of altered neurotransmitter
circuits should be considered carefully because the DCM method is
likely to underestimate the processing complexity in neurobiolog-
ical circuits. Nonetheless, a strength of DCM lies in interpretation
of altered synaptic plasticity based on the inference of mechanistic
information.
The consideration of schizophrenia as a cognitive brain net-
work disorder from computational neuropsychiatry offers a holis-
tic view of schizophrenia. Computational neuropsychiatry seeks
to bridge the gap between neurobiology and cognitive and clinical
neurosciences in subjects with schizophrenia. It is hoped that this
research will enhance our understanding of schizophrenia, clinical
treatment, and improve outcome in people with schizophrenia.
FUTURE OUTLOOK AND OPEN QUESTIONS
The reviewed findings in biophysical modeling of functional large-
scale networks are promising. In order to reach the objective of
predicting and improving clinical treatment in subjects with schiz-
ophrenia, longitudinal study designs, and the combination of sub-
fields within computational neuropsychiatry should be pursued.
We consider computational neuropsychiatric research areas
for the combination of biophysical modeling of functional
large-scale networks and other computational (neuro)psychiatric





• Effects of antipsychotic medication
• Clinical outcome.
We suggest specific study designs, which may increase our
understanding for developing clinical treatment for subjects with
schizophrenia:
(i) Combination of biophysical modeling of functional large-
scale networks with computation, for example:
(a) Brain function and brain circuit model (12);
(b) Brain function and behavior (141);
(c) Brain function and effect of antipsychotic medication:
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(ii) Combination of biophysical modeling of functional large-
scale networks with multimodal neuroimaging study designs,
for example:
(a) FMRI and EEG/magnetoencephalography study designs;
(b) FMRI and transcranial magnetic stimulation study
designs (142);
(c) FMRI and MRS study designs;
(d) FMRI and PET study designs;
(iii) Combination of biophysical modeling of functional large-
scale networks and computational modeling for the investi-
gation of clinical (sub)groups, for example:
(a) Associative learning (143, 144);
(b) Machine learning approach (139, 145);
(c) Reinforcement learning (109).
Findings of modeling functional large-scale networks con-
tribute to shaping the understanding of schizophrenia as a cog-
nitive brain network disorder. The combination of computa-
tional neuropsychiatric areas may bring researchers closer to the
common long-term objectives of developing a diagnostic tool
for schizophrenia along with the development of more effective
treatments.
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APPENDIX
DYNAMIC CAUSAL MODELING
Dynamic causal modeling is general framework for model-
based assessment of competing theories about neuronal cir-
cuits (18, 146). In particular, DCM is a generic Bayesian system
identification technique, which allows for inference on “hid-
den” neurophysiological mechanisms that generated observed
measures, such as blood-oxygen-level-dependent signal in func-
tional magnetic resonance imaging (fMRI) or evoked responses
measured with electroencephalography (EEG). The principle
idea thereby is to formulate a simplified model of neuronal
population responses (z) and combine this with a modality-
specific forward model (λ) such that one can predict the mea-
surement (y) that would arise from any particular neuronal
circuit (18).
In DCM for fMRI, the dynamics of the neural states under-
lying regional BOLD response are modeled by a bilinear dif-
ferential equation that describes how the neural states (x)
change over time (t ) as a function of endogenous inter-regional
connections (matrix A), modulatory effects on these connec-
tions (matrix B), and direct (driving) inputs (matrix C) (Eq.
A1) (18, 122). The endogenous connections represent coupling
strengths in the absence of input uj to the system, whereas
the modulatory effects represent task-specific alterations in this
connectivity.










x + Cu (A1)
The bilinear state equation has subsequently been extended by
a non-linear term, where the modulation of connection strengths
by experimental inputs is supplemented by direct modulation
with neural activity in one or more regions (119). In other
words, non-linear DCMs allow addressing how the connection
between two neuronal units is gated by activity in other units.
This is of particular interest as gating processes represent a key
mechanism for many neurobiological processes and thus increas-
ing the biological realism of non-linear compared to bilinear
DCMs. To this end, compared with the bilinear state equation,
the new term in the non-linear equations are the D matrices
(Eq. A2), which encode how the n regions gate connections in
the system.











 x + Cu (A2)
BAYESIAN MODEL SELECTION AND BAYESIAN MODEL AVERAGING
Bayesian model selection is an essential procedure of DCM studies
as it can be used to test competing hypotheses (different DCMs)
about the neural mechanisms generating the data. BMS rests on
comparing the evidence of a predefined set of models (the model
space). The model evidence is the probability of observing the
empirical data, given a model, and represents a principled mea-
sure of model quality, derived from probability theory (147, 148).
Concretely, it represents the mean predicted data under random
sampling from the model’s priors or, alternatively, a principled
measure of the balance between model fit and model complexity. A
random-effects BMS approach has been suggested for group stud-
ies, which is capable of quantifying the degree of heterogeneity in a
population while being extremely robust to potential outliers (20,
67). The probability that one model is more likely than any other
model, given the group data, can be expressed by the exceedance
probability (ϕk) of each model:
∃k ∈ {1 . . . k},∀j ∈ {1 . . . k|j 6= k} :
ϕk = p(rk > rj |y ; a)
After inference on the most likely network architecture under-
lying a specific neural process, one can compare the parameter
estimates of the most likely model obtained from BMS (winning
model) for between-group inferences. However, statistical com-
parison of model parameter estimates across groups is only valid
if those estimates stem from the same model. Given that different
models may be found to be optimal across groups, Bayesian model
averaging (BMA) has been recommended as standard approach
for clinical DCM studies (146). BMA averages posterior para-
meter estimates over models, weighted by the posterior model
probabilities (148). Thus, models with a low posterior probabil-
ity contribute little to the estimation of the marginal posterior.
In brief, BMS and BMA are central components of DCM studies
to infer on neural mechanisms at the neural system level and on
specific model parameters across groups, respectively (146).
In non-linear DCM analysis, the connection strengths between
selected nodes are assessed for activity-dependent modulation of
the reciprocal neuronal projections by the introduction of gating
mechanisms. Non-linear DCM is applied to the models identified
as winning models from the application of bilinear state equation.
The bilinear model and the non-linear models differ only in the
introduction of gating mechanisms such as a parametric response
in the tested functional task. Such gating mechanisms are applied
to nodal connections, which are expected to explain the varia-
tion in subject response to the functional task. The appropriate
placement of the gating input is assessed through the application
of model space partitioning and family inference. The exceedance
probabilities of the models are compared and the non-linear mod-
els,which provide higher exceedance probabilities than the bilinear
models are identified as winning models.
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High genetic risk of schizophrenia
Nonlinear Dynamic Causal Modelling (DCM) for fMRI provides computational modelling of gating mechanisms
at the neuronal population level. It allows for estimations of connection strengths with nonlinear modulation
within task-dependent networks.
This paper presents an application of nonlinear DCM in subjects at high familial risk of schizophrenia
performing the Hayling Sentence Completion Task (HSCT). We analysed scans of 19 healthy controls and
46 subjects at high familial risk of schizophrenia, which included 26 high risk subjects without psychotic
symptoms and 20 subjects with psychotic symptoms. The activity-dependent network consists of the intra
parietal cortex (IPS), inferior frontal gyrus (IFG), middle temporal gyrus (MTG), anterior cingulate cortex
(ACC) and the mediodorsal (MD) thalamus. The connections between the MD thalamus and the IFG were
gated by the MD thalamus. We used DCM to investigate altered connection strength of these connections.
Bayesian Model Selection (BMS) at the group and family level was used to compare the optimal bilinear
and nonlinear models. Bayesian Model Averaging (BMA) was used to assess the connection strengths with
the gating from the MD thalamus and the IFG.
The nonlinear models provided the better explanation of the data. Furthermore, the BMA analysis showed
significantly lower connection strength of the thalamocortical connection with nonlinear modulation from
the MD thalamus in high risk subjects with psychotic symptoms and those who subsequently developed
schizophrenia.
These findings demonstrate that nonlinear DCM provides a method to investigate altered connectivity at the
level of neural circuits. The reduced connection strength with thalamic gating may be a neurobiomarker
implicated in the development of psychotic symptoms. This study suggests that nonlinear DCM could lead to
new insights into functional and effective dysconnection at the network level in subjects at high familial risk.
© 2013 Elsevier Inc. All rights reserved.
Introduction
Dynamic Causal Modelling is an established method for the compu-
tation of synaptic plasticity from fMRI data (Stephan et al., 2006, 2009a).
Bilinear DCM provides for the inference of causal mechanisms, which at
the regional neuronal level give estimations of how the rate of change of
neuronal activity in one region influences neuronal activity in other re-
gions (Friston, 2009; Friston et al., 2003; Stephan et al., 2008). Nonlinear
DCM is an extension of bilinear DCM, which assesses inhibitions of a
neuronal connection and provides a means to model nonlinearities
in fMRI data (Stephan et al., 2008). It is assumed that these nonlinear
effects originate from activity-dependent synaptic plasticity processes
(Abbott et al., 1997; Rothman et al., 2009; Salinas and Sejnowski,
2001; Shu et al., 2003). Furthermore, it has been suggested that altered
gain control (i.e. nonlinear modulation of neuronal connections) of
the thalamocortical connection could be the underlying factor for al-
tered synaptic plasticity and cortical dysconnectivity in schizophrenia
(Andreasen et al., 1997; Negyessy and Goldman-Rakic, 2005).
We know from neurophysiological studies that nonlinear mecha-
nisms are integral to short-term synaptic plasticity. Nonlinear modu-
lation has been shown to regulate synaptic plasticity modulated by
neurotransmitters (Berends et al., 2005; Neher and Sakaba, 2008;
Pan and Zucker, 2009; Sun and Beierlein, 2011). Also thalamocortical
NeuroImage 73 (2013) 16–29
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synapses underlie nonlinear dynamicmodulationwhich indicates gating
of these connections (Alelú-Paz and Giménez-Amaya, 2008; Chance
et al., 2002; Deng and Klyachko, 2011; Destexhe, 2009; Kolluri et al.,
2005; Negyessy and Goldman-Rakic, 2005). Thus, we have indications
that nonlinear DCM is a means of modelling nonlinear mechanisms of
short-term modulatory processes between neuronal groups.
The ‘Disconnection Hypothesis’ of schizophrenia proposes that al-
teredmodulation of synaptic efficacymay lead to a disruption of learning
processes, which underlie cognitive deficits in schizophrenia (Friston,
1999). FMRI studies analysing verbal fluency tasks using a variety of con-
nectivity techniques consistently report cortical dysconnection in the
established illness (Alelú-Paz and Giménez-Amaya, 2008; Boksman et
al., 2005; Curtis et al., 1998; Fu et al., 2002; Lawrie et al., 2002), which
support the ‘Disconnection Hypothesis’. Also, deficits in cortical con-
nectivity have been reported in the prodromal stage of the illness,
suggesting possible trait-related neurobiological markers of the disorder
(Fusar-Poli et al., 2011; Lencz et al., 2006; Simon et al., 2007). It has been
proposed that cortical dysfunction in verbal fluency tasks could bemedi-
ated by thalamic disruption (Fusar-Poli et al., 2011) and/or alterations of
the thalamocortical neuronal projection (Byne et al., 2009; Lewis and
Lieberman, 2000; Pakkenberg et al., 2009; Sodhi et al., 2011; Watis et
al., 2008). We are however unaware of any fMRI studies of effective con-
nectivity addressing thalamic dysconnectivity in unaffected individuals
at high familial risk.
Previous fMRI findings using the Hayling Sentence Completion Task
(HSCT), a test considered to be an extension of verbalfluency paradigms,
demonstrated significantly reduced activation of the mediodorsal (MD)
thalamus in the Edinburgh High Risk Study (EHRS) (Whalley et al.,
2004). In this study, subjects at high familial risk of schizophrenia are
compared to healthy controls (Johnstone et al., 2003). This finding of re-
duced activation in the high risk (HR) subjects was further supported by
reduced functional connectivity measures between the inferior frontal
gyrus (IFG) and the MD thalamus only in the HR group (Whalley et al.,
2005). A recent study of functional connectivity in the EHRS cohort
suggested that the reduced functional connectivity between the IFG
and the MD thalamus, which was associated with increased PFC folding,
was predictive of subsequent schizophrenia and may be a trait charac-
teristic of vulnerability of the illness (Dauvermann et al., 2012; Harris
et al., 2007).
We use nonlinear DCM to investigate the causal factors of reduced
thalamocortical connectivity for the HR subjects in the EHRS data. To en-
sure that we followed a structured approach, we developed a heuristic
search protocol for the application of nonlinear DCM. In this protocol
we test the fitness of both bilinear and nonlinear models and consider
how these models perform across the clinical groupings in the
EHRS study. We analyse the connection strengths with nonlinear
modulation of the thalamocortical connectivity in the healthy controls
subjects, the HR subjects who remained well and the HR subjects who
subsequently developed schizophrenia. We consider whether reduced
thalamocortical connection strength with nonlinear modulation may be
aneurobiomarker implicated in the development of psychotic symptoms.
Material and methods
Subjects
The EHRS examined young healthy adults at enhanced genetic risk
of schizophrenia over the period at which they were at greatest risk of
becoming ill. The subjects recruited for the EHRS were aged between
16 and 25 and had at least two first or second degree relatives with
schizophrenia (Hodges et al., 1999; Johnstone et al., 2000). The control
group had no family history of the illness or a serious mental disorder.
All subjects were well at time of scanning and were antipsychotic
naïve throughout the study. The study was approved by the Psychiatry
and Clinical Psychology subcommittee of the Lothian research ethics
committee.
Functional imaging of the HSCT was added to the EHRS study in 1999
and full details of the sample and the respective functional localisation re-
sults for the HSCT have been presented previously (Whalley et al., 2004).
On detailed interview (the Present State Examination, PSE; Wing et
al., 1974) at the time of the scans none of the subjects met diagnostic
criteria for any psychotic disorder. Twenty six high risk subjects reported
isolated transient or partial psychotic symptoms (all subclinical) at the
time of the functional scan (referred to as HR+), the other subjects of
the high risk group reported no psychotic symptoms (referred to as
HR−). HR+ and HR− are referred to as HRall. In addition to the PSE,
the PANSS interview was administered at the time of the functional
scan. The rescaled PANSS scoring system was used (Kay et al., 1987).
Four HR subjects subsequently developed schizophrenia (referred to as
four ill subjects) (Whalley et al., 2004).
Functional experimental details
Experimental details of the HSCT have been presented previously
(Whalley et al., 2004, 2005). Briefly, subjects were shown sentences
with the last word missing and were asked to think of an appropriate
word to complete the sentence (without speaking the word), and
press a button when they had done so. Our experimental design was a
block design alternating rest conditions with task conditions, where
the task conditions had four levels of difficulty, which characterised
the differences in activation over parametric manipulations of task dif-
ficulty in sentence completion blocks. Immediately after scanning, sub-
jectswere presentedwith the same sequence of sentences on paper and
requested to complete each sentence with the word they first thought
of in the scanner. ‘Word appropriateness’ scores were determined
from the word frequency list of sentence completion norms (Bloom
and Fischler, 1980).
Functional scanning procedure
Functional imaging was carried out at the Brain Imaging Research
Centre for Scotland (Edinburgh, Scotland, UK) on a GE 1.5 T Signa
scanner (GE Medical, Milwaukee, USA). Functional data was acquired
using an EPI sequence. The HSCT was acquired using the following pa-
rameters: axial orientation TR/TE=4000/40 ms; matrix 64×128;
FOV 22×44 cm2; 38 slices; 5 mm slice thickness; no gap. A total of
204 volumes were acquired. Visual stimuli were presented using a
screen (IFIS, MRI Devices, Waukesha, WI, USA) placed in the bore of
the magnet; corrective lenses were used where necessary.
FMRI data analysis
Data processing and statistical analyses for the current analysiswere
performed with the Statistical Parametric Mapping SPM8 software
package (Wellcome Trust Centre for Neuroimaging; http://www.fil.
ion.ucl.ac.uk/spm/). All functional volumes were spatially realigned,
unwarped, normalized to MNI space and spatially smoothed with an
isotropic 8 mm full-width at half-maximum Gaussian kernel to com-
pensate for residual variability in functional anatomy after spatial nor-
malization and to facilitate application of Gaussian random field
theory for adjusted statistical inference. The voxel size generated from
the above acquisition parameters was oversampled to 1×1×1 mm3.
We applied established SPM first and second-level analyses
employing the settings used in our previous analyses (Whalley et al.,
2004). From this second-level analysis we generated statistical para-
metric maps of the T statistic and F statistic at each voxel SPM {t} and
SPM {F}, which characterised differences in activation for the paramet-
ric modulation.
Subject and ROI selection
DCM has stringent requirements for the subject and region selec-
tion. In addition to the selection of the fMRI scans (Whalley et al.,
2004), the condition of activation in each ROI must be met.
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The second-level analysis in the initial sample of 21 healthy controls
and 69 HR subjects identified robust left-lateralized activations in the in-
ferior parietal sulcus (IPS), inferior frontal gyrus (IFG), middle temporal
gyrus (MTG), anterior cingulate cortex (ACC) and the MD thalamus as
previously reported (Whalley et al., 2004). ROIs located in all five regions
were selected for the DCM analyses. The selection of the IPS, IFG, MTG
and the ACC ROIs is consistent with other functional imaging studies
of the HSCT (studies in healthy controls: Allen et al., 2008; Collette et
al., 2001; Frith et al., 1991, 1995; Nathaniel-James and Frith, 2002;
Nathaniel-James et al., 1997; studies in HR subjects of schizophrenia
and healthy controls: Allen et al., 2010). Our previous reports demon-
strated deficits in functional connectivity between the MD thalamus
and the IFG in HR subjects when they were compared to healthy con-
trols (Dauvermann et al., 2012; Whalley et al., 2005). Thus we included
the MD thalamus in the network used for our DCM study. Also it has
been established that altered synaptic plasticity of the connection
from the MD thalamus to the PFC may underlie cortical dysfunction in
schizophrenia (Negyessy and Goldman-Rakic, 2005).
The ROIs for DCM were defined by extracting the eigenvectors
(i.e. time series) from each subject's individual activation map
thresholded at pb0.05 uncorrected at the closest maxima within a dis-
tance of 8 mm of the group peak voxel (for the IPS, IFG and MTG) and
within 6 mm of the group peak voxel respectively (for the ACC and
MD thalamus). This rationale ensured that the functional regions in-
cluded in the DCM models were consistent across subjects (Stephan
et al., 2007). In cases where the subject did not show activation in all
five ROIs that satisfied the criteria, data from these subjects were
excluded (2 healthy controls and 23 HR subjects). The final subject
selection included 19 healthy controls and 46 high risk subjects. This
selection included the four subjects who subsequently developed
schizophrenia. Demographic details are presented in Table 1.
Contrast images of parameter estimates encoding condition-specific
effects were created for each subject and entered separately into voxel-
wise one-sample t-tests, to implement a second-level random effects
analysis. We report regions that survive cluster-level correction for
multiple comparisons across the whole brain at pb0.05. The ROI loca-
tions detailed in Table 2 are given in accordance with the standard
Talairach and Tournoux atlas (Talairach and Tournoux, 1988).
DCM analyses
It has been assumed that the thalamocortical projections can be gated
by neuronal regions in the MD thalamus or the IFG in schizophrenia
(Andreasen et al., 1997; Negyessy and Goldman-Rakic, 2005). Thus, we
adopted an approach that would allow us to model nonlinear biological
responses expected for the HCST by the means of nonlinear DCMs.
Application of DCM to the EHRS data
In order to follow the established DCM methods for determining
whether bilinear or nonlinearmodellingwould be themost appropriate
andwould hold for the experimental groupings that had been previous-
ly employed in our analyses of the EHRS data, we developed a heuristic
search protocol to optimise the DCM architecture and evaluate group
differences. Specifically, there are three phases in this DCM protocol:
(i) In phase 1, bilinear DCM was used in order to test the structure
for the HSCT across all subjects; (ii) in phase 2, nonlinear DCM was
applied to model the nonlinear mechanisms and (iii) in phase 3,
connection strengths with nonlinear modulation within the winning
models were assessed. A flow diagram for our DCM protocol is given
in Fig. 1.
In order to ensure that the DCM based analyses were consistent
across the contrast groupings we ran the phased protocol on three
separate groupings of the EHRS data. In the first grouping, the DCM
analyses were applied to healthy controls (n=19) and HRall subjects
(n=46). In the second grouping, the DCM analyses were applied to
healthy controls (n=19), HR− (n=26) and HR+ (n=20). In the
third grouping, the DCM analyses were applied to healthy controls
(n=19), HR− (n=25), HR+ (n=17) and the four ill HR subjects
(n=4) who subsequently developed schizophrenia.
Overview of phased approach as laid out in Fig. 1.
1) In phase 1, bilinear DCM was used in order to select the structure for
the HSCT network across all subjects. This analysis containedmodula-
tions for the activity-dependent neuronal interactions between the
five regions. The analysis steps are depicted in the protocol (column
1; Fig. 1). The optimalmodel of this analysis was entered into phase 2.
2) In phase 2, nonlinear DCM was applied to model the connection
strengths with activity-dependent modulation of the reciprocal
neuronal projection between the MD thalamus and the IFG. In
order to ensure the modelling of the gating (i.e. nonlinear models),
two preconditions were met:
(i) The specification of the nonlinear models was based on the op-
timal bilinear model. Therefore, the bilinear model and the
nonlinear models differed only in the single parameter of
nonlinearity from each other.
(ii) The implementation of Model Space Partitioning and Family In-
ference was applied to compare between the bilinear and
nonlinearmodelswhich ensured the advantage of the nonlinear
models over the bilinear model.
Table 1
Demographic details.
Healthy controls HR− HR+ Four ill Test p-Value
Number 19 26 20 4 – –
Mean age (SD) 26.9 (3.5) 25.8 (3.2) 26.1 (3.1) 22.8 (4.50) F=.518a .598
Gender (M:F) 12:7 12:14 9:11 3:1 x2=2.56b .345
Mean NART IQ (SD) 99.94 (9.50) 96.74 (8.90) 98.58 (10.00) 97.95 (16.33) F=1.175 .211
Handedness (R:L) 16:3 23:3 18:2 4:0 x2=4.36c .099
PSE scored (0/1:2:3) 19:0:0 26:0:0 0:16:4 0:0:4 – –
HR−, high risk subjects without psychotic symptoms; HR+, high risk subjects with psychotic symptoms, four ill subjects, four HR subjects who became subsequently ill; NART,





d Simplified PSE scoring system, see text. No subject received a score of 4 at the baseline interview.
Table 2
Coordinates of the five ROIs.
Coordinates in Talairach space
IPS BA40 −42, −48, 48
IFG BA47 −50, 18, −4
MTG BA21 −50, −37, −5
ACC BA32 0, 22, 34
MD Thal −8, −13, 6
ACC, anterior cingulate cortex; IFG, inferior frontal gyrus; IPS, intra parietal sulcus; MD
Thal, mediodorsal thalamus; MTG, middle temporal gyrus.
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The analysis steps are depicted in the protocol (column 2,
Fig. 1). The winning models of this analysis entered the third
phase.
3) In phase 3, the connection strengthswith the gating of the nonlinear
models within the winning model family were assessed using the
posterior densities over connection strengths as assessed with
Bayesian Model Averaging (BMA). This step allowed inference of
the connection strengths with nonlinear modulation of the bidirec-
tional thalamocortical projection. The analysis steps are depicted
in the protocol (column 3, Fig. 1).
The theoretical implementations of bilinear DCM (Friston et al.,
2003), nonlinear DCM (Stephan et al., 2008) and Family Level Inference
(e.g. Model Space Partitioning, Bayesian Model Selection (BMS) at the
model family level and BMA; Penny et al., 2010) have been reported
previously. The application of bilinear DCM, Model Space Partitioning,
Family Inference and BMA has been shown to produce reliable results
(Seghier et al., 2011).
Theoretically, the inference computations (i.e. Inference onNonlinear
DCM, Inference Level on Family Level with BMS on the family level allow
to test an infinite number of models (Penny et al., 2010)). However,
we considered a limited but plausible model space that comprised of
eight bilinear models and four nonlinear variants of the winning bilinear
model.
Phase 1 — detailed description — bilinear DCM
Theoretical background. DCM is a tool for assessing inter-regional effec-
tive connectivity by its experimentally induced changes (Friston et al.,
2003). DCM allows one to infer neuronal function mechanistically by
the means of estimation of how the neural activity changes the neural
activity in another region. The ensuing responses are then entered into
a biophysical model of haemodynamic responses at each region or
voxel (Friston, 2009; Friston et al., 2003). Hidden neural dynamics are
described by coupled differential equations and linked to predicted
BOLD responses. The bilinear neuronal state equation (Eq. (1)) describes
the timing and the place of the onset of the inputs as well as the modu-
lation of the neuronal states and endogenous connectivity changes,
given m known inputs (Friston et al., 2003; Stephan et al., 2007):














Fig. 1. Protocol for the Application of Nonlinear DCM. This protocol is subdivided into three phases which allow the modelling of connection strength with nonlinear modulation.
The protocol was run for each grouping: (i) Healthy controls and all high risk subjects, (ii) healthy controls, high risk subjects without psychotic symptoms and high risk subjects
with psychotic symptoms, (iii) healthy controls, high risk subjects without psychotic symptoms, high risk subjects with psychotic symptoms and four ill subjects who subsequently
developed schizophrenia.
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The neuronal states, which represent the neuronal population
activity of the modelled brain regions, change accordingly to the
system's connectivity and experimentally controlled inputs. In this
equation, matrix A represents the endogenous strength with the con-
nections in the absence of experimental manipulations; matrix B
denotes the modulation of those connections by the experimental
manipulation (here, the measured changes in effective connectivity
induced by the four difficulty levels of the HSCT); matrix C reflects
driving inputs, which represent extrinsic parameters that change
the neuronal state of brain regions within the model (here, visual pre-
sentation of the sentences with the last word missing). The bilinear
effects were driven by box car stimulus functions encoding task diffi-
culty, whereas the driving inputs were driven by box car stimulus
functions encoding the main effect of task.
Model space of bilinear models.We derived our biophysical DCMs from
neurobiological and neurocellular studies. Evidence for the bidirec-
tional connections between the MD thalamus and IFG (matrix A)
was based on (Abitz et al., 2007; Kolluri et al., 2005; Lewis and
Lieberman, 2000; Onn and Wang, 2005), and for the bidirectional
connections between the MD thalamus and the ACC (matrix A) we
considered findings from (Lee et al., 2007; Lewis and Lieberman,
2000; Onn andWang, 2005;Welsh et al., 2010). For modelling the ex-
perimental manipulations, well established PET studies and fMRI in
healthy subjects performing the HSCT were used (Collette et al.,
2001; Frith et al., 1991, 1995; Nathaniel-James and Frith, 2002;
Nathaniel-James et al., 1997) as well as functional connectivity results
in HR subjects of schizophrenia (Whalley et al., 2005). Specifically,
two previous DCM studies on the task in healthy subjects (Allen
et al., 2008) and HR subjects of schizophrenia (Allen et al., 2010)
enabled the modelling of the matrices B and C.
For each subject, eight bilinear DCMs were modelled. Firstly, the
models differed in their unidirectional and bidirectional connections
between the five regions (matrix A). Specifically, the eight models
are subdivided into two groups: (i) Endogenous connection from
the IPS to the IFG (Models 1–4; Figs. 2(a–d)) and (ii) endogenous
connection from the IPS to the MTG (Models 5–8; Figs. 2(e–h)).
This subdivision was based on findings, which suggest that either
neuronal connections between the IPS and the IFG or between the
IPS and the MTG can underlie the processing of verbal fluency
(Allen et al., 2008, 2010). Secondly, the models are specified in
terms of the bilinear effect of the parametric (difficulty) of the task.
Thirdly, the processing of visual stimuli was modelled by the driving
input that corresponded to the main effect of task (relative to rest).
Random-effects Bayesian Model Selection. The aim of this step within
phase 1 was to identify the most likely model to explain the fMRI data
using the random-effects BMS process as implemented in SPM8. We
estimated the model evidence with the negative free energy (Stephan
et al., 2009b). This measure takes into account not only the relative fit
of competing models but also their relative complexity (cf. number of
free parameters) (Stephan et al., 2009b). After the estimation of the
model evidence, we computed the model evidence at the group level
(Penny et al., 2004) by applying a hierarchical Bayesian approach
(Stephan et al., 2009b) in order to correct for outliers. The application
of the posterior exceedance probability estimates the criterion for the
conditional likelihood of the model given the data at random (Stephan
et al., 2009b). In Eq. (2), the exceedance probability (φk) is the likelihood
that model k is more likely than any other model (of the K models
tested), given the group data.
∃k∈ 1…kf g;∀j∈ 1…kf jj≠kg :
φk ¼ p rk > rj
 y; aÞ
φk ¼ exceedance probabilities sum to one over all models testedð Þ
ð2Þ
Phase 2 — detailed description — nonlinear DCM
Theoretical background. The advantage of bilinear DCM lies in the
possibility of inferring the dynamics of biophysical processes at the
neuronal level that translates neuronal activity of regions into pre-
dicted BOLD measurements (Stephan et al., 2008).
Nonlinear DCM represents a straightforward extension of bilinear
DCM, where the modulation of connection strengths by experimental
inputs is supplemented by direct modulation with neural activity in
one or more regions (Friston et al., 2003; Stephan et al., 2008). This
corresponds to an activity-dependent modulation of synaptic efficacy,
which models the short-term plasticity we are interested in.
The well-established computations for gating in neural networks is
the multiplicative computation of nonlinear modulation (Salinas and
Sejnowski, 2001; Volman et al., 2010). In order to infer gating within
the assumed network, we used nonlinear DCM as implemented in
DCM8 in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/spm8) software
(Stephan et al., 2008). Nonlinear DCM (Stephan et al., 2007, 2008) can
be used to examine whether the connection strength of a connection is
modulated by activity of other neuronal populations. To model nonlinear
interactions within the network, the bilinear state equation (Eq. (1)) ex-
tends the Taylor series to set matrix D to be second order in the neuronal
states (Stephan et al., 2008; Eq. (3)).











D jð Þ ¼ ⊖j12 ∂2f∂x2j ju ¼ 0 1≤j≤nð Þ :





















The matrices A, B and C were modelled as described in bilinear
DCM (see section on Model space of bilinear models). Matrix D re-
sembles the gating of a connection between two regions by the activ-
ity of a third region. Therefore, nonlinear DCM enables to infer
whether the strength of a connection (here, the connections of inter-
est are the connection from the IFG to the MD thalamus and the con-
nection from the MD thalamus to the IFG) depends on the activity of
other neuronal populations (here, the focus of the study was on the
MD thalamus and the IFG; Alelú-Paz and Giménez-Amaya, 2008;
Kolluri et al., 2005). Thus, the nonlinear modulation of the network
interactions can be allocated to an explicit neuronal population
(Stephan et al., 2007, 2008).
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Model Space of Nonlinear Models. The bilinear modelling in phase 1
specified the constraints on the A, B and C matrices. Thus, the optimal
Model 7 from the bilinear DCM analyses serves as the “basic” struc-
ture of the nonlinear models. In phase 2, our primary aim was to
model the connectivity with the nonlinear modulation of the recipro-
cal neuronal projection between the MD thalamus and the IFG.
The nonlinear DCMs were specified on the basis of neurobiological
evidence for nonlinear mechanisms in neuronal functions, includ-
ing cognitive tasks for evidence on altered corticothalamic and
thalamocortical connections (Alelú-Paz and Giménez-Amaya, 2008;
Kolluri et al., 2005) in schizophrenia. Fig. 3 shows the four different
nonlinear models that were used to identify the gating of the bidirec-
tional endogenous connection between the IFG and the MD thalamus.
Two nonlinear models were specified by the nonlinear modulation
from the MD thalamus onto both endogenous connections between
the IFG and the MD thalamus (i.e. nonlinear models — MD thalamus;
Figs. 3a and b).
Two further models were specified by the nonlinear modulation
from the IFG onto both endogenous connections between the IFG
and the MD thalamus (i.e. nonlinear models — IFG; Figs. 3c and d).
Model Space Partitioning — Family Level Inference — Bayesian Model
Averaging. The well-established Bayesian inference approach of Fam-
ily Level Inference and BMA (Penny et al., 2010) was applied. Family
Level Inference allows the comparison of models of different charac-
teristics (i.e. bilinear and nonlinear models) at the family level. Family
Level Inference removes uncertainty about aspects of model charac-
teristics by focusing on the criterion of interest (Penny et al., 2010).
To this end, the models differed from each other in the nonlinear
aspect.
Here, the model space was partitioned into three model families:
i) Model Family 1: bilinear model
Model Family 1 contained the optimal bilinear model (Fig. 2(g)).
ii) Model Family 2: nonlinear models — MD thalamus
Model Family 2 contained the two nonlinear models with
nonlinearmodulation from theMD thalamus (see Figs. 3a and b).
iii) Model Family 3: nonlinear models — IFG
Model Family 3 contained the two nonlinear models with
nonlinear modulation from the IFG (see Figs. 3c and d).
Family Level Inference provides an approach for random-effects
analyses (Penny et al., 2010) for this schizophrenia study. This infer-
ence is hypothesised in this study since it is very likely that different
subject groups use different coping strategies to solve the HSCT.
Additionally, this inference method deals with model families that
contain different number of models (Penny et al., 2010). Random-
effect BMS at the family level uses a Gibbs sampling method (with
1,000,000 samples) and a Dirichlet distribution to compute the
family frequencies of each model family in the population and de-
fining a prior over these likelihoods and the exceedance probabili-
ties. In Eq. (4), the exceedance probability (φk) is the likelihood
that a model family k is more likely than any other model family
(of K families compared), given the fMRI data (Penny et al., 2010).
It has been previously shown that this approach is reliable (Seghier
et al., 2011).
Phase 3 — detailed description — Bayesian Model Averaging
Theoretical background. We applied BMA over the winning models
resulting from the BMS at the family level. BMA assesses the full poste-
rior density on parameters by weighting the evidence to the contribu-
tion of each model to the mean effect (Penny et al., 2010). Posterior
density means that models with the highest evidence maximize their
contribution to the evidence, while models with weak evidence mini-
mize their contribution to the evidence. These results can be computed
for posterior means of connectivity on single subject level.
The significance of connection strength with the nonlinear modu-
lation for the four nonlinear models was computed by the fraction
of samples in the posterior density different from zero. Significant
effects are reported at a posterior probability level of 0.95. This ap-
proach has been shown to produce reliable results (Seghier et al.,
2011). In short, we used BMA to assess the posterior density over
the bidirectional connections between the MD thalamus and the IFG
by pooling evidence from different groups of subjects, in a way that
accounts for uncertainty about the particular model generating the
data.
Correlation between the connection strengthwith the nonlinearmodulation
and the PANSS symptoms severity delusions and hallucinations
Finally, the individual posterior densities of the connection strengths
with the nonlinearmodulation entered the following statistical analyses
for within-group correlations between the connection strengths with
the nonlinear modulation and the clinical symptoms assessed using
PANSS scores. In order to estimate the sampling error of the original sub-
populations, bivariate Pearson correlation with Bootstrapping and Con-
fidence Intervals of 95% were constructed (Cohen, 1988; Efron and
Tibshirani, 1993). These analyses were run in the healthy controls,
HRall andHR+but not in the four ill subjects because of the small num-
ber of this group. The statistical analyses were conducted in SPSS (SPSS
BMI 19.0).
Results
Demographic and behavioural results
Demographic and behavioural performancemeasures have been pre-
viously presented (Whalley et al., 2004, 2005). Briefly, therewere no sig-
nificant differences in mean age, gender, mean intelligence quotient
(NART IQ) or handedness between the groups. Subjects performed the
task appropriately during scanning. Behavioural performance between
the groups was not significantly different.
DCM analyses
Results summary
The results are summarised for the grouped analyses by following
the protocol given in Fig. 1 and the phased approach detailed in the
methods section. In the first phase, the optimal model for the HSCT
identified the general structure of the network. In the second phase,
this structure was further interrogated to reveal the model families
that best explain the expected group separation in our cohort. In the
Fig. 2. Model space of bilinear models. Models 1 to 4 are characterised by the endogenous connections from IPS to IFG. a. Model 1 is specified by driving inputs into the IFG and the
MD Thal and modulatory input onto the connection from the MTG to the IFG. b. Model 2 is specified by driving input into the IFG and modulatory inputs onto the connection from
the MTG to the IFG and from the MD Thal to the ACC. c. Model 3 is specified by driving input into the IFG and modulatory inputs onto the connection from the MTG to the IFG and
from the MD Thal to the IFG. d. Model 4 is specified by driving input into the IFG and modulatory inputs onto the connection from the MTG to the IFG and from the IFG to the MD
Thal. Models 5 to 8 are denoted by the endogenous connection from IFG to MTG. e. Model 5 is specified by driving inputs into the IFG and the MD Thal and modulatory input onto
the connection from the MTG to the IFG. f. Model 6 is specified by driving input into the IFG and modulatory inputs onto the connection from the MTG to the IFG and from the MD
Thal to the ACC. g. Model 7 is specified by driving input into the IFG and modulatory inputs onto the connection from the MTG to the IFG and from the MD Thal to the IFG. h. Model 8
is specified by driving input into the IFG and modulatory inputs onto the connection from the MTG to the IFG and from the IFG to the MD Thal. ACC, anterior cingulate cortex; IFG,
inferior frontal gyrus; IPS, inferior parietal sulcus; MTG, middle temporal gyrus; MD Thal, mediodorsal thalamus. Black arrows denote endogenous connections. Blue arrows denote
modulatory inputs. Red arrows denote driving inputs.
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third phase, the nonlinear modulation was assessed within the
two winning model families resulting from the analyses in phase 2.
The findings of each phase are compared between the three groupings.
Phase 1 — bilinear DCM — optimal model
In Fig. 4, the exceedance probabilities of the eight bilinear models la-
belled M1 to M8 across the three subject groupings are presented. In
Fig. 4a, the BMS results are shown for the first grouping of healthy con-
trols and all HR. In Fig. 4b, the BMS results are shown for the second
grouping of healthy controls, HR− and HR+. In Fig. 4c, the BMS results
are shown for the third grouping of healthy controls, HR−, HR+ and
the four ill subjects who subsequently developed schizophrenia. This
random-effects BMS analyses showed that Model 7 (M7) outperformed
all other models for the tested groupings. Model 7 demonstrated ex-
ceedance probability (Xp) of 0.63 in healthy controls and Xp=0.52 in
HRall (Fig. 4a); Xp=0.59 in HR− and Xp=0.63 in HR+(Fig. 4b);
and Xp=0.63 in the four ill subjects (Fig. 4c). The likelihood of Model
7 is three times the probability of the closest likelyModel 6 andModel 8.
Model 7 is illustrated in Fig. 2(g). It contains one unidirectional
connection from the IPS to the MTG and reciprocal endogenous con-
nections between all the other regions. The BMS results from Model
5 to Model 8 demonstrate that the unidirectional connection from
the IPS to the MTG is more likely than the connection from the IPS
to the IFG. Furthermore, the exceedance probabilities from Model 3
and particularly Model 7 show that the task-dependent modulation
was optimal for the forward connection between the MTG and the
IFG and the forward connection between the MD thalamus and the
IFG. Model 7 is similarly structured to the optimal model found in
the HSCT study reported by Allen et al. (2010) although this study
did not include the (MD) thalamus.
We note that the exceedance probability in the implementation of
Model 7 is consistent across the tested groups. The exceedance prob-
abilities for Model 7 vary from a minimum of 0.58 to a maximum of
0.63 across all subjects and three groupings. We also note similar con-
sistency in exceedance probabilities for the other tested bilinear
models. This consistency in BMS exceedance probabilities in healthy
controls and HR subjects was also reported by Allen et al. (2010).
Phase 2 — nonlinear DCM — winning model families
The results of this phase are presented for the repeated grouping
analyses. Three model families were compared against each other.
The partitioning of the model space was the same for each grouping
(see section on Model Space Partitioning – Family Level Inference –
Bayesian Model Averaging).
Fig. 3. Model space of nonlinear models. Model_MDThal_MDThal_IFG and Model_MDThal_IFG_MDThal are characterised by the nonlinear modulation from the MD Thal onto the
bidirectional connection between the MD Thal and the IFG. Both models are specified upon the winning bilinear model and form Model Family 2. a. Model_MDThal_MDThal_IFG is
specified by the nonlinear modulation from the MD Thal onto the connection from the MD Thal to the IFG. b. Model_MDThal_IFG_MDThal is specified by the nonlinear modulation
from the MD Thal onto the connection from the IFG to the MD Thal. Model_IFG_MDThal_IFG and Model_IFG_IFG_MDThal are characterised by the nonlinear modulation from
the IFG onto the bidirectional connection between the MD Thal and the IFG. Both models are specified upon the winning bilinear model and form Model Family 3.
c. Model_IFG_MDThal_IFG is specified by the nonlinear modulation from the IFG onto the connection from the MD Thal to the IFG. d. Model_IFG_IFG_MDThal is specified by the
nonlinear modulation from the IFG onto the connection from the IFG to the MD Thal. ACC, anterior cingulate cortex; IFG, inferior frontal gyrus; IPS, inferior parietal sulcus; MTG,
middle temporal gyrus; MD Thal, mediodorsal thalamus. Black arrows denote endogenous connections. Blue arrows denote modulatory inputs. Red arrows denote driving inputs.
Green arrows denote nonlinear modulations. All nonlinear models are specified on the basis of Model 7 (Fig. 2g).
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We compared the differentmodel families using the random-effects
BMS approach at the family level to reveal the optimal model family
across the three groupings in healthy controls and the high risk subjects.
The BMS analysis over the model families resulted in different exceed-
ance probabilities (Xp) between the healthy controls and the HR sub-
jects (Fig. 5). The main findings of this phase are structured following
the structure of Figs. 5a, b and c, which summarises and compares the
three groupings. The exceedance probabilities for the two winning
Model Families 2 and 3 were summarised (for a similar approach see
Penny et al., 2010; Seghier et al., 2011).
i) The two winning model families 2 and 3 outperform the model
family 1 in every group. In other words, both model families 2
and 3 are more likely than model family 1 to explain the HSCT
fMRI data.
ii) Model families 2 and 3 accounted for a total of Xp=0.95 in
healthy controls and Xp=0.99 in HRall in the first run
(Fig. 5a).
iii) Model families 2 and 3 accounted for a total of Xp=0.95 in
healthy controls, Xp=0.99 in HR− and Xp=0.99 in HR+ in
the second run (Fig. 5b).
Fig. 4. Bayesian Model Selection at the group level for bilinear models. a. Bayesian Model
Selection at the group level for healthy controls and all high risk subjects. First grouping of
the BMS analysis for healthy controls and HRall. Model 7 is the optimal model in both
healthy controls and HRall. b. BayesianModel Selection at the group level for healthy con-
trols, high risk subjects without psychotic symptoms and high risk subjectswith psychotic
symptoms. Second grouping of the BMS analysis for healthy controls, HR− and HR+.
Model 7 is the optimal model in healthy controls, HR− and HR+. c. Bayesian Model Se-
lection at the group level for healthy controls, high risk subjects without psychotic symp-
toms, high risk subjects with psychotic symptoms and the four ill subjects. Third grouping
of BMS analysis for healthy controls, HR−, HR+ and four ill subjects. Model 7 is the opti-
mal model in healthy controls, HR−, HR+ and the four ill subjects. BMS, Bayesian Model
Selection; HC, healthy controls; HRall, all HR subjects; HR−, high risk subjects without
psychotic symptoms; HR+, high risk subjects with psychotic symptoms; Four ill subjects,
four HR subjects who subsequently became ill; eight bilinear models (Fig. 2) are labelled
M1 to M8; M7, Model 7 (Fig. 2g); Xp, exceedance probability.
Fig. 5. Bayesian Model Selection at the model family level. a. Bayesian Model Selection
at the model family level for healthy controls and all high risk subjects. First grouping
of the BMS analysis for healthy controls and HRall. The winning model families are
Model Families 2 and 3 in both healthy controls and HRall. b. Bayesian Model Selection
at the level for healthy controls, high risk subjects without psychotic symptoms and
high risk subjects with psychotic symptoms. Second grouping of the BMS analysis for
healthy controls, HR− and HR+. The winning model families are Model Families 2
and 3 in healthy controls, HR− and HR+. c. Bayesian Model Selection at the level
for healthy controls, high risk subjects without psychotic symptoms, high risk subjects
with psychotic symptoms and the four ill subjects. Third grouping of the BMS analysis
for healthy controls, HR−, HR+ and four ill subjects. The winning model families are
Model Families 2 and 3 healthy controls, HR−, HR+ and the four ill subjects. BMS,
Bayesian Model Selection; HC, healthy controls; HRall, all HR subjects; HR−, high
risk subjects without psychotic symptoms; HR+, high risk subjects with psychotic
symptoms; Four ill subjects, four HR subjects who subsequently became ill; Xp, ex-
ceedance probability. Red column: Model Family 1 — bilinear Model 7; Blue Column:
Model Family 2 — Nonlinear Models with nonlinear modulation from MD Thalamus:
Green Column: Model Family 3 — Nonlinear Models with nonlinear modulations
from IFG.
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iv) Model families 2 and 3 accounted for a total of Xp=0.95 in
healthy controls, Xp=0.95 in HR−, Xp=0.99 in HR+ and
Xp=0.86 in the four ill subjects in the third run (Fig. 5c).
In both model families 2 and 3, the nonlinear modulations onto
both reciprocal connections between the MD thalamus and the IFG
reveal the optimal modelling.
The results of the three groupings demonstrated that the distribu-
tion of likelihoods of the model families 2 and 3 differentiated between
the groupings of HR subjects. In the first grouping, the HRall showed a
different distribution of exceedance probabilities to healthy controls.
In the second run, the finding revealed that the distribution of the
HR+ seemed to resemble the distribution of the HRall. In the third
run, the additional subgroup of four ill subjects demonstrated that the
pattern of the HR+ was repeated in the four ill subjects.
Phase 3— significant connection strength with the nonlinear modulation
The results of this phase are presented for the repeated grouping
analyses. In order to investigate the posterior probabilities of the con-
nectivity with the nonlinear modulation, we assessed the connection
strengths from model family 2, nonlinear models — MD thalamus in
every grouping. The BMA analysis within the two winning models
resulted in different posterior probabilities of the nonlinearmodulation
in theModel MDThal_MDThal_IFG (Fig. 3a; Fig. 6). Themain findings of
this phase are structured following the structure of Figs. 6a, b and c,
which summarises and compares the three groupings.
i) The connection strength with the nonlinear modulation was
reduced in HRall, HR+ and the four ill subjects across the
three groups; this parameter was significantly lower in the
HR+ and the four ill subjects who subsequently developed
schizophrenia in contrast to the healthy controls (posterior
probability 0.95).
ii) The connection strength with nonlinear modulation was not
significantly different between the healthy controls and the
HRall (Fig. 6a).
iii) The connection strength with nonlinear modulation was sig-
nificantly reduced in the HR+ in contrast to healthy controls
(posterior probability 0.95; Fig. 6b).
iv) The connection strength with nonlinear modulation was sig-
nificantly reduced in the HR+ in contrast to healthy controls
(posterior probability 0.95; Fig. 6c). Furthermore, this parame-
ter was significantly lower in the four ill subjects in compari-
son to healthy controls (posterior probability 0.95; Fig. 6c).
The connection strengths with the nonlinear modulation from the
other nonlinear model (model family 2, Model MDThal_IFG_MDThal)
were not significantly different between the groups.
Correlation between the connection strengthwith the nonlinearmodulation
and the PANSS symptoms severity for delusions and hallucinations
The result of the significant connection strength with the nonlinear
modulation for the Model MDThal_MDThal_IFG demonstrated reduced
connection strengths with the nonlinear modulation in HR+ and the
four ill subjects but not in HRall. In the next step we examined whether
the finding of effective dysconnectivity could underlie the clinical
symptoms in the HR+. A significant correlation was found between
the individual connection strength with the nonlinear modulation of
Model_MDThal_MDThal_IFG and the symptom ‘delusion’ in HR+
(r=− .246; p=0.041; 95% CI (−0.543;−0.024)). The significant asso-
ciation in HR+ supported the more pronounced reduction of this con-
nection strength with nonlinear modulation in the four ill subjects
(Fig. 6c), who showed delusions at the time of transition to the illness.
Furthermore, the correlation in HR+ in addition to the significant
relationship in HRall (r=− .201; p=0.05; 95% CI (−0.446; 0.02))
confirms the BMS results on the model family level (Figs. 5a in HRall
and b in HR+). The distribution of the likelihood of the model families
2 and 3 between HRall, HR− and HR+ (Figs. 5a and b) can therefore
be explained by the lower connection strength with the nonlinear
modulation (in the Model MDThal_MDThal_IFG) as a state-marker
in the HRall and HR+ groups. There was no significant association
between the symptom ‘hallucination’ and the connection strength
with the gating.
Fig. 6. Bayesian Model Averaging Results for the Thalamocortical Connection with
nonlinear modulation from the MD thalamus — Model_MDThal_MDThal_IFG. a. Aver-
age of posterior densities of connection strength with nonlinear modulation for
healthy controls and all high risk subjects. First grouping of the BMA analysis for
healthy controls and HRall. The connection strength with the nonlinear modulation
was not significantly different. b. Average of posterior densities of connection strength
with nonlinear modulation for healthy controls and high risk subjects with psychotic
symptoms. Second grouping of the BMA analysis for healthy controls and HR+. The
connection strength with the nonlinear modulation was significantly reduced in
HR+ in contrast to healthy controls. c. Average of posterior densities of connection
strength with nonlinear modulation for healthy controls, high risk subjects with
psychotic symptoms and the four ill subjects. Third grouping of the BMA analysis for
healthy controls, HR+ and four ill subjects. The connection strength with the
nonlinear modulation was significantly reduced in HR+ in contrast to healthy controls
and the four ill subjects in contrast to the healthy controls. Average of posterior densi-
ties of connection strength with nonlinear modulation (in Hertz), (all significant at
posterior probability threshold p>0.95). BMA, Bayesian Model Averaging; HC, healthy
controls; HRall, all high risk subjects; HR+, high risk subjects with psychotic symp-
toms; four ill subjects, 4 subjects who subsequently became ill.
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Discussion
We have reported the application of nonlinear DCM to fMRI data
for the HSCT in subjects at high genetic risk of schizophrenia. For
the HSCT, nonlinear DCM allowed us to effectively model connection
strength with the nonlinear modulation and the interactions between
neuronal populations in the MD thalamus and the IFG. Our results
demonstrate that the connection strength with nonlinear modulation
of the thalamocortical connection is reduced in HR+. This could re-
sult in reduced prefrontal-thalamic functional connectivity and corti-
cal dysconnectivity and both is in keeping with and extends our
previous findings of functional connectivity on this cohort (Whalley
et al., 2005). In addition, we see further reductions of connection
strength with the nonlinear modulation in the four ill subjects in
our HR cohort although this should be considered preliminary given
the small subject number in this group. Furthermore, we found signif-
icantly negative correlations between lower connection strength with
nonlinear modulation and the PANSS symptom severity of delusion in
HR+ and the HRall. This indicates that the presence of active symp-
tomatology in HR+ (and to a lesser extent in the HRall) may be a
factor for the state-related differences between HR− and HR+. All
subjects disavowed the presence of psychotic symptoms at more
than a subclinical level at the time of scanning and indeed regarded
themselves as well. None were on antipsychotic medication. Thus
our findings are not confounded by the effect of medication.
The altered connection strengthwith the gating of the thalamocortical
neuronal projection may represent the neurobiophysiological cause for
cortical functional and effective dysconnectivity found in the HR stage
and the established illness of schizophrenia. Alterations of the MD thala-
mus have been associated with the pathology of schizophrenia (Clinton
and Meador-Woodruff, 2004; Meador-Woodruff et al., 2003; Oh et al.,
2009) because of its cortio-thalamo-cortico network (Briggs and Usray,
2008; Kantrowitz and Javitt, 2012; Oh et al., 2009). Further evidence for
such alterations is seen in fMRI studies, which report cortical dysfunction
and cognitive deficits in schizophrenia for verbal fluency tasks (Curtis
et al., 1998; Fu et al., 2002; Fusar-Poli et al., 2011). Other studies have
also demonstrated that the disrupted connection between the left MD
thalamus and the dorsolateral prefrontal cortex plays a crucial role in
schizophrenia (Hazlett et al., 2004; Krystal et al., 2003; Mitelman et al.,
2005; Thermenos et al., 2004), which could result in cognitive deficits
(Clinton and Meador-Woodruff, 2004; Jones, 1997; Meador-Woodruff
et al., 2003). These alterations of the thalamocortical connectionmay con-
tribute to cortical dysfunction observed in schizophrenia (Balu and Coyle,
2012; Byne et al., 2009; Lewis and Lieberman, 2000; Pakkenberg et al.,
2009; Sodhi et al., 2011; Watis et al., 2008).
Our results of lower connection strength with the nonlinear modula-
tion are in keeping with those studies proposing that nonlinear models
can resemble reduced gating and provide a better explanation to the
fMRI data than linearmodels. Thefinding of reduced connection strength
with the thalamocortical projection via the MD thalamus in the HR+
and the four ill subjects supports the hypothesis of disrupted synaptic
plasticity, which is gated by nonlinear biophysical processes. Short-
term synaptic modulation encompasses biophysical processes which
are known to be highly relevant for cognitive tasks (Abbott and
Regehr, 2004; Deng and Klyachko, 2011; Neher and Sakaba, 2008; Pan
and Zucker, 2009). It has been reported that probabilistic computational
modelling of short-term depression processes resembles gating mecha-
nisms at the synaptic level (Pfister et al., 2010). The thalamocortical syn-
apses underlie nonlinear dynamicmodulation (Chance et al., 2002; Deng
and Klyachko, 2011; Destexhe, 2009; Negyessy and Goldman-Rakic,
2005), which has also been shown for the corticothalamic connection
(Freyer et al., 2011; Shu et al., 2003). Gating processes show comparable
nonlinearmechanisms (Abbott et al., 1997; Ardid et al., 2007; Berends et
al., 2005; Chance et al., 2002; Freyer et al., 2011; Murphy and Miller,
2003; Rothman et al., 2009; Salinas and Sejnowski, 2001; Shu et al.,
2003), which gate cognitive functions (Salinas and Sejnowski, 2001;
Stephan et al., 2008) in a multiplicative nonlinear way. That means that
neurons from two or more sources integrate information for cognitive
performance (Salinas and Sejnowski, 2001; Stephan et al., 2008). Our
results support previous findings of disrupted synaptic plasticity of
the thalamocortical connection (Krystal et al., 2003; Negyessy and
Goldman-Rakic, 2005) resulting in cortical dysconnectivity in schizo-
phrenia (Balu and Coyle, 2012; Byne et al., 2009; Goff and Coyle, 2001;
Lewis and Lieberman, 2000; Pakkenberg et al., 2009; Sodhi et al., 2011;
Watis et al., 2008).
We consider that our indications of lower connection strengths
with the nonlinear modulation of the thalamocortical connection
during the HSCT suggest that altered glutamatergic transmission of
the MD thalamus could underlie the reduced gating of the task. We
acknowledge the lack of a measure of glutamate concentration in
the MD thalamus in this study. However, the translation of the
neurobiophysical dynamic system of the connection strength with
the gating of a neuronal region is valid because of the computational
framework of DCM, specifically nonlinear DCM (Friston et al., 2003;
Stephan et al., 2008), which employs second-order nonlinear compu-
tations. Studies applying these second-order nonlinear computations
have demonstrated that gating at the neuronal region modulates
glutamatergic neurotransmission (Berends et al., 2005; Sun and
Beierlein, 2011; Volman et al., 2010). Also, nonlinear DCM assesses
selective changes in each region, which can be used to indirectly esti-
mate excitatory glutamatergic subpopulations (Stephan et al., 2008).
Our findings of the reduced connection strength with the nonlinear
modulation of the thalamocortical projection offer a mechanistic in-
terpretation for cortical dysconnection in schizophrenia.
There is extensive evidence that alterations of glutamatergic neu-
rotransmission may contribute to disrupted synaptic plasticity in
schizophrenia (Balu and Coyle, 2012; Coyle, 2006). The N-methyl-D-
aspartate (NMDA) receptor hypofunction model for schizophrenia
proposes that altered glutamatergic modulation may underlie the
pathophysiology of the disorder (Coyle, 2006; Coyle et al., 2011;
Javitt, 2010). This suggests that glutamate neurotransmission, specifi-
cally NMDA receptor-mediated transmission, may be disrupted in
schizophrenia (Goff and Coyle, 2001; Goff et al., 1995; Javitt et al.,
1994; Moghaddam et al., 1997). Several studies have shown that the
modulation of the thalamocortical projection is primarily altered by ex-
citatory glutamatergic neurotransmission (Balu and Coyle, 2012; Gray
and Roth, 2007; McCormick and Bal, 1997; Romanides et al., 1999;
Watis et al., 2008),which could be attributed toNMDA receptor dysfunc-
tions (Kiss et al., 2011; Santana et al., 2009), but also to thalamic inhibi-
tory interneurons (Augustinaite and Heggelund, 2007; Crandall and Cox,
2012; Errington et al., 2010; Lewis and González-Burgos, 2008; Neher
and Sakaba, 2008; Pan and Zucker, 2009), interneurons in the DLPFC
(Wang, 2010); metabotropic Glutamate receptors (mGluR) (Jones,
1997; Newpher and Ehlers, 2008; Pinault, 2011; Sodhi et al., 2011)
and ionotropic receptors (Meador-Woodruff et al., 2003). Importantly,
it has been shown that gating at the synaptic level is mediated
by glutamatergic neurotransmission (Berends et al., 2005; Neher and
Sakaba, 2008; Pan and Zucker, 2009; Sun and Beierlein, 2011; Volman
et al., 2010), which is modulated by excitatory (mainly glutamatergic)
and inhibitory (inhibitory interneurons) inputs (Murphy and Miller,
2003; Salinas and Sejnowski, 2001; Salinas and Sejnowski, 2000;
Wang, 2010). These knownprocesses of glutamatergic neuromodulation
have also been reported for the corticothalamic connection viaNMDA re-
ceptors and mGluR (McCormick, 1992). Despite the evidence for
glutamatergic neurotransmission, it is assumed that altered interactions
between glutamatergic and dopaminergic neurotransmission may lead
to the cortical dysconnectivity (Alelú-Paz and Giménez-Amaya, 2008;
Coyle, 2006; Javitt, 2010; Moghaddam et al., 1997).
DCM is a translational brain modelling framework with physiolog-
ically interpretable dynamic system models, which are combined
with dynamic causal models fitted to the fMRI data to provide esti-
mates of pathophysiological mechanisms of a neuronal group. The
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main advantage of DCM is the inference of causal mechanisms (for
example gating) at the neuronal level that provides a more precise es-
timation of how the rate of change of activity in one region influences
the rate of change in other regions (Friston, 2009; Friston et al., 2003;
Stephan et al., 2008). The main advantage of nonlinear DCM over bi-
linear DCM is anchored in the differentiation between nonlinearities
in the BOLD signal at the level of neuronal or haemodynamic mecha-
nisms (Friston et al., 2003; Stephan et al., 2007, 2008) by combining
neuronal state equations with a haemodynamic feedforward net-
work. Specifically, in nonlinear DCM (Stephan et al., 2008) inhibitions
of a neuronal group or neuronal connection can be modelled. In addi-
tion, nonlinear DCM assesses selective changes in each region, which
can be used to model effects exerted by neurotransmitters like gluta-
mate. In other words, the modelling of activity-dependent gating of
connections allows indirect estimations of excitatory glutamatergic
subpopulations.
There are general limitations of bilinear and nonlinear DCM and
specific limitations of this study. The temporal resolution of fMRI is
limited, which leads to an inability to consider conduction delays in
inputs and interregional interactions (Friston et al., 2003). DCM re-
quires strict subject and ROI inclusion criteria (Stephan et al., 2007),
which results in exclusion of more subjects compared to the usual
fMRI analyses, leading to a smaller sample size for this study than
for our previous analyses (Whalley et al., 2004, 2005). Also DCM8
does not allow a direct assessment of alterations of excitatory
glutamatergic subpopulations in the models (Marreiros et al., 2008)
or an explicit neuronal population (Daunizeau et al., 2009). Thus,
we cannot definitely state that glutamatergic neurotransmission is
implicated in the lower connection strength with the gating in the
high risk subjects. The nonlinear dynamical systems were estimated
by deterministic inference methods, and these do not fully represent
the random or stochastic noise of neuronal activity (Saarinen et al.,
2008) and hidden neuronal and physiological processes (Li et al.,
2011). Our DCM analyses of subjects who subsequently develop
schizophrenia were limited to four individuals. Because of the small
size in this group in the DCM analysis it is not possible to consider
the DCM results to have predictive validity although the four individ-
uals can be treated as single-subject results (Stephan et al., 2007). For
predictive studies using DCM results, the DCM-based generative em-
bedding approach using support vector machines (Brodersen et al.,
2011) is an additional approach. Finally, the DCM analyses in this
study were run in DCM8 limiting us to deterministic and one-state
DCM.
Conclusion
This is the first study to report on the clinical application of
nonlinear DCM to fMRI data. Our results show that gating mechanism
at the neuronal population level of the MD thalamus is altered and
may contribute to or be an underlying cause for the development of
psychotic symptoms. This study suggests that nonlinear DCM may
further our understanding of altered connectivity in subjects at high
familial risk stage of schizophrenia.
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